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Short Summary 
 
Skin penetration of nanoparticles was the focus of several recent studies. This is of 
major importance in basic research for potential future applications, e.g. designing 
topical and transdermal delivery systems, as well as for health risk analysis. Yet, 
there is a controversy among researchers on the status of their skin penetration due 
to different experimental setups. Meanwhile, there is little known about the 
mechanism and determinants of nanoparticle penetration. 
The main thesis objective was hence to study the penetration of model gold 
nanoparticles of different physicochemical and formulation parameters through 
human skin of different degrees of barrier integrity. Multiphoton microscopy was 
used for nanoparticle detection. Imaging parameters were determined in terms of 
resolution and depth profiling of gold nanoparticles in skin. A semiquantitative 
approach based on pixel analysis of gold nanoparticles was developed to compare 
nanoparticle localization in different skin locations under different conditions. Based 
on penetration experiments, determinants that favor or limit particle penetration were 
determined as well as the barrier to penetration (intercellular lipids). Finally 
nanoparticle penetration was successfully enhanced using a chemical enhancement 
approach. 
Results obtained are important to enhance our understanding of nanoparticle 
interaction with the skin barrier. Future studies are required to reduce the gap 
between research and applications. 
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Kurzzusammenfassung 
 
Die Penetration von Nanopartikeln ist Gegenstand der aktuellen Forschung. Diese 
Frage ist von großer Bedeutung für die Anwendung im Bereich der Nanomedizin als 
auch für die Abschätzung des Risikopotenzials bei Kontakt mit solchen Systemen. 
Bis dato sind allerdings keine eindeutigen Aussagen möglich.  
Das Ziel dieser Arbeit war daher die Untersuchung des Penetrationsverhaltens 
anhand von kolloidalem Gold (AuNP). Dieses Modellsystem erlaubt die 
Untersuchung der Penetration in Abhängigkeit von verschiedenen 
physikochemischen Eigenschaften der Partikel (oberflächenmodifiziert), als auch von 
Formulierungseigenschaften (Vehikel). Die AuNP erlauben eine Visualisierung 
mittels Multiphotonen Mikroskopie. Daher wurden die Auflösung und die optischen 
Parameter für AuNP in Haut bestimmt. Des Weitern wurde ein Pixel-basiertes 
Verfahren ermittelt, dass eine semiquantitative Analyse der penetrierten Objekten 
ermöglicht. Dies erlaubt eine Abschätzung der Partikelpenetration.   
Penetrationsexperimente erlaubten die Parameter, die die Penetration beeinflussen, 
hinsichtlich Größe und Oberflächenpolarität einzuschränken. Außerdem konnte 
gezeigt werden, dass auch die Penetration von Nanopartikeln mit Hilfe von 
Penetrationsverbesserern gesteigert werden kann. 
Die Ergebnisse dieser Arbeit sind wichtige Bausteine für das Verständnis der 
Interaktion von Nanopartikeln mit der Hautbarriere. Zukünftige Studien sind dennoch 
nötig, um die Lücke zwischen Forschung und möglicher Anwendung zu schließen. 
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1. Background and Literature Survey 
 
 
 
 
 
 
 
 
 
The chapter is part of a review article in due publication: 
Hagar I. Labouta and Marc Schneider, ―Interaction of inorganic nanoparticles with 
the skin barrier: current status and critical review‖. 
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1.1. Introduction 
Nanomaterials of approximately 1 – 100 nm size range show new functions and 
applications rather than bulk materials primarily because of their high surface to 
volume ratio. Additionally, unusual physical, chemical, and biological properties can 
emerge in materials at this nanoscale dimension. These properties may significantly 
differ from that of bulk materials and single atoms or molecules [1]. However, there is 
no guarantee that unique properties appear below such boundary, 100 nm [2]. In 
most cases, these unusual new properties are attributed to inorganic nanomaterials. 
Gold in the bulk state, for instance, is an excellent conductor of heat and electricity, 
but no heat transfer reaction occurs on directing light onto it. Gold nanoparticles 
(AuNP) can however absorb light and transfer it into heat acting like miniature 
thermal scalpels that can kill unwanted cells in the body, such as cancer cells [3]. 
Titanium dioxide and zinc oxide, used as sunscreen agents, have the disadvantage 
of being visible masking the skin with a white color. Titanium dioxide and zinc oxide 
nanoparticles are transparent and are thus preferred to microparticle counterparts in 
sunscreen products [4]. On the other hand, polymeric nanosystems usually acquire 
properties that are essentially an interpolation of that of the same material at the 
larger scale. It is also relatively easy to prepare inorganic nanoparticles in such size 
range rather than polymeric nanoparticles. Last but not least, inorganic nanoparticles 
have been recently the subject of several applications in nanomedicine and drug 
delivery. Fine-tuning the surface properties of inorganic nanoparticles by surface 
functionalization has further extended their applications [5]. Selected applications of 
some inorganic nanoparticles are highlighted in the next section and relevant review 
articles are cited for further more detailed readings. 
 
1.1.1. Inorganic nanoparticles and their pharmaceutical and biomedical 
applications 
Quantum dots (QD). QD are nanocrystals comprised of a semiconductor material, 
e.g. CdS. QD have attracted widespread interest in biology and medicine due to their 
unique electronic and optical properties over organic dyes and fluorescent proteins, 
e.g. size- and composition-tunable emission wavelength, improved signal to noise 
ratio, higher photostability, etc. Therefore, QD have rapidly emerged as a new class 
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of fluorescent probes for biomolecular and cellular imaging [6-7]. Surface 
functionalization of QD and bioconjugation to biomolecules via a covalent linkage 
was then adopted to enhance the dispersibility of QD, reduce toxicity and for better 
in vivo and cellular targeting. This has further allowed for the use of QD in medical 
diagnostics especially in cancer diagnosis [6-9]. Further development of QD might 
enable their application in tracking drug delivery, and monitoring the efficacy of 
therapeutics non-invasively in real time [7]. 
 
Silica nanoparticles. Another fascinating bioprobes are nanosized silica particles, 
which were also reported to be an ideal protein host because of their high chemical, 
physical and mechanical stability, large surface area, good dispersibility in aqueous 
solution and relative inertness. Silica nanoparticles have a high surface silanol 
concentration which facilitates a wide variety of surface reactions and the binding of 
biomolecules [10]. Therefore they attracted wide spread interest in applications in 
bioanalysis, and diagnosis especially in the diagnosis of cancer cells. Silica 
nanoparticles were also considered good candidates for drug and gene  
delivery [10-11]. 
 
Silver nanoparticles. Silver compounds are well-known for centuries as 
antimicrobial agents and are widely exploited in the treatment of bacterial infections 
encountered in burns, open wounds, and chronic ulcers [12]. Recently, however, 
silver nanoparticles showed higher antimicrobial efficiency compared to silver salts 
due to their extremely large surface area with diameters generally smaller than 100 
nm containing 20-15000 silver atoms, providing better contact with microorganisms. 
Thus, on cellular or tissue exposure to silver nanoparticles, the active surface of 
silver nanoparticles would be large compared to silver compounds, and thereby 
exhibiting remarkably unusual physicochemical properties and biological activities 
[13-16]. They interact with bacteria and produce electronic effects, which enhance 
the reactivity of nanoparticles [16]. Thus, the bactericidal effect of silver 
nanoparticles was proved to be size [14] and shape [17] dependent due to different 
interactions with the microorganism. Several dressings for wound healing 
incorporating silver nanoparticles as a topical antibacterial agent have already found 
Background and Literature Survey 
-12- 
 
their way to the market, e.g. ActicoatTM (Westaim Biomedical Inc., Fort 
Saskatchewan, Alberta, Canada) and Silverlon® (Argentum Medical, L.L.C., 
Lakemont, Georgia). They have the advantage of providing a more controlled and 
prolonged release of nanocrystalline silver to the wound area. This mode of silver 
delivery allows the dressings to be changed less frequent, thereby reducing the risk 
of nosocomial infection, cost of care, further tissue damage and definitely improves 
patient compliance [12]. 
 
Gold nanoparticles (AuNP). Applications of AuNP in biology and life sciences is a 
fast growing field. These bio-applications can be classified into four areas: labeling, 
delivery, hyperthermia, and sensing [18]. Similar to silver nanoparticles, AuNP have 
unique optical properties. They have the ability to resonantly scatter visible and near-
infrared light upon the excitation of their surface plasmon oscillation. The scattering 
light intensity is sensitive to the size and shape of particles [19]. Therefore they were 
useful as biosensors and diagnostic agents, especially in cancer diagnosis [20-21]. 
AuNP hold promise as the future ―magic bullet‖ for cancer treatment. Based on their 
physical properties, AuNP cause local heating when they are irradiated with light in 
the range of 800–1200 nm. El-Sayed group [22] has showed the potential use of 
AuNP in photothermal destruction of tumors. Recently, AuNP have emerged as a 
delivery system for various payloads [23-24] either drug molecules [25-27] or large 
biomolecules such as proteins [28], DNA [29-30] and RNA [31].  
 
Magnetic nanoparticles. Nanoparticles with a magnetic core allow for the magnetic 
manipulation of the particles in presence of an external magnetic field. In this size 
range, below 100 nm, there is a fundamental change in the magnetic structure of 
ferro- and ferrimagnetic materials. Their superparamagnetic moment with high 
magnetic saturation value has resulted in exploring the use of magnetic 
nanoparticles as targeting agents in a number of applications including drug and 
gene delivery, in addition to tumor diagnostics and therapeutics. Another important 
therapeutic application is hyperthermia, which involves heating organs or tissues 
resulting in tumor cell necrosis [32-36]. Functionalization of magnetic nanoparticles 
has further extended their in vivo applications based on higher biocompatibility and 
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reduced toxicity, in addition to adopting additional targeting approach on coating the 
surface with biofunctional molecules and thus enhancing the targeting efficiency of 
the final developed system [35-36]. 
 
Titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles. TiO2 and ZnO 
nanoparticles are currently used in many sunscreen formulations as UV filters to 
protect against UV-induced skin damage. TiO2 and ZnO have the advantage over 
other chemical agents not to undergo any chemical decomposition on exposure to 
UV radiation. Moreover, they offer a wider range of protection against UVA and UVB 
types of radiation, compared to other organic compounds. Nowadays in the 
cosmetics industry, TiO2 and ZnO are included as nanosized particles because in 
this form they are transparent and more esthetically acceptable to consumers [4, 37]. 
This is in addition to the size-dependent antibacterial activity of ZnO  
nanoparticles [38]. 
 
1.1.2. Significance and scope of the chapter 
 
One could so far reach a conclusion that inorganic nanoparticles have found several 
applications, especially in cancer diagnosis and therapy and more recently in drug 
and gene delivery. This potential for applications has triggered the investigation of 
the nanoparticle interaction with the various biological barriers. An excellent 
biological barrier, the skin, has been addressed in several recent studies regarding 
nanoparticle penetration. 
Skin is a unique barrier composed of several highly organized and heterogeneous 
layers that also includes a number of appendages such as hair follicles, sweat and 
sebaceous glands. Skin is composed of three layers from outwards moving deeper 
inside the skin: epidermis, dermis, and hypodermis. However, from a penetration 
perspective only epidermis and dermis are important. The outermost layer of the 
epidermis is the stratum corneum (SC), to which the main barrier function of the skin 
is attributed [39-40]. Nevertheless, topical and transdermal drug delivery systems 
has always been a main target of many researchers avoiding the numerous 
problems encountered with the oral route. Though the mechanism is still unclear, 
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nanoparticles were shown to enhance the skin penetration of several active  
agents [41-42]. 
 
Hence, studying the skin penetration of nanoparticles is crucial for the following 
reasons: 
 Design of potential topical and transdermal nanocarriers and biomedical 
diagnostic agents.  
Understanding the behavior of nanoparticles when coming in contact with the 
skin surface and their interaction with the different skin layers would ultimately 
lead to the design of the ―ideal‖ carrier or diagnostic agent in terms of the 
physicochemical parameters of the nanoparticles, e.g. size, shape, surface 
chemistry, in addition to other factors, e.g. formulation and environmental 
factors, influencing skin penetration of nanoparticles. 
 Health risk analysis.  
The public could come in contact with nanomaterials intentionally on applying 
topical cosmetic preparations containing nanoparticles, or non-intentionally 
through the handling of several products used in our daily life and contain 
nanoparticles such as sport clothes, surface cleaning agents, computer 
devices, paints, etc. [16, 37]. Environmental exposure comprises water or 
even air contaminated with nanoparticles. This is in addition to the people 
handling nanoparticles in research and industry. In hospitals, physicians and 
patients may also come in contact with nanoparticles e.g. silver impregnated 
medical devices such as surgical masks and implantable devices [16]. The 
exposure occasions to nanoparticles are thus increasing constantly. 
In this chapter, recent research on the interaction of inorganic nanoparticles with the 
skin barrier are discussed and analyzed in an attempt to answer still open questions; 
(1) How do inorganic nanoparticles, in the size range less than 100 nm, as well as 
sub-micron particles interact with the skin barrier? (2) Do they have the ability to 
penetrate the SC into the viable deeper skin layers (DSL)? And if so, (3) what is the 
possible mechanism of skin penetration? Finally, (4) what are the factors contributing 
to their penetration? 
Background and Literature Survey 
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But first, it is important to define two important terms used in this chapter, ―skin 
penetration‖ and ―skin permeation‖. The first indicates transport of an agent, here 
nanoparticles, across the SC into DSL. The latter however stands for transport 
across the whole skin into the receptor solution, (in vitro) or to the systemic 
circulation (in vivo) [43]. 
 
1.2. Current dilemma in the status of skin penetration of inorganic 
nanoparticles 
Investigating the ability and the possible mechanism of particle penetration through 
skin is a recent area of research receiving great interest of researchers due to the 
aforementioned reasons. Starting from the year 2004 till now the number of studies 
focusing on skin penetration of inorganic particles is generally increasing. To the 
best of our knowledge, the total number of research papers in this field is 40 
(excluding replicate studies common in skin penetration/permeation experiments and 
including the papers presented in this thesis), in which 125 different 
penetration/permeation experiments (different in particle type and size, skin type, 
skin treatment, etc.) were conducted. Yet, the ability of inorganic nanoparticles to 
overcome the barrier function of the SC into DSL is a point of debate among 
researchers. Different outcomes were reported for particle penetration as shown in 
Table 1.1. About 49% of all these experiments were reported to result in particle 
penetration with or without adopting a mechanical or a chemical enhancement 
approach or a combination thereof. Some of these studies, four studies, showed 
even particle permeation of the whole skin thickness either in vitro [44-45]  or  
in vivo [44, 46-47]. The other 51% of these experiments however resulted in neither 
passive particle penetration nor particle penetration on physical or chemical skin 
treatment (discussed in section  1.4). Further analysis of the reported outcomes over 
the years 2008-2010, witnessing most of the conducted particle skin experiments, 
one could observe an increase in the frequency of research articles reporting particle 
penetration, increasing from ~ 38% in 2008 to ~ 67% in 2010, relative to the total 
number of research papers reported at that year. This could be due to implementing 
more and more approaches for enhancing skin penetration in addition to the 
improvements of the analytical techniques for detection of nanoparticles inside the 
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skin (discussed in section  1.7). Unfortunately, the feasibility to publish studies 
showing particle penetration, being more attractive to the research community could 
be also a contributing factor. Nevertheless, to further add to this dilemma, the size 
range of inorganic particles, regarded as the primary determinant of skin penetration, 
is overlapping for particles reported to penetrate the SC (4 nm to 1.5 µm) and 
particles that could not (4 nm to few microns). 
Overall, the reported experimental set-ups regarding skin type, environmental and 
mechanical conditions, revealed a high diversity. This might be the basis of the 
current controversy among researchers on whether nanoparticles do or do not 
penetrate the SC into DSL, as highlighted in the following points: 
 Animal versus human skin. Though excised human skin is regarded as the 
―gold standard‖ for in vitro skin penetration studies especially in human dermal 
risk assessment [48], it was only used in 51 % of the used experimental set-
ups in particle penetration studies (35 % in vitro and 16 % in vivo). However, 
47 % of these experiments were conducted on animal skin (pig, mouse and 
rat skin) in vitro (31 %) or in vivo (16 %) (Figure 1.1). This is apparently due to 
the limited availability of human skin driving most of the research laboratories 
to depend on animal skin. However, structural and morphological differences 
between human and animal skin especially in terms of the density of the hair 
follicles, SC and total skin thickness, the amount of skin lipids, in addition to 
variations among animal species could certainly result in different penetration 
behaviors [48-49]. Furthermore, only one study was conducted on an in vitro 
reconstructed human skin model using 7 nm QD [50]. However, no 
penetration was reported though these models are generally known to 
overestimate drug flux across human skin due to the lower barrier properties 
relative to human skin [48, 51].  
All this makes it quite difficult to compare the data generated by different 
laboratories and reach a conclusion regarding the current status of skin 
penetration of inorganic nanoparticles.  
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Figure 1.1: In vitro and in vivo skin penetration/permeation experiments in the literature classified 
according to the skin type: human, reconstructed human and animal (pig, mouse and rat) skin. 
Percentage frequency of using each of these skin models in examining nanoparticles penetration, 
either in vitro or in vivo, is indicated in the figure. 
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Table 1.1: Overview on the skin penetration studies of various inorganic particles applied to different 
skin types under different experimental conditions (including our research papers presented in this 
thesis). 
Particle Diameter, nm 
Skin type 
(in vitro/in vivo) 
Additional 
enhancement approach 
Reported outcome Ref 
QD-COOH 4 Human (in vitro) 
- 
Massage 
Tape-stripping 
Tape-stripping+Massage 
No penetration 
No penetration 
No penetration 
Penetration 
[52] 
Fe2O3-TMAOH 4.9±1.3 ‖ - Penetration [53] 
AuNP 10 ‖ 
- 
 
Dermaportation by 
pulsed electromagnetic 
field 
No Penetration 
 
Penetration 
 
 
[54] 
AuNP-thiol
*
 
AuNP-lecithin 
AuNP-cetrimide
*
 
 
AuNP-citrate 
 
~6 
~6 
~15 
 
~15 
 
‖ 
- 
- 
- 
 
- 
CHCl3/methanol 
Tape-stripping 
Penetration 
Penetration 
Penetration 
 
No Penetration 
Penetration 
Penetration 
[55-
56] 
 
TiO2 10–50 Human (in vivo) - Penetration
† 
[57] 
AuNP ~12.9 Human (in vitro) 
- 
Dermabrasion 
Penetration 
Penetration 
[58] 
AuNP ~15 ‖ 
- 
Urea 
Tween 80 
SLS 
DMSO 
No penetration 
No penetration 
Negligible penetration 
No penetration 
Penetration 
[59] 
ZnO 15–40 ‖ - No penetration [60] 
TiO2 20 Human (in vivo, in vitro) 
- 
- 
No penetration 
No penetration 
[61] 
TiO2 
TiO2 in 
sunscreens with 
and without ZnO 
20 
 
 
 
Human (in vitro) 
- 
 
No penetration [62] 
ZnO 20–30 Human (in vitro, in vivo) - No penetration [63] 
TiO2 
ZnO 
20–70 
< 200 
Human (in vitro) 
- 
- 
No penetration 
No penetration 
[64] 
 
AgNP 25±7.1 ‖ 
- 
Abrasion 
Low penetration 
(both),   but higher 
for damaged skin 
[65-
66] 
ZnO 30 ‖ - No penetration [67] 
TiO2(Hydrophobic) 
TiO2 (Amphiphilic) 
TiO2 (Hydrophilic) 
20–100 nm aggregates Human (in vivo) 
- 
- 
- 
No penetration 
No penetration 
No penetration 
[68-
69] 
TiO2 platelets 
ZnO platelets 
not stated (nm range) 
116.8 length, 57.5 width 
Human (in vitro) 
- 
- 
No penetration 
No penetration 
[70] 
AuNP not stated (nm range) ‖ Electrophoresis No penetration [71] 
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Particle Diameter, nm 
Skin type 
(in vitro/in vivo) 
Additional 
enhancement approach 
Reported outcome Ref 
TiO2 not stated (nm range) 
Human(in vivo, healthy) 
Human(in vivo, psoriatic) 
- 
- 
No penetration 
No penetration 
[72] 
QD-PEG, QD-PEG-
amine & QD-COOH 
12.65–29.35 nm 
(at different pH values) 
Human (in vitro) 
- 
 
 
Tape-stripping 
Penetration of only  
QD-PEG at pH8.3 
 
Penetration 
[73] 
QD-PEG-amine 7±2 Reconstructed human skin - No penetration [50] 
AuNP 4.6±1.5 
Porcine-full thickness(in vitro) 
Porcine-dermatomed(in vitro) 
Ultrasound & SLS 
Ultrasound & SLS 
Penetration 
Penetration 
[74] 
QD-PEG, QD-PEG-
amine & QD-COOH 
15–45 
(spherical & ellipsoid) 
Porcine (in vitro) - Penetration [75] 
Polymer coated QD 20 ‖ 
Ultrasound with or 
without SLS 
Penetration (further 
increased with 
SLS) 
[76] 
AgNP-uncoated 
AgNP -carbon coated 
20, 50 & 80 
25 & 35 
Porcine (In vivo) - No penetration [77] 
TiO2 with different 
coatings 
35uncoat.,35coat., 
10x100,250
‡ Porcine (in vitro) 
- 
Tape-stripping 
Hair removal 
No penetration 
No Penetration 
Penetration for 
35coat. 
[78] 
PEG-coated QD 
Nail shaped: 
5.78 width & 8.4 length 
39±1 hydrodynamic 
diameter 
Porcine-dermatomed 
(in vitro) 
- No penetration [79] 
TiO2 
(four formulations) 
45-150 length, 17-35 
width 
(lanceolate shape) 
Porcine (in vitro) - Penetration [80] 
ZnO 
TiO2 Agglomerates 
80 
up to 200 
‖ - 
No penetration 
 
[81] 
Au particles 900±600 ‖ Ballistic delivery Penetration [82] 
TiO2 (uncoated sub-
micron sized, 
uncoated nano- or 
Al(OH)3, 
dimethicone/methico
ne copolymer-
coated nano-sized 
207±53
§
, 
30±8
§
 & 
Fibrils of 57±18 
length & 15±5 
width
§
 
 
Porcine (in vivo) - No penetration [83] 
QD-COOH 4.1 Mouse (in vitro & in vivo) 
- 
 
Permeation [44] 
Fe2O3 4.6–10 Mouse (in vitro) 
Blade incision, 1 µm 
width 
Penetration [84] 
ZnO 10 ‖ 
- 
OA, EtOH & OA-EtOH 
No penetration 
Penetration 
[85] 
AuNP 11.6 Mouse (in vivo) - Penetration [86] 
QD-COOH 
~20 & ~33 [87]/ 
~12-20 [88] 
‖ 
- 
UV exposure 
Low penetration for 
both but higher on 
UV exposure 
[87-
88] 
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Particle Diameter, nm 
Skin type 
(in vitro/in vivo) 
Additional 
enhancement approach 
Reported outcome Ref 
QD-PEG 37 ‖ 
- 
Acetone pretreated 
Tape-stripped 
Dermabraded 
No penetration 
No penetration 
No penetration 
Permeation 
[47] 
Diphtheria toxoid-QD-
COOH conjugate 
Size not stated  
(nm range) 
(nail-shaped) 
‖ Hyperthermea Penetration
¶
 [89] 
QD-COOH 6±2 
Rat (in vitro) 
 
- 
Flexion 
Tape-stripping 
Abrasion 
No penetration 
No penetration 
No penetration 
Penetration 
[90] 
AuNP 15, 102, 198 ‖ - Permeation [45] 
TiO2 
4,10,21,25,60,90 
4,60 
10,21,25,60 
Porcine (in vitro-1 day) 
Porcine (in vivo-30days) 
Mouse (in vivo-60 days)
# 
- 
- 
- 
No penetration 
Penetration 
Permeation 
[46] 
TiO2 Width: 20, length 100 
Human (in vitro) 
Porcine (in vitro) 
- 
 
No penetration [91] 
TiO2 20–100 
Porcine (in vitro) 
human skin grafted on 
SCID mouse (in vivo) 
- 
- 
 
No penetration 
No penetration 
 
[92] 
TiO2 
Size not stated 
(commercial formulation) 
Human foreskin grafted on 
SCID mouse (in vivo) 
- No penetration [93] 
 
* 
Dispersed in toluene.
 † 
Non-statistically significant higher Ti levels in the deeper layers versus 
background levels of Ti normally present in the skin (non-exposed control). 
‡ 
These reported sizes (35 
nm (uncoated and coated particles), 10x100 and 250 nm) are the primary sizes, however aggregation 
was reported for these nanodispersions. 
§
 These sizes are not the primary size diameters but are 
those determined by TEM of the particles in skin after application. 
¶ 
No proof for penetration was 
provided by the authors (only fluorescent images without depth information). 
# 
Different pathological 
lesions were observed in several organs especially the skin and liver. AgNP: silver nanoparticles, 
AuNP: gold nanoparticles, DMSO: dimethyl sulphoxide, DOTAP: 1,2-dioleoyl-3-trimethylammonium 
propane chloride (cationic surfactant), EtOH: ethanol, Fe2O3: iron oxide nanoparticles, OA: oleic acid, 
QD: quantum dots, SCID: severe combined immune deficient, SLS: sodium lauryl sulphate, TGA: 
thioglycolic acid, TiO2: titanium dioxide nanoparticles, TMAOH: tetramethylammonium hydroxide, VE: 
viable epidermis and ZnO: zinc oxide nanoparticles. 
―Skin penetration‖ indicates transport of nanoparticles, across the SC (stratum corneum) into the DSL 
(deeper skin layers). ―skin permeation‖ stands for transport across the whole skin thickness into the 
receptor solution, in vitro or to the systemic circulation, for in vivo experiments. 
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 Among the different animal species, there are hairy animals used for 
conducting particle penetration experiments. Therefore, hair removal is often 
indicated to be able to apply a formulation. Removal of hair by means of a 
clipper, cosmetic grade hair removal cream or even by shaving before the 
penetration experiment possibly has an effect on the barrier function of the 
used skin. Consequently, particle penetration might also be affected. For 
instance, 11.6 nm AuNP could penetrate into mouse skin in vivo after hair was 
clipped [86]. On the other hand, no penetration was reported for QD having 
nearly the same size, ~ 12 nm, through hairless mouse skin in vivo [88]. 
Recently, Senzui et al. [78] have shown the effect of hair removal on 
penetration of TiO2 nanoparticles through pig skin. Particles were shown not 
to penetrate through intact or stripped skin, however penetration was 
observed on hair removal possibly by entering empty hair follicles. Therefore, 
hair removal should be taken into consideration especially when assessing 
the safety of nanoparticles. This also implies that the dermatomed skin of 
thickness 200-400 µm recommended by the OECD (Organization for 
Economic Co-operation and Development) according to the guideline 428 for 
in vitro testing of skin absorption [94] could possibly overestimate the skin 
penetration/permeation of nanoparticles. Overestimation is especially the 
case for particles likely to accumulate in the hair follicles, because the hair 
follicle is cut on splitting the dermis and the nanoparticles can then diffuse into 
the dermis/receptor solution [78]. 
 Skin exposure time to particles also differed greatly among previous studies. 
Penetration of particles were tracked over a period of as short as a few hours, 
e.g. 1 hour [71], 3 hours [86] up to several days (60 days) [46]. However, 
unlike monitoring penetration of drug molecules especially lipophilic 
molecules, it is usually not practically feasible to generate appropriate 
pharmacokinetic parameters for particles, including the flux for normalizing the 
effect of exposure time, due to absence or a scarce concentration of particles 
penetrating into the skin. This further limits the ability to analyze data based 
on different studies raising an analytical problem in determination of the 
amount of nanoparticles present in the skin in typical penetration-permeation 
experiments. This will be discussed in detail later in section  1.7. 
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 The application dose and volume and the diffusion area are important 
factors that would significantly affect the results of any penetration 
experiment.  
 Different skin treatment approaches, physical or chemical, were adopted for 
inducing or enhancing skin penetration of nanoparticles. This would rather 
limit the ability of a study-with-study comparison which will be discussed in 
detail in Section  1.4. This is in addition to other factors such as formulation 
factors, e.g. surface coatings, vehicle, etc. which differ greatly from one study 
to another. These factors were shown as important determinants of particle 
penetration as detailed in the next section. 
 
1.3. Factors affecting skin penetration 
In addition to the aforementioned experimental variations among different studies, 
there are several factors which were systematically studied and found to contribute 
significantly in the skin penetration of nanoparticles. Critical determinants of skin 
penetration of nanoparticles could be categorized into physicochemical attributes of 
the nanoparticles (size, surface charge and surface chemistry), formulation factors 
(vehicle) and experimental factors (concentration and skin exposure time to 
nanoparticles). 
1.3.1. Physicochemical attributes of the nanoparticles and formulation factors 
The physicochemical attributes of nanoparticles and the nature of the dispersing 
vehicle are key factors governing their skin penetration. Sonavane et al. [45] showed 
size-dependent skin permeation of AuNP through rat skin. Higher permeation for 
15 nm AuNP compared to 102 nm and 198 nm AuNP was described through rat skin 
and the permeability coefficient was reported to decrease on increasing the particle 
size.  
The effect of particle surface charge and shape on penetration through skin was the 
focus of a study by Ryman-Rasmussen et al. [75]. They studied the effect of different 
surface charge imparting coatings (cationic, anionic and neutral) on the skin 
penetration of two types of QD of different size and shape, spherical QD of 4.6 nm 
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core/shell diameter and ellipsoid QD 12 nm (major axis) by 6 nm (minor axis) 
core/shell diameter. Following skin exposure, confocal examination of longitudinal 
skin sections showed penetration of the spherical nanoparticles into the viable 
epidermis and dermis after only 8 h regardless of the surface charge. Similar 
behavior was reported for cationic and neutral ellipsoid nanoparticles. However, 24 h 
of contact of the anionic ellipsoid QD with the skin surface was required for their 
penetration into DSL. Based on these findings, the authors concluded a shape 
dependency for particle penetration, especially due to the fact that the two anionic 
spherical and ellipsoid QD had a more or less similar hydrodynamic diameter, 14 
and 18 nm, respectively. Faster skin penetration for cationic and non-ionic ellipsoid 
QD relative to anionic ellipsoid QD could be attributed to the negative surface charge 
of the pig skin used in the latter study; isoelectric point of pig skin is ~ 4.4 [95].  
1.3.2. Experimental factors 
Concentration of the applied nanodispersion and skin exposure time could greatly 
influence the skin penetration of nanoparticles. For instance, Baroli et al. [53] studied 
the penetration of magnetic nanoparticles through human skin after 3, 6, 12 and 24 
h, where particle penetration was reported starting from 6 h skin exposure time.  
Though more studies are still required at the basic level to advance our 
understanding and to gain a deeper insight into the mechanism and determinants of 
skin penetration of nanoparticles, several approaches have been adopted by 
researchers in an attempt to enhance skin penetration of inorganic nanoparticles via 
breaching the barrier function of the skin. These approaches, however, did not 
always assure an increase or even occurrence of skin penetration of particles. 
 
1.4. Approaches adopted to enhance skin penetration of inorganic 
nanoparticles 
There is no study systemically investigating the possibilities of enhancement of 
particle penetration. Some approaches were however adopted to enhance skin 
penetration of inorganic nanoparticles. Most of these approaches were physical 
methods. Yet, the use of chemical enhancers was also explored. 
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1.4.1. Physical/mechanical enhancement 
UV-exposure. UV radiation is known to have a deleterious effect on the skin barrier 
function by causing  biophysical and morphological changes of the SC lipids [96]. As 
mentioned earlier, inorganic nanoparticles, titanium dioxide and zinc oxide 
nanoparticles,  are currently used in sunscreen formulations [4]. Therefore studying 
particle penetration into the skin was of outmost importance for these applied 
particles [87-88]. 
Increased penetration of QD, by the effect of UV radiation, as a model particle, by 
the effect of UV radiation, was observed through damaged skin, by the effect of UV 
radiation compared to intact mouse skin [87-88]. Though in both cases, low levels of 
penetration were qualitatively detected. However, according to the authors, 
penetration was mostly detected in areas with defects in the SC or around hair 
follicles, referring to this as another possible mechanism for the transport of particles 
in addition to the SC intercellular weakening effect of UV radiation. These results 
should raise the public concern regarding the use of nanoparticle-based formulations 
intended for topical use. However, one should also consider the effect of the surface 
properties on skin penetration of the applied particles when extrapolating these 
results to commercial sunscreens containing titanium dioxide and zinc oxide 
nanoparticles.  
Hyperthermia. Upadhyay [89] explored the application of mild local hyperthermia for 
transdermal delivery of diphtheria toxoid (DT) vaccine. DT-conjugated to QD were 
applied to mice in vivo with concomitant application of pads for local hyperthermia. 
According to the author, this has led to skin transport of the QD-labeled vaccine. 
However, it should be noted here that the evidence the author provided for skin 
penetration was based on top-view fluorescence images of QD in skin specimens 
with no depth information. However, the unlabeled vaccine was found to induce an 
immune response when applied topically to mice as effective as intramuscular 
injection of the vaccine. Nevertheless, care should be taken construing the results of 
this study with respect to particle penetration. 
Iontophoresis. Iontophoresis provides a mechanism to enhance the penetration of 
hydrophilic and charged molecules across the skin by application of constant  
current [97]. Similarly, a transdermal delivery chip system was used to deliver 
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negatively charged citrate-stabilized AuNP across human skin [71]. At zero voltage, 
AuNP were localized on the surface of the SC. On application of 6 V, AuNP were 
shown to pass through the intercellular routes of the SC. Further transport to the 
DSL was not shown. The results obtained from this particular study however are 
quite questionable as the experimental set-up was not fully explained in terms of the 
particle size, surface charge, concentration and volume of the applied dispersion. 
Dermaportation. Dermaportation is a novel transdermal drug delivery technology 
that uses pulsed electromagnetic fields to enhance the transport across the skin. A 
preliminary experiment by Krishnan et al. [54] showed enhanced penetration of 10 
nm AuNP into epidermal human skin sheets. A potential mechanism proposed by the 
authors for enhanced transport is the formation of transient pores through which 
particles can diffuse more easily. 
Sonophoresis. Sonophoresis, defined as the application of ultrasound, particularly 
at low frequency (20-100 kHz) has been shown to greatly enhance the skin 
permeability of a variety of drugs [98]. Based on this, low frequency sonophoresis 
was also applied for enhancing the skin penetration of 20 nm QD [76]. Application of 
ultrasound on porcine skin increased the frequency of the formation of scattered and 
separated lacunar spaces in the SC which are assumed to eventually lead to higher 
connectivity of these voids and formation of porous networks within the SC. This has 
induced significant transport of QD through the lipid regions of the SC into the viable 
tissue. However, QD were also found in few occasions in the corneodesmosomes 
and even occasionally inside the corneocytes [76]. Simultaneous application of this 
technique and sodium lauryl sulphate induced similar but more pronounced effect on 
the SC ultrastucture and consequently higher QD penetration. The same combined 
approach was recently exploited by Seto et al. [74] to enhance the skin penetration 
of smaller particles, ~ 4.6 nm AuNP, through porcine skin. 
Tape-stripping and dermabrasion. In view of the fact that the skin barrier function 
resides primarily in the SC, its total or partial removal by tape-stripping or 
dermabrasion can disrupt the skin barrier enhancing transport across the skin. Tape-
stripping has been commonly used to enhance drug delivery across the skin, and to 
obtain information about the SC function. Moreover, tape-stripping has been 
proposed by the FDA as a part of the standard method to evaluate the 
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bioequivalence of topical dermatological dosage forms [99-100]. However, tape-
stripping of the SC prior to application of inorganic nanoparticles did not always lead 
to satisfactory results. For instance, ~ 4 nm [52], 6 nm [90] and ~ 37 nm [47] QD 
could not penetrate tape-stripped human (20 tape-strips), rat (10 tape-strips) and 
mouse (5-20 tape-strips) skin, respectively. Abrasion is another technique which 
involves the removal or disruption of the upper skin layers to facilitate the skin 
permeation of several drugs [101-103]. Dermabrasion is often used in clinical 
practice by dermatologists as a facial resurfacing technique in the treatment of acne, 
scars, hyperpigmentaion, and other skin blemishes [101]. Based on this, the effect of 
abrasion on skin penetration of rigid inorganic nanoparticles was examined. 
Dermabrasion of excised rat skin [90] and mouse (in vivo) [47] resulted in skin 
penetration and permeation of 6 nm and 37 nm QD, respectively, whereas no 
penetration was reported through intact skin in these studies. 
Skin flexion and massage. The impact of mechanical stress on the barrier function 
of the skin with regard to skin penetration of inorganic nanoparticles was further 
examined via flexion and massage. Skin flexion is a method that simulates flexing 
movements such as repetitive wrist bending. Zhang and Monteiro-Riviere [90] 
studied the effect of mechanical flexion on skin penetration of ~ 6 nm QD. However, 
no penetration was reported after flexing the skin on an automated apparatus for 60 
min. More clinically acceptable manual approach, massaging, for short time (5-10 
min) was later explored by Gratieri et al. [52] to drive QD to penetrate into the DSL of 
human skin. However, QD could be found in the DSL only after massaging of tape-
stripped skin for 10 min.  
Ballastic bombardment. Ballastic bombardment of particles, a needle free 
technique of targeting cells within defined layers of the viable epidermis, was used 
by Kendall et al. [82]. A hand-held supersonic device was used to impact porcine 
skin at high rate with sub-micron gold particles, 900 ± 600 nm, resulting expectedly 
in skin penetration. Environmental relative humidity and temperature were shown to 
affect particle penetration using this method. 
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1.4.2. Chemical enhancement 
Chemical permeation enhancers are defined as agents that promote drug diffusion 
through the SC and the epidermis. These agents have been extensively studied and 
used as enhancers in favoring transdermal drug permeation. They work mainly by 
temporarily reducing the barrier function of the SC allowing for more drug  
transport [104]. Few studies however focused on the use of these enhancers for skin 
delivery of inorganic nanoparticles. Kuo et al. [85] studied the effect of chemical 
enhancers, oleic acid and ethanol, on the penetration of ~ 10 nm zinc oxide 
nanoparticles through mouse skin. They showed enhanced transport values for 
nanoparticles in presence of oleic acid, ethanol and oleic acid-ethanol mixture. 
Gopee et al. [47] have also pretreated mouse skin with acetone, however no 
penetration of QD was observed.  
As a conclusion so far, many studies have focused on treating the skin physically or 
chemically for enhancing the skin penetration of inorganic nanoparticles based on 
the previous knowledge and understanding of transdermal drug delivery. However, 
some of these have shown contradictory results on using the same enhancing 
approach. In other cases, non-satisfactory results were obtained. This could be 
again attributed to the different experimental set-ups used in different studies. 
Nevertheless, the basic knowledge on the potential mechanism is still somehow 
missing or at least not yet clear. 
 
1.5. Mechanism of skin penetration 
The exact contribution of the relevant parameters for potential skin penetration of 
inorganic nanoparticles is still unknown. Studying the skin architecture could provide 
a possible explanation for the skin penetration of nanoparticles (Figure 1.2). The 
intercellular lipids in the SC arrange themselves in a head-to-head and a tail-to-tail 
manner. The lipophilic pores formed by tail-to-tail configuration of the lipids are 
estimated to be approximately ≤ 6.94 nm. The aqueous pores, hydrophilic regions 
delimited by lipid heads, have been estimated to have a diameter of 2.8 ± 1.3 nm 
[105]. However, it has been suggested that the skin may contain different types of 
aqueous pores, whose dimensions of superficial openings (0.4–36 nm) may not be 
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maintained in the internal channel [105]. Though the aqueous pores provide a 
possible route for penetration of hydrophilic penetrants, the penetration of water and 
polar molecules is reported to be poor [106]. Based on this, one could question 
whether the penetration of inorganic nanoparticles is dependent on these pores. 
Nevertheless, from an exclusively dimension point of view, agents of size < 5-7 nm 
or 36 nm can penetrate SC through lipidic intercellular route or aqueous pores, 
respectively. Even larger agents may enter the skin appendages, hair follicles and 
pilosebaceous pores (10 - 70 µm) or sweat gland pores (60 - 80 µm) but still have to 
penetrate the respective tissue [105]. 
 
In a study by Zhang et al. [79], TEM examination showed the localization of most 
PEG- coated QD in the intercellular lipids of the outermost SC layers, thereby 
concluding that nanoparticles penetrate the skin via the intercellular pathway. They 
suggested theoretically that since the outer PEG coating is a soft coating, it thereby 
allows the particles to squeeze through the intercellular spaces. In contrast, Lee et 
al. [84], showed that on application of iron oxide nanoparticles (4.6-10 nm) on skin 
after superficial skin incision, 1 µm width, particles were found to distribute in both 
the intercellular and intracellular spaces of the SC and viable epidermis near the 
area of incision, but only in the intracellular spaces of the viable epidermis at longer 
distances.  
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Figure 1.2: A sketch showing possibilities for nanoparticle penetration and localization in the 
skin barrier. Nanoparticles could penetrate the skin through intercellular pathways and 
localize in the stratum corneum or even permeate the whole stratum corneum into deeper 
skin layers. On the other hand, hair follicles could be a depot for particles that could further 
penetrate into the deeper skin layers. 
 
Finally, the follicular pathway is also a possible mechanism for skin penetration of 
inorganic nanoparticles, however the skin appendages occupy only a small fraction 
(about 1/1000) of the entire skin surface [107]. It has been hypothesized by 
Lademann et al. [108] that the hair and the hair follicle might act as a pumping 
system pushing the nanoparticles into the hair follicles when the hair is moving (in 
vivo). Hair movement could be simulated in vitro by massaging excised skin. Based 
on this, medium-sized nanoparticles (approximately 400-700 nm) could diffuse 
deeper into the porcine hair follicles rather than smaller or larger particles allowing 
for selective follicular targeting by size modification [108-109]. Lekki et al. [91] have 
studied the possible role of the follicular pathway on the percutaneous uptake of TiO2 
nanoparticles of 20 nm width and 100 nm length. Though particles were observed as 
deep as ~400 nm inside the hair follicle, no particles were observed in the 
surrounding viable tissue. Overall, nanoparticle penetration into the appendages is 
apparently not sufficient for increased skin penetration. 
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Away from the exact mechanism of skin penetration of inorganic nanoparticles, it is 
important to know whether nanoparticles potentially penetrate the skin only due to 
the ―nano‖ effect, i.e. passive penetration or under the influence of other factors.  
 
1.6. Penetration of inorganic nanoparticles through human skin: Dissecting 
the “nano” effect 
Whether particle penetration is studied for risk assessment or drug delivery 
purposes, the basic knowledge about the underlying mechanisms is an essential 
aspect. For nanoparticles, the size is the most prominent parameter. Hence the 
contribution and importance of the particle size was always in focus facing several 
difficulties. 
Following in vivo studies on human volunteers (difficult to perform), excised human 
skin is regarded as the ―gold standard‖ for in vitro skin penetration studies especially 
in human dermal risk assessment [48]. Therefore, careful analysis of the reported 
data using either human skin in vivo was done in an attempt to reach to a conclusion 
on the feasibility of skin penetration of nanoparticles in real-case scenarios. To our 
knowledge, there are 22 different studies investigating skin penetration of inorganic 
nanoparticles through human skin (including the studies presented in the thesis). Of 
these studies, 14 studies reported no particle penetration into the DSL using either in 
vitro [60-64, 67, 70, 72, 91-92] or in vivo [61, 63, 68, 71-72] human skin, as well as 
human skin grafted in severe combined immune deficient mice [92-93]. In three other 
studies, skin penetration was only induced by skin treatment, such as massage of 
tape-stripped skin [52], dermaportation using pulsed electromagnetic field [54] or by 
the use of chemical penetration enhancers [59]. For the other remaining studies, the 
skin was not treated physically or chemically prior to or concomitant with the 
application of the particulate formulations. However, the applied nanodispersion 
included some ingredients used in the synthesis of nanoparticles that could have an 
effect on the skin integrity, hence favoring particle penetration. For instance, some 
particles were coated with trimethylammonium hydroxide (skin corrosive) [53], 
docusate sodium (anionic surfactant) [53] or dispersed in absolute alcohol, 99% [65-
66]. Even if the amounts used do not allow the skin penetration of nanoparticles, this 
should be regarded as a contributing factor. As a conclusion, it is very difficult to 
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dissect the single effect of bringing inorganic materials to the nano-range on their 
behavior with the skin barrier. This is presumably due to interplay of multivariate 
factors including the physicochemical attributes of the nanoparticles as well as the 
formulation, environmental and mechanical factors. The challenge would be to have 
a system which is tunable in size in the respective range of interest providing the 
same chemistry and hence the same properties regarding dispersibility and skin 
interaction. 
 
1.7. Qualitative and quantitative analysis of inorganic nanoparticles in the 
skin 
The rapid development of sensitive analytical techniques in the past decades has 
enabled researchers to monitor and accurately quantitate the amount of drugs 
present in the skin after penetration/permeation experiments and study the factors 
which either hinder or enhance their penetration. Among these techniques, HPLC 
provides a convenient method with a suitable limit of detection for accurate drug 
quantitation. On the other hand, quantitation of nanoparticles often represents a 
great analytical challenge; the scarce concentration of nanoparticles able to 
penetrate the skin with regard to the detection limit as well as the integrity of the 
particulate nature limits the available techniques or requires combination of at least 
two approaches of the available techniques. Table 1.2 lists the currently employed 
techniques with some examples from literature. 
As shown from Table 1.2, so far monitoring skin penetration of nanoparticles is 
mostly based on qualitative microscopical visualization. This includes histology, SEM 
and TEM, fluorescence microscopy, confocal and multiphoton microscopy. Of all 
these methods, development of both confocal and multiphoton laser scanning 
microscopy was considered a great addition to the field allowing obtaining 3D 
information of the distribution of nanoparticles in different skin layers via optical 
sectioning. This would rather avoid artifacts due to mechanical sectioning and 
sample preparation. However, this is limited by the loss of laser power and the loss 
of resolution with depth inside the skin tissue [110-111].  
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Further attempts were made with the aim of establishing a quantitative approach 
which would allow for a better understanding of skin penetration of nanoparticles and 
provide a sound scientific basis for diverse biomedical applications and health risk 
assessment. This involves adopting quantitative analytical methods such as 
inductively-coupled plasma optical emission spectroscopy, inductively-coupled 
plasma mass spectroscopy and atomic absorption spectroscopy. However, these 
techniques suffer the disadvantage of not detecting the particles themselves but their 
elemental composition. This would raise doubts whether these analyzed atoms or 
ions originate from the nanoparticles themselves or from raw salts or chemical 
ingredients used in particle synthesis. This is in addition to possible interference with 
trace elements in biological materials, skin, such as zinc. Other approaches involved 
intensity measurement of fluorescence [89] and confocal [52] images or even 
manual counting of the number of fluorescent spots per field in confocal  
images [112].  
This leads us to a side-question: what would be a good model for studying skin 
penetration of nanoparticles? From the analytical perspective, away from the clinical 
significance (mentioned earlier), inorganic nanoparticles especially quantum dots, 
gold and silver nanoparticles could be better tracked inside the skin rather than 
polymeric ones. This represents a further reason why most of the studies concerned 
with skin penetration of nanoparticles were conducted using inorganic particles 
rather polymeric ones. Other technical reason for that is the relative ease to prepare 
inorganic nanoparticles with respect to polymeric nanoparticles with a size smaller 
than 100 nm down to around 4 nm. 
 
Table 1.2: Analytical methods used for monitoring particle penetration in the skin barrier. 
Analytical method 
Examples from 
literature 
Comments 
Microscopical visualization 
Light microscopy of 
stained skin samples 
[82, 86] 
Advantage: easy technique. 
Disadvantage: artifacts on staining 
and mechanical sectioning. 
Background and Literature Survey 
-33- 
 
SEM [53, 63, 78] Advantage: high resolution. 
Disadvantage: artifacts on mechanical 
sectioning. 
TEM [45, 71, 76-77, 83-
84, 87, 92] 
Advantage: high resolution for 
electron dense materials. 
Disadvantage: artifacts on mechanical 
sectioning. 
Fluorescence 
microscopy 
[88-89] Advantage: higher selectivity, 
availability. 
Disadvantage: no depth information. 
Confocal laser 
scanning microscopy 
[47, 52, 75-76, 87] Advantage: optical sectioning. 
Disadvantage: loss of laser power 
with depth in the skin specimen, 
expensive. 
Multiphoton laser 
scanning microscopy 
[63, 85] Advantages: intrinsic optical 
sectioning, less scattering by the 
tissues and less phototoxicity than 
confocal. 
Disadvantage: loss of laser power 
with depth in the skin specimen, 
expensive. 
MPM-FLIM [54, 67] Advantages: capability of studying the 
effect of nanoparticles on skin 
metabolism by measuring 
autofluorescence of the endogenous 
fluorophores without the need of 
extrinsic labels. 
Disadvantage: loss of laser power 
with depth in the skin specimen, more 
expensive. 
Nuclear imaging [62, 113] 
[91]: Ion microscopy 
and autoradiography 
such as particle-induced X-ray 
emission, scanning transmission ion 
microscopy and Rutherford 
backscattering. 
Disadvantages: determination of the 
elemental composition of the 
particles, not the particle themselves 
thus an interference possibility. 
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Other analytical techniques 
ICP-optical emission 
spectrometry 
[44, 53] Advantage: quantitative techniques. 
Disadvantage: determination of the 
elemental composition of the 
particles, not the particle themselves 
thus an interference possibility. 
ICP-MS [47, 60, 74, 78, 83] 
Atomic absorption 
spectroscopy 
[46, 65-66, 81]  
 
1.8. Standpoint and recommendations for future directions 
Applications of inorganic nanoparticles in pharmaceutical and biomedical fields have 
been established and are increasing progressively. Yet, their behavior with the skin 
barrier is still in question with several contradicting results reported in literature. In an 
attempt to solve this dilemma some points should be taken into consideration as 
recommendations for future investigations: 
 Human skin should be used as the first choice ―gold‖ standard skin model for  
in vitro penetration experiments. In parallel, more studies should be 
conducted on finding a correlation between in vitro and in vivo animal 
experiments and human studies with regard to penetration for several 
particles of different physicochemical parameters. This would allow better 
prediction of in vitro absorption when using these validated animal models. 
 At the level of the experimental set-up, development of a more or less 
―universal‖ model with technical guidelines for testing skin 
penetration/permeation of nanoparticles is required. This also involves 
incubation times and concentration which are critical for sufficient and 
detectable penetration. 
 Both the experimental conditions and the characteristics of the nanoparticles 
should be fully described; publications with missing information such as size 
were occasionally published. 
 Formulation ingredients should be always addressed when discussing the 
results of the penetration/permeation experiments. Similarly, skin preparation 
prior to the experiment, such as shaving of the hair, should be considered as 
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critical parameter influencing the barrier function of the skin model and thus 
the results of the penetration/permeation experiment. 
 Last but not least, data obtained should be well-presented to allow the reader 
to extract the same conclusion made by the authors. For instance,  
Upadhyay, P. [89] has reported penetration of diphtheria toxoid-QD conjugate 
through mouse skin in vivo using local thermia. However, only images 
captured by conventional fluorescence microscope were presented with no 
depth information. As another example, the FLIM-multiphoton images shown 
by Krishnan et al. [54] for AuNP in human epidermis are also somehow 
unclear. It is not stated by the authors whether these images do show depth 
information of AuNP in the SC and the underlying viable epidermal layers or 
not. This would unfortunately leave the reader in a state of uncertainty of the 
reported results.  
Nevertheless, investigation of the skin penetration of nanoparticles, especially 
inorganic nanoparticles, for the aim of designing ideal transdermal carriers or for 
health risk analysis, is a very recent area of research that holds great promise 
especially on development of new analytical approaches and higher sensitivity 
techniques which allow tracking and quantitation of minute concentration of 
nanoparticles present in the skin. A further challenge facing future studies, however, 
could be the ability to dissect the ―nano‖ effect on nanoparticle penetration through 
the skin barrier, since the resultant penetration indicated in several studies was not 
exclusively due to bringing the material into the nano-size range, but also due to 
other concomitant formulation and environmental factors, in addition to the barrier 
state of the skin. 
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From the literature survey and the introductory part of the thesis, it can be concluded 
that studying nanoparticle interaction with the skin barrier is a topic of major 
importance that still needs further research efforts. This is on the level of basic 
research, as well as in the aim of designing potential topical and transdermal 
nanocarriers and biomedical diagnostic agents, in addition to health risk analysis. 
The main focus of the present thesis was to investigate the potential penetration of 
nanoparticles, using model gold nanoparticles, through human skin and studying the 
effect of the physicochemical properties of nanoparticles, namely size and surface 
properties, other formulation factors such as the vehicle of the nanodispersion, skin 
barrier conditions, etc., on their skin interaction. 
 Excised human skin was the selected skin model for penetration experiments, 
being regarded as the ―gold standard‖ for in vitro penetration experiments related 
to human dermal risk assessment [48]. 
 
 Gold nanoparticles (AuNP) were chosen as a good model for our study for the 
following reasons: 
 
 They have unique optical properties. They show distinctive extinction bands in 
the visible region, due to surface plasmon oscillation of free electrons [114]. 
This allows for visible, as well as spectrophotometric detection of particle 
aggregation. This is in addition to feasibility of detection in human skin on 
non-linear photon excitation. 
 They can be tailored in terms of size and surface chemistry offering a flexible 
system for studying the effect of physicochemical properties of nanoparticles 
on skin penetration. 
 Besides, AuNP have recently emerged as a delivery system of various  
payloads [23-24]. The payload could be a drug molecule [25-27] or a large 
biomolecule, such as protein [28], DNA [29-30], or RNA [31].  
 In addition, their physical properties could be exploited for clinical 
applications. AuNP cause local heating when they are irradiated with light in 
the range of 800-1200 nm. El-Sayed et al. [22] have showed the potential use 
of AuNP in photothermal destruction of tumors.  
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In summary, it was hypothesized that AuNP could serve as a good model for 
nanoparticle penetration of high pharmaceutical and clinical significance. 
 
Penetration of AuNP through human skin was previously induced or enhanced by 
dermaportation using pulsed electromagnetic field [54] and dermabrasion [58]. 
Seto et al. [74] investigated the simultaneous application of ultrasound and 
sodium lauryl sulphate to pig skin as a synergistic mechanical and chemical 
approach to enhance the delivery of AuNP.  
 
 Finally, multiphoton laser scanning microscopy was used for detection of gold 
nanoparticles in skin specimens. Multiphoton was found an efficient technique to 
track the penetration of nanoparticles in skin [85, 115]. 
 
In order to achieve the aimed research objectives (outlined in Figure 2.1), the work in 
this thesis passed through several stages: 
Stage one: Development of a method for detection of gold nanoparticles in human 
skin using multiphoton microscopy. For a better understanding, this was followed by 
establishment of an experimental approach for semi-quantitation of gold 
nanoparticles in the different skin regions. The goals of this stage were met in 
―Publication 3.1”. 
Stage two: Determination of the imaging parameters of multiphoton microscopy in 
skin in terms of the achievable detection depths and the resolution limit. 
Reconstructed human skin and excised human skin were employed for the study 
and the results were presented in “Publication 3.2”. 
Stage three: Investigation of the behavior of the prepared gold nanoparticles, of 
different physicochemical and formulation parameters, when coming in contact with 
the skin barrier, as well as tracking possible penetration. The results of this stage 
were published in “Publications 3.3 and 3.4”. 
Stage four: Enhancement of the skin penetration of gold nanoparticles using 
chemical penetration enhancers. This was in focus in “Publication 3.5”. 
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Figure 2.1: outline of the main research objective of the present thesis. 
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Abstract 
Interaction of nanoparticles with the skin barrier is a recent area of research that 
draws a lot of attention from the researchers. However, monitoring nanoparticles in 
or through the skin is mainly based on qualitative microscopical techniques. Yet, a 
quantitative approach is required for a better basic understanding. In response, a 
combined ―multiphoton-pixel analysis‖ method was developed in this study for 
semiquantitation of gold nanoparticles penetration into different skin layers. The 
developed approach provides a useful tool for future studies focusing on skin 
penetration of nanoparticles for the aim of health risk assessment or for the design of 
topical and transdermal drug delivery systems. 
 
Keywords: multiphoton imaging; semiquatitation nanoparticles skin penetration; 
gold nanoparticles. 
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Studying the skin penetration of nanoparticles is of great pharmaceutical importance 
for the design of potential topical and transdermal nanocarriers. Understanding the 
behavior of nanoparticles and their interaction with different skin layers would 
ultimately lead to the design of the ―ideal‖ carrier [42]. Hence exploration of the 
relevant parameters of the nanoparticles, e.g. size, shape, surface chemistry, 
influencing skin penetration of nanoparticles is necessary. Furthermore, the amount 
of penetrating particles is crucial. Quantitative estimation of skin penetration of 
nanoparticles is however problematic due to detection limits of the available 
techniques with regard to the scarce concentrations of nanoparticles present in the 
skin in typical permeation-penetration experiments. The uncertainty whether 
penetration really occurs and the expected reduced diffusion rates of  
nanoparticles [42] are the key reasons for that. Therefore, monitoring skin 
penetration of nanoparticles has been based mainly on qualitative visualization by 
microscopy techniques. These include electron [77], fluorescence [88], confocal and 
multiphoton [115], Raman [116] and nuclear [113] microscopy. Other analytical 
methods including inductively-coupled plasma mass [86] and atomic absorption [46] 
spectroscopy do not detect the particles themselves. A quantitative approach based 
on nanoparticles’ detection would allow a better understanding of skin penetration of 
nanoparticles and provide a sound scientific basis for diverse biomedical applications 
and health risk assessment. 
We have established a method by multiphoton microscopy for investigating skin 
penetration of gold nanoparticles (AuNP) based on gold luminescence [56]. The 
objective of this study was to explore this method for semiquantification of AuNP 
penetrating into the stratum corneum (SC) and deeper skin layers (DSL). Pixel 
frequency was chosen as an indicator for the amount of AuNP avoiding the 
limitations of intensity measurement introduced previously [85]. 
Thiol-coated AuNP dispersion (diameter=6.00 ± 0.81 nm) were applied on human 
skin in vitro at CAuNP = 437 µg/ml in a vertical Franz diffusion set-up at 32°C for 24 h 
under occlusive conditions. Skin was then longitudinally cryo-sectioned, 10 µm 
thickness, at –20°C and subjected to two-photon excitation fluorescence microscopy 
(ZEISS_LSM_510_META system, Carl Zeiss, Jena, Germany). On sectioning, skin 
piece was not placed parallel to the cutting blade to avoid dislocation of the particles 
from outside into DSL or vice versa, but in a perpendicular position limiting 
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sectioning artifacts (Figure 3.1.1). Furthermore, imaging was done within the tissue 
and not on the surface of the cut. Longitudinal skin sections were used over full-
thickness skin to reduce loss of laser power going deeper inside the skin. A 
wavelength of 800nm and energy of 0.485 and 0.647mW in the focal plane were 
used for both excitation of AuNP and scanning the skin, respectively. Signal due to 
gold luminescence and a light transmission image of the skin were simultaneously 
collected with no signal interference among tracks. 
 
Figure 3.1.1: A schematic presentation showing different possibilities for longitudinal cryosectioning 
of a skin punch. The arrows indicate the direction of cutting. Placing the skin punch parallel to the 
cutting blade (a, b) results in possible dislocation of the particles on the surface into the DSL (a) or 
vice versa (b). On the other hand, placing the skin punch in a perpendicular position (c) (adopted 
cryosectioning method) avoids particle dislocation limiting sectioning artifacts. 
 
Images of the longitudinal skin sections were then analyzed using ZEISS-LSM 
software, also feasible by any image analysis software. Semiquantitative data for the 
distribution of AuNP in different skin layers were extracted as follows: z-stacks, with 
optical layers 1µm thickness each, were adopted for analysis. The starting position 
(n=1) was defined as the first optical layer with detected signals in the AuNP track. 
Similarly, the end position (n=x) was the last optical layer showing AuNP. Each 
optical scan was composed of 512x512 pixel2 and 71.4x71.4 µm2. For each layer, 
the intensity was first thresholded in order to remove the contribution of the 
background such as second harmonic generation from collagen [117]. The pixels 
due to gold luminescence were determined in the SC and in the DSL for this optical 
layer. Summing up these values for all the optical layers of the z-stack resulted in 
∑pixel frequency (∑Pixel) due to AuNP in the SC and in the DSL of this z-stack. 
Figure 3.1.2 illustrates the method used for semiquantitation. 
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Figure 3.1.2: A schematic presentation of the experimental approach used for semiquantitation of the 
penetration of AuNP in a z-stack of a longitudinal skin section imaged by multiphoton microscopy. SC 
and DSL stand for the stratum corneum and the deeper skin layers, respectively. 
 
Finally, ∑Pixel of AuNP was normalized to determine the weighed number of 
particles (Nw) as follows: Considering an emission spectrum for AuNP of λ=~530-640 
nm [118], the mean theoretical lateral resolution (rxy) was calculated from Equation 
3.1.1 [119] as ~0.341 µm, i.e. the area of a single diffraction-limited AuNP (Aparticle) 
=~0.365 µm2. 
NA
70 λ.
rxy   (Equation 3.1.1), 
where NA is the objective numerical aperture. Knowing the area of one pixel (Apixel), 
0.139 x 0.139 µm² in this study, Nw, the weighed number of nanoparticles, is 
calculated from: 
particle
pixel
A
APixel
wN  (Equation 3.1.2) 
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This method of analysis has the advantage of measuring the number of events not 
their intensity. Therefore, the gain settings of multiphoton imaging could be freely 
adjusted for each measurement individually according to the energy of the laser 
required to excite AuNP at different depths in the examined skin specimens reducing 
the limitations for typical comparative measurements. Only the objective (water 
immersion objective, 63X magnification, NA=1.2) and the image size should be kept 
the same throughout the measurements. This represents a great advantage over 
methods based on intensity measurement [85], where the gain settings have to be 
fixed for all experiments. This would rather limit the imaging capability of 
nanoparticles in deep positions of some imaged skin specimens resulting possibly in 
inaccurate results. This limitation was discussed by Gratieri et al. [52] when 
measuring the intensity of quantum dots as an indicator of their concentration in 
different skin layers using multiphoton microscopy. Our method overrides previous 
attempts involving manual counting of the number of fluorescent spots per field in 
confocal images [112]. Apart from human errors, adoption of the latter approach 
results in overlooking the area of the fluorescent spots if larger than the resolution 
limit. Moreover, a previous attempt to analyze fluorescence images [89] used only 
one image field of the examined skin for each experimental condition for analysis. 
However, as shown in Figure 3.1.3(i), one optical layer is not always descriptive for 
the overall penetration profile of nanoparticles. On the other hand, calculation of 
∑Pixel and Nw of AuNP in the SC and DSL in optical z-stacks of the examined 
longitudinal skin sections showed a depth-profile for AuNP concentrating more in the 
SC rather than in DSL (Figure 3.1.3(iii)).  
In conclusion, a combined multiphoton imaging-pixel analysis approach was 
developed for semiquantitation of AuNP population in different skin locations in terms 
of pixels, from which the weighed number of particles could be calculated. These 
values could be used to determine the amount of AuNP penetrating into the SC and 
DSL in the same skin penetration experiment and correlate data among different 
experiments. The experimental approach described herein provides a valuable tool 
to advance our understanding of the interaction of nanoparticles with biological 
barriers, e.g. skin, and help identify various factors that enhance or limit their 
penetration. For future work, this method should be validated by the aid of analytical 
techniques such as inductively-coupled plasma mass and atomic absorption 
spectroscopy. 
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Figure 3.1.3: (i) Representative overlaid multiphoton/transmission images (upper panel) and the 
correspondent AuNP track (lower panel), each showing AuNP (indicated as white spots) at 
different optical layers of a z-stack of a longitudinal skin section, in which different amounts of 
AuNP in the SC (stratum corneum) and DSL (deeper skin layers) after 24 h of skin exposure were 
detected in each layer. A single layer is not descriptive for the overall penetration pattern. This is 
in comparison to (ii) an only vehicle-treated control skin specimen; the left image is an overlaid 
multiphoton/transmission image and the right image is the gold track only. (iii) Skin penetration of 
AuNP into the SC and DSL, expressed as ∑pixel frequency of AuNP (∑Pixel) in all optical layers 
of the z-stack was determined and the respective weighed number of particles (Nw) were then 
calculated, as shown above, showing depth-profile for AuNP concentrating more in the SC rather 
than in DSL. Note that pixel values due to AuNP nanoparticles were recorded following 
thresholding of background intensity. Therefore, zero pixels were recorded for control skin 
specimens (not displayed). 
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Abstract 
Multiphoton microscopy has become popular in studying dermal nanoparticle 
penetration. This necessitates studying the imaging parameters of multiphoton 
microscopy in skin as an imaging medium, in terms of achievable detection depths 
and the resolution limit. This would simulate real-case scenarios rather than 
depending on theoretical values determined under ideal conditions. This study has 
focused on depth profiling of sub-resolution gold nanoparticles (AuNP) in 
reconstructed (fixed and unfixed) and human skin using multiphoton microscopy. 
Point spread functions (PSF) were determined for the used water-immersion 
objective of 63X/NA=1.2. Factors such as skin tissue compactness and the presence 
of wrinkles were found to deteriorate the accuracy of depth profiling. Broad range of 
AuNP detectable depths (20-100μm) in reconstructed skin was observed. AuNP 
could only be detected up to ~14μm depth in human skin. Mean lateral (0.5±0.1μm) 
and axial (1.0±0.3μm) PSF in reconstructed and human specimens were 
determined. Skin cells and intercellular components didn’t degrade the PSF with 
depth. In summary, the imaging parameters of multiphoton microscopy in skin and 
practical limitations encountered in tracking nanoparticle penetration using this 
approach were investigated. 
 
Keywords: multiphoton imaging; gold nanoparticles; skin nanoparticle penetration; 
point spread function; nanoparticle depth profiling. 
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3.2.1. Introduction 
Optical techniques are of great importance as a non-destructive tool to study dermal 
penetration. Especially laser scanning microscopy (LSM) has shown its great 
potential. In confocal microscopy, a fluorophore is excited by the absorption of one 
photon of relatively high energy in the visible or ultraviolet spectrum. Multiphoton 
excitation, however, is a non-linear process in which a fluorophore is excited by two 
or more photons simultaneously of lower energy and longer wavelength in the 
infrared region [120]. Lower energy input, hence a reduced phototoxicity, and higher 
penetration of the excitation light are the distinct advantages over conventional  
LSM [121].  
An important aspect for particle imaging is the ability to distinguish them from each 
other and to estimate if single or agglomerated particles are present. This ability is, 
however, limited by the resolution which is the minimal size when a sub-resolution 
light emitting object is imaged. Therefore, the imaging function, represented by the 
point spread function (PSF) needs to be known, to judge the image quality and for 
possible quantification of particle number. For biological systems the optical 
conditions are not well defined as scattering occurs when the refractive index 
changes e.g. due to mismatch of refractive index between the specimen and the 
objective or due to localized particles with refractive indices different from their 
surrounding imaging environment. This is clearly evident in imaging biological 
tissues with several scattering centers, cells and their organelles, different in size, 
shape and structure [122-124]. These effects limit and reduce the resolving power. 
Furthermore, absorption and scattering of excitation and emission radiations lead to 
signal attenuation with depth limiting the useful range of depth penetration [125-127]. 
Aberrations encountered on imaging biological samples are discussed in details by 
de Grauw et al. [124]. Skin represents a highly complex system due to its high 
optical density and complex structure, being composed of several skin layers 
different in physicochemical parameters of the cells in addition to the different inter- 
and intra-cellular components. As a consequence, experimental investigations are 
the only direct approach to determine reliable PSF in lateral and axial direction.  
Two-photon excitation PSF was previously determined in water [128], glycerol [129] 
and in turbid media (gel and lipid emulsion) [130] containing fluorescent beads of 
diameter 100-220 nm. Interestingly, PSF was further determined in biological 
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specimens, lymph nodes [125], brain [125] and fixed kidney tissues [126] using sub-
resolution fluorescent beads, showing strong dependence on tissue constitution and 
depth into the tissue. Possibly due to the great difficulty in inserting fluorescent 
nanoparticles inside the skin due to the barrier properties of the stratum corneum 
(SC), the early trial to measure PSF in skin was based on imaging beads placed on 
the top of skin samples of different thickness. This experimental setup, however, 
could not yield true PSF in the different skin layers [131]. Later, Guldbrand  
et al. [110-111] measured the PSF of fluorescent nanoparticles in human skin 
inserting them inside the skin specimen either by injection [110] or passive diffusion 
into the tissue after tape-stripping the SC [111]. However, both insertion methods did 
not assure homogenous distribution of the beads throughout the specimen and 
across the whole thickness.  
Therefore, the objective of this study was the depth profiling of gold nanoparticles 
(AuNP) having sub-resolution dimensions in reconstructed skin specimens using 
two-photon excitation laser scanning microscopy, in addition to axial and lateral PSF 
determination at different depths from the skin surface. Reconstructed skin was 
grown from keratinocytes and fibroblasts together with AuNP in the culture medium. 
This would allow for the uniform particles distribution throughout the tissue. The 
compactness of the skin tissue was addressed by using fixed and non-fixed 
reconstructed skin specimens for examination. To complete the study, human skin 
injected with AuNP was also chosen for examination. 
 
3.2.2. Materials and Methods 
Preparation and characterization of AuNP. Ionically-stabilized, polar gold 
nanoparticles (AuNP) were prepared according to Turkevich method [25, 132]. 
Briefly, 70 ml solution of hydrogen tetrachloroaurate (HAuCl4·3H2O, Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany) containing about 100 µg/ml was reduced by 
trisodium citrate dihydrate (Na3C6H5O7·2H2O, Sigma-Aldrich) containing 5-fold the 
molar concentration of the gold salt under reflux at 100°C.  
The mean particle size of the gold core of the prepared nanodispersion was then 
determined by transmission electron microscopy (TEM) using a JOEL Model JEM 
2010 instrument (JOEL GmbH, Eching, Germany) operated at an accelerating 
voltage of 120 kV. The hydrodynamic diameter and the polydispersity were 
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measured using Malvern Zetasizer Nano (Malvern Instruments, Malvern, UK) based 
on dynamic light scattering at 25°C. The surface charge was estimated by measuring 
the zeta potential based on the electrophoretic mobility using Malvern Zetasizer 
Nano (Malvern Instruments, Malvern, UK). 
AuNP were sterilized by filtration then dispersed in Dulbecco’s Modified Eagle’s 
medium (DMEM) containing 10% fetal calf serum (FCS) under sterile conditions. 
Samples with two different concentrations, 97.4 and 487.1 µg/ml, in the culture 
medium were prepared. Under these conditions, colloidal gold dispersion was stable. 
 
Growing a reconstructed skin from fibroblasts and keratinocytes together with 
the provided AuNP in the culture medium. A reconstructed skin equivalents were 
grown from human foreskin fibroblasts and keratinocytes in which AuNP were 
provided in the culture medium to be dispersed throughout the tissue according to 
the following protocol: Collagen gel containing human fibroblasts was pipetted on the 
top of a cell culture insert in a standard 24 well cell culture plate. The fibroblast-
containing gel was cultured for 1 day at 37°C and 5% CO2 under submersed 
conditions applying a total of 2.5 ml DMEM medium with 5% FCS per well and insert. 
On the following day, 25 µl of the prepared AuNP dispersion in culture medium was 
added on each of the prepared gels, in either of the two concentrations of AuNP and 
incubated for 1 h at 37°C. A volume of 50 µl fibronectin solution (5 µg/ml) was then 
added and incubated again for 10 min at 37°C. Human foreskin keratinocytes in 100 
µl KBM basal medium (Cambrex Bio Sciences) with 5% FCS were subsequently 
seeded on the top of the collagen gels. After 1 h incubation at 37°C, a total of 2.5 ml 
keratinocyte basal medium (KBM) containing FCS (5%), hEGF (0.1 µg/ 500 ml) and 
BPE (15 mg/ 500 ml) was added to each insert. While maintaining submersed 
culture conditions, medium was exchanged on day 3, 4 and 5, thereby gradually 
lowering the FCS concentration from 5% to 0%. At the end of the submersed culture 
period, inserts with the skin equivalents were transferred into 6 well cell culture plate. 
KBM medium with 1.88 mM CaCl2 was filled into each well up to the level of the 
insert membrane (air-lift culture). The air-lift culture was performed for up to 13 days. 
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Treatment of human skin with AuNP. Human skin was obtained from female 
patients, who had undergone abdominal plastic surgery after approval of the ethic 
committee of Saarland, Germany (Ärztekammer des Saarlandes, Dec. 2008). After 
excision, the skin was cut into pieces and the subcutaneous fatty tissue was 
removed from the skin specimen using a scalpel. The surface of each specimen was 
cleaned with water, dried, wrapped in aluminum foil and stored in polyethylene bags 
at –26°C until usage. 
Human skin was exposed to AuNP under extreme conditions to assure distribution of 
the AuNP all over the tissue, but carefully so as not to damage the skin tissue. A 
punch of human skin, 8 mm in diameter, was injected with 1 ml of AuNP with a 
concentration 97.4 µg/ml using a hypodermic needle, 0.3 mm in diameter (Sterican®, 
absolute medical healthcare, Prague, Czech Republic). Injection sites were chosen 
on the top surface (SC), bottom surface (bottom layer of the viable deeper skin 
layers (DSL)) and from lateral sides of the skin punch. After injection, the skin turned 
red and was swollen in comparison to untreated skin punch (Supplementary 3.2.1). 
Human skin was, further, soaked in a dispersion of AuNP, 97.4 µg/ml, for 24 h.  
 
Preparation of the skin specimens for examination using multiphoton 
microscopy. 
i. Reconstructed skin 
(a) Non-fixed (duplicate samples for each concentration of AuNP).  
The culture media were carefully removed and freshly prepared phosphate buffer 
saline (pH 7.4) was added and specimens were then stored in an incubator (37°C, 
5% CO2) till further use. Specimens were stored under these conditions no longer 
than 1 day before usage. Specimens are either examined directly from the top by 
multiphoton microscopy or after longitudinal sectioning, 10 µm thickness, at –26°C 
using a SLEE cryostat type mev (SLEE medical GmbH, Mainz, Germany). 
(b) Fixed (duplicate samples for each concentration of AuNP) 
The culture media were removed and skin specimens were fixed with 3.7% formalin 
in phosphate buffer saline for 2 h, followed by washing with phosphate buffer saline. 
Skin specimens were then treated as described above. 
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ii. Human skin 
The treated skin specimen was frozen and 5 mm punch was taken for further 
examination. As mentioned before, the skin was examined from the top view and 
after longitudinal sectioning to examine the distribution of the particles throughout the 
skin tissue. Skin samples were then measured in duplicate using multiphoton 
microscopy as detailed below. 
 
Multiphoton microscopy. Imaging was performed using an inverted confocal/two 
photon excitation fluorescence microscope (ZEISS LSM 510 META system, Carl 
Zeiss, Jena, Germany), equipped with a tunable Chameleon IR laser (λ=720-930 
nm) for multiphoton laser microscopy, in addition to other conventional laser lines for 
confocal microscopy. A wavelength of 800 nm was used for both excitation of AuNP 
and the skin autofluorescence with a transmission energy of 0.467 and 0.485 mW, 
respectively, and a water immersion objective 63X (NA=1.2). The pulse width at the 
laser output was less than 140 femtosecond and the repetition frequency was 80 
MHz. Only for longitudinal skin sections, a light transmission image of the skin was 
taken. The gain settings were adjusted for each measurement individually. No 
significant photobleaching was observed in our experiments under the conditions 
used for imaging AuNP in the different skin layers. z-stacks of the skin samples were 
acquired at 0.5 μm step. Each optical scan was composed of 512 x 512 pixel2 or 
higher (2048 X 2048 pixel2). 
z-stacks were subjected to analysis using the software of the supplier. Images were 
analyzed for depth profiling of AuNP in the imaged skin specimens and to determine 
the PSF of multiphoton microscopy in skin specimens at different depths from the 
surface in both XY (lateral resolution) and XZ (axial resolution) directions. 
Measurements were based on measurement of the mean intensity per pixel ± 
standard deviation and pixel frequency. Prior to intensity and pixel measurements, 
the track of AuNP was only selected. The high background signals masking that from 
the particles were thresholded until only particles are selected. The threshold value 
was thus different from one case to another. Signals due to AuNP were then 
semiquatified in terms of pixels and intensity. 
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Data analysis. Generated data of PSF measurement were fitted to Gaussian 
function using Sigmaplot®, version 11 (Systat Software GmBH, Germany) as follows: 
2)(5.0
exp)( 



x
axf  Equation 3.2.1 
Where, 
a: height of the curve’s peak 
µ: position of the peak 
σ: standard deviation which controls the width of the peak 
 
For each function, FWHM was then calculated using the following equation: 
 
2ln22FWHM    Equation 3.2.2 
Measuring FWHM of the central peak of PSF in XY and Z directions is a quite 
common experimental approach to determine lateral (rxy) and axial (rz) resolution. 
Practically-determined FWHM were compared to theoretically calculated lateral (rxy) 
and axial resolution (rz), determined based on Rayleigh criterion. Rayleigh criterion 
suggests that two point objects are resolved when the first minimum of one airy disc 
is aligned with the central maximum of the second airy disc. Therefore resolution, 
according to Rayleigh criterion, is defined as the distance between the central 
maximum and first minimum of the first airy disc and could be calculated from [119]: 
 
NA
7.0 
xyr   Equation 3.2.3 
2NA
3.2 n
rz

    Equation 3.2.4 
where, λ is the wavelength of the emitted radiation, NA is the numerical aperture of 
the objective and n is the refractive index of the medium. 
Lateral and axial PSF were determined for reconstructed skin specimens containing 
a concentration of 97.4 and 487.1 µg/ml (fixed and non-fixed specimens) and for 
human skin specimens. For each of them, five z-stacks were analyzed for axial and 
lateral PSF at different depths from which the respective FWHM were determined. 
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Experimental FWHM in lateral and axial directions were compared to theoretical 
values calculated based on Rayleigh criterion according to Equations 3.2.3 and 
3.2.4. 
 
3.2.3. Results and discussion 
The main objective of this study was to examine the imaging properties of 
multiphoton microscopy in skin specimens, reconstructed and human skin in which 
AuNP are distributed throughout the skin tissue. Therefore, AuNP with a size of 
(14.9±1.8) nm for gold core and a hydrodynamic diameter of (15.3±0.7) nm 
(polydispersity index 0.1±0.0) and a zeta potential of (-35.1±1.9) mV were prepared, 
sterilized by filtration, then redispersed in the culture medium together with 
keratinocytes and fibroblasts under sterile conditions to build up a reconstructed skin 
tissue in which AuNP are dispersed as shown in the protocol above. AuNP from the 
same batch were also used in treatment of human skin specimens. 
On applying AuNP at the beginning of the growth phase of the reconstructed skin, 
the tissue could grow normally with a well distribution of AuNP throughout the tissue. 
This was shown from examination of the longitudinal sections (Figure 3.2.1). 
However, on examination of skin specimens from the top (Figure 3.2.2), AuNP could 
only be detected up to variable depths from the skin surface varying from around 20 
to 100 µm (Table 3.2.1). Variable detection depths of the AuNP could be attributed to 
variable compactness of the examined tissues, with spaces of no particular pattern 
and of variable areas separating skin layers, where laser suffers much less 
scattering. Compact organization is not easy to obtain when the artificial organ is 
constructed in vitro, reconstructed skin in this case. However, the use of fixatives 
was found effective in structural preservation of reconstructed skin [133]. This could 
explain the limited variations in detection depths of AuNP in examined skin 
specimens after fixation with formalin, where AuNP could be detected up to a depth 
of around 20 µm, except for one replicate (~50 µm) which could be attributed to 
imaging round wrinkles, representing another problem of accurate determination of 
depth of nanoparticles in skin specimen examined from the top by means of 
multiphoton microscopy. In other words, the inaccurate definition of the skin surface 
would contribute in the variation of the maximum detectable depth for AuNP in skin 
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specimens. This would represent a problem when tracking skin penetration of 
nanoparticles, especially on detecting whether particles are located on the SC-viable 
epidermis border or have already penetrated into the viable tissue. This could be 
shown by imaging smaller skin areas (an optical image of 23.8 x 23.8 µm2 rather 
than 47.6 x 47.6 µm2, where AuNP could be only detected up to a depth of around 
20 µm from the skin surface (Figure 3.2.2d). In Figure 3.2.2, the initial increase in the 
intensity per pixel values or the number of detected events for AuNP (pixel 
frequency) is mainly due to surface washing of skin specimen before examination. 
Note that intensity per pixel and pixel values shown in Figure 3.2.2 are thresholded 
values to eliminate the contribution of the background. 
 
 
Table 3.2.1: Maximum depths for detected signals of AuNP in reconstructed skin specimens, grown 
from fibroblasts and keratinocytes examined from the top view by multiphoton laser scanning 
microscopy. The size of each optical scan of the z-stack was 47.62 x 47.62 µm
2
. 
Treatment of skin specimen Un-fixed Fixed 
AuNP concentration, µg/ml 97.4 487.1 97.4 487.1 
Maximum detection depth, µm 
(duplicate skin specimens)* 
~ 20 ~ 50 
~ 20 
~ 20 
~ 90-100 ~ 90 ~ 50 
*For each skin specimen, the whole skin surface was roughly scanned for detection depth. 
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Figure 3.2.1: Representative images of AuNP (indicated as white spots) in longitudinal sections of 
reconstructed skin, grown from fibroblasts and keratinocytes together with AuNP at a concentration of 
487.1 µg/ml, imaged by multiphoton laser scanning microscopy, showing distribution of AuNP in (a) 
the SC (stratum corneum) and DSL (deeper skin layers) and (b) even in much deeper layers inside 
the skin. The left panel is overlaid multiphoton/transmission images of AuNP in skin, while signals due 
to AuNP alone are shown in the right panel. 
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(a)            (b) 
 
(c)            (d) 
 
Figure 3.2.2: (a, c) Intensity-depth and (b, d) pixel-depth profiles of AuNP in z-stacks of a 
reconstructed skin specimen grown from fibroblasts and keratinocytes together with AuNP in a 
concentration of 487.1 µg/ml imaged by multiphoton laser scanning microscopy from the top. Profiles 
are generated based on z-stacks with an optical scan size of 47.6 x 47.6 µm
2
 (a, b) and 23.8 x 23.8 
µm
2
 (c, d) The intensity and pixel frequency increase at the beginning then decrease going deeper 
inside the skin, however zero intensity and pixel values were reached at different depths from the skin 
surface. The presented intensity and pixel values were thresholded to eliminate the contribution of the 
background and skin autofluorescence. 
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Another aim of this study was to determine the PSF for multiphoton microscopy in 
skin as an imaging medium instead of water [128] and turbid liquids [130] already 
explored before. This would represent a more realistic condition when imaging ultra-
small particles (particles with sub-resolution dimensions) in skin specimens for the 
purpose of resolution estimation, penetration estimation, etc. Determined PSF values 
could be useful to get more precise number of nanoparticles in skin specimens using 
multiphoton microscope, rather than depending on theoretical values [55, 134]. 
Lateral and axial PSF of multiphoton microscopy under these conditions were then 
determined by fitting the generated data to Gaussian function (Equation 3.2.1) then 
measuring the respective FWHM according to Equation 3.2.2 (Figure 3.2.3 and 
Figure 3.2.4). This was determined in reconstructed skin specimens grown from 
fibroblasts and keratinocytes together with AuNP in the culture medium at a 
concentration of 97.4 (fixed specimens) and 487.1 (non-fixed and fixed specimens) 
µg/ml using a water immersion objective 63 X (NA = 1.2). At least five z-stacks were 
analyzed for each of them at different levels from the skin surface. Considering an 
objective NA of 1.2, a broad emission spectrum for AuNP of around 530-640 nm 
[118] and a refractive index for skin around 1.4 µm (1.443-1.448 µm and 1.378-1.396 
µm for the epidermis and dermis, respectively) [135], theoretical lateral (rxy) and axial 
resolution (rz) could be calculated from Equations 3.2.3 and 3.2.4. The theoretical 
value of lateral resolution in both the epidermis and the dermis was calculated in the 
range of ~0.3-0.4 µm due to a broad emission spectrum. The theoretical axial 
resolution, however, should be in the range of ~1.2-1.5 µm and ~1.2-1.4 µm for the 
epidermis and dermis, respectively. 
For PSF determination, the pixel size must be reduced sufficiently so that at least 
one pixel at a measurably lower intensity separates the objects of interest. 
Practically, a pixel 2.3 times smaller than the optical resolution limit of the system is 
required to digitally resolve that separation. This is known as the Nyquist criterion 
[136]. Therefore, on imaging, the pixel size was always kept 2.3 times below the 
theoretical values for lateral and axial resolution calculated from Equations 3.2.3 and 
3.2.4, preventing undersampling for the aim of accurate determination of PSF 
experimentally. Sub-diffraction limited spots with individual out-of-focus rings (airy 
discs) not intersecting with out-of-focus rings from neighboring ones at different 
depths from the skin surface were chosen for PSF determination. 
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Figure 3.2.3: Multiphoton image of AuNP in reconstructed skin, grown from keratinocytes and 
fibroblasts together with AuNP at a concentration of 487.1 µg/ml at a depth of 5.5 µm from the skin 
surface. A single representative particle is viewed from lateral, denoted as XY, and axial, denoted as 
XZ, for calculation of FWHM (full-width half maxima) for the determination of lateral and axial point 
spread functions of the imaging system. 
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Figure 3.2.4: Point spread functions in lateral (a) and axial (b) directions in reconstructed skin grown 
from fibroblasts and keratinocytes together with AuNP at a concentration of 487.1 µg/ml at variable 
depths from the skin surface (4-44 µm) fitted to Gaussian function showing independency of the 
lateral (XY) and axial (XZ) FWHM (full-width half maxima) on the depth from the skin surface. 
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The mean value of lateral PSF, determined in terms of FWHM, in all examined 
reconstructed skin specimens determined at different depths from the surface was 
(0.50±0.1) µm and that for axial FWHM (1.0±0.3) µm. Both determined lateral and 
axial FWHM in skin specimens were higher than experimental values determined in 
water [128], glycerol [129] and turbid media [130] due to higher optical density of the 
skin as an imaging medium. On the other hand, only lateral FWHM values 
determined practically were higher than theoretical values calculated from Equations 
3.2.3 and 3.2.4. However experimental axial FWHM values were in accordance with 
theoretical values. This could be attributed to the high refractive index of skin [135] 
and the consequent mismatch in refractive index of the skin specimen and the 
objective since theoretical lateral FWHM values were calculated independent of the 
refractive index of the skin (Equation 3.2.3). This calls for re-adaptation of the 
mathematical equation to include the refractive index of the medium as one of the 
determinants of lateral resolution, when imaging biological specimens. However for 
axial resolution, the refractive index of the medium is already considered (Equation 
3.2.4) yielding closer values to the real case. Experimentally measured axial PSF 
were even slightly lower in some cases than theoretically computed ones. This could 
be due to the broad emission spectrum of AuNP on two-photon excitation [118]. It 
was also reported that axial FWHM is 10% lower than resolution determined based 
on Rayleigh criterion (Equation 3.2.4) [119]. 
No statistical significance (p > 0.05) was found between the resolution in fixed and 
non-fixed specimens. The mean values ± SD are shown in Table 3.2.2. Though 
lateral and axial resolution were expected to get worse going deeper inside the skin 
due to scattering of incident radiation, this was not the case with no or slight variation  
(p > 0.05) among lateral and axial PSF values versus depth from the skin surface 
(Figure 3.2.4). This could be attributed to the poor compactness of the reconstructed 
skin, with spaces of no particular pattern and of variable areas separating various 
skin layers, where the laser suffers much less scattering. The same results were 
obtained for specimens with different concentration of AuNP (94.7 and 487.1 µg/ml). 
This would rather indicate that the determined values are for sub-resolution particles 
and not for aggregated population of particles; otherwise great variation among 
results would have been observed depending on the size of aggregates. Moreover, 
much higher values would have been generally expected on examining skin 
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specimens with higher concentration of AuNP in case of aggregation, since it is a 
phenomenon that is expected to increase on increasing concentration. All this 
eliminates the possibility of aggregation and insures that the measured values are 
essentially higher than the values reported in literature for lateral and axial resolution 
under ideal conditions, for instance ~0.2 and 0.7 µm [130], respectively due to the 
scattering phenomenon in the complex non-homogenous skin tissue. 
Optical z-sectioning was further performed on longitudinal sections in different skin 
regions, SC and DSL, and lateral FWHM were determined, where nearly the same 
values were obtained (Table 3.2.2). Again, the lateral resolution did not change 
significantly going deeper inside the SC from the side view. Similarly, this could be 
due to the non-dense fibrous structure of the SC characterizing reconstructed skin. 
In DSL, a relatively denser part of the skin full of living cells, showed an increase in 
the lateral FWHM going deeper inside the tissue (Figure 3.2.5). This emphasizes the 
effect of tissue compactness on the imaging parameters by multiphoton microscopy. 
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Figure 3.2.5: lateral point spread functions (fitted to Gaussian function) at different depths from the 
surface, 2.5, 6 and 7 µm in DSL (deeper skin layers) of a longitudinal section of reconstructed skin 
grown from fibroblasts and keratinocytes together with AuNP, at a concentration of 487.1 µg/ml. 
Determined values of FWHM are noted on the curves. 
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Table 3.2.2: (a) Summary of the results of determination of lateral and axial PSF of a multiphoton 
microscope using a water immersion objective of 63X, NA 1.2 in fixed and non-fixed specimens of 
reconstructed skin grown from fibroblasts and keratinocytes together with AuNP at a concentration of 
94.7 and 487.1 µg/ml. (b) Mean values of lateral PSF in longitudinal sections of skin specimens grown 
with AuNP, 487.1 µg/ml, in the SC (stratum corneum) and DSL (deeper skin layers) measured at 
different depths from the surface (first layer of the side view). 
(a) 
 
Lateral PSF, µm 
(mean±SD) 
Axial PSF, µm 
(mean±SD) 
All data 0.5±0.1 1.0±0.3 
At a depth from the skin surface of *: 
1-15 µm: 0.5±0.1 0.9±0.3 
15-20 µm: 0.5±0.1 1.0±0.3 
>20 µm: 0.5±0.1 1.1±0.4 
Fixed** 0.5±0.1 1.0±0.2 
Non-fixed specimens with a concentration of AuNP (µg/ml) of: 
97.4 0.5±0.1 1.0±0.2 
487.1 0.5±0.1 1.0±0.3 
*For each depth from the skin surface, at least 3 particles were used for analysis for each AuNP 
concentration in fixed and unfixed skin specimens.  
**AuNP concentration = 487.1 µg/ml. 
 
(b) 
Location in the longitudinal skin 
section 
Lateral PSF, µm 
(mean±SD) 
SC 0.6±0.1 
DSL 0.6±0.1 
AuNP Concentration = 487.1 µg/ml  
 
 
A complementary part of the study was the depth profiling of the prepared AuNP in 
human skin and measuring the PSF in human skin instead. The results were then 
compared to that of reconstructed skin to further study the effect of the skin type and 
tissue compactness on imaging using multiphoton microscopy. Human skin is of 
more complex and denser structure. To assure distribution of AuNP allover the skin 
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thickness, human skin was exposed to AuNP, at a concentration of 97.4 µg/ml, 
under extreme conditions, as shown above. Longitudinal skin sections showed 
distribution of AuNP in almost all skin layers (Supplementary 3.2.2). On examination 
of the skin punch from the top view, however, AuNP could be detected up to a depth 
of only ~ 14 µm. Maximum detected depth was 23 µm. The latter was in an area of 
evident wrinkles on the skin surface, a parameter which contributes negatively to the 
accuracy of depth determination from the top view. A representative intensity-depth 
profile is shown in Figure 3.2.6a, where signal levels slowly attenuate with depth into 
the tissues reaching zero-intensity at a depth of 14.5 µm. Figure 3.2.6b shows a 
pixel-depth profile of this z-stack, where the number of events for AuNP detected 
signals initially increased followed by a subsequent decrease until 14.5 µm depth. 
Determined penetration depths were independent of the scan size (data not shown). 
Nevertheless, this again implies that the wide variations in detected penetration 
depths on z-optical sectioning of the examined reconstructed skin specimens could 
be due to its loose structure [133].  More important, our results in human skin show 
that nanoparticles could be tracked up to a shallow depth less than or equal to the 
average thickness of the SC due to scattering phenomenon in the heterogenous skin 
tissue with depth. This represents a major problem when tracking the penetration of 
nanoparticles into DSL. Different results were, however, obtained by  Guldbrand  
et al. [110-111] detecting a signal due to their fluorescent particles up to a depth of 
35-40 µm, implying an effect of the emission wavelength of the imaged fluorescent 
particles, 580 nm relative to a broad emission spectrum for AuNP 530-640 nm, as 
reported by Farrer et al. [118] and the high emission intensity. A second contributing 
factor would be the anatomical region of the excised skin, using breast skin versus 
abdominal skin used in our study. Moreover, in one approach they reported tissue 
damage on injecting their particles in the skin [110] and in another they stripped the 
SC before application of AuNP to allow for better penetration into the skin tissue 
[111]. This would certainly have an impact on the refractive index of the tissue; the 
epidermis has higher optical density than the dermis [135], and consequently on the 
spherical aberrations caused by the mismatch of the refractive index of the skin and 
the objective. 
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(a)               (b) 
 
Figure 3.2.6: (a) Intensity-depth and (b) pixel-depth profiles of AuNP in a z-stack (optical scan size of 
47.6 x 47.6 µm
2
) of human skin treated with AuNP in a concentration of 97.4 µg/ml imaged by 
multiphoton laser scanning microscopy from the top. Both the intensity and pixel frequency increased 
at the beginning then decreased going deeper inside the skin. The presented intensity and pixel 
values were thresholded to eliminate the contribution of the background. 
 
Table 3.2.3 shows the mean values of FWHM determined in human skin specimens 
from the top view and after longitudinal sectioning in the SC and DSL. Results of 
FWHM determination in human skin were comparable to our results in reconstructed 
skin with slightly higher values for human skin possibly due to the higher complexity 
and density of human skin compared to in vitro skin models grown from skin cell 
lines. These values are in line with previously determined FWHM by Guldbrand et al. 
[111] reporting a lateral resolution in the range of ~0.4-0.6 µm and an axial resolution 
of ~0.9-1.6 µm. However, up to the limited imaging depth achievable in skin tissue by 
multiphoton microscopy, ~ 14 µm, scattering did not appear to significantly degrade 
the imaging PSF (p > 0.05) (Table 3.2.3). The same trend was recently reported by 
Guldbrand et al. [111], showing no influence of the imaging depth on the FWHM 
when imaging fluorescent beads in human skin. According to them, this was 
attributed to the higher influence of the distortions caused by the optical system.  
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Table 3.2.3: (a) Summary of the results of determination of lateral and axial PSF of a multiphoton 
microscope using a water immersion objective of 63X, NA 1.2 in human skin injected and soaked in 
AuNP at a concentration of 94.7 µg/ml. (b) Mean values of lateral PSF in longitudinal sections of 
human skin specimens injected and soaked in AuNP, 487.1 µg/ml, in the SC (stratum corneum) and 
DSL (deeper skin layers) measured at different depths from the surface (first layer of the side view). 
 
(a) 
 
Lateral PSF, µm 
(mean±SD) 
Axial PSF, µm 
(mean±SD) 
All data 0.5±0.1 1.3±0.3 
At a depth from the skin surface of *: 
1-6 µm: 0.5±0.1 1.3±0.2 
6-10 µm: 0.6±0.0 1.1±0.3 
10-20 µm: 0.5±0.1 1.3±0.5 
*For each depth from the skin surface, at least 3 particles were used for analysis  
 
(b) 
Location in the longitudinal skin 
section 
Lateral PSF, µm 
(mean±SD) 
SC 0.6±0.1 
DSL 0.7±0.1 
 
3.2.4. Conclusion 
In conclusion, multiphoton laser scanning microscopy is a promising non-invasive 
technique in tracking skin penetration of nanoparticles. However, it suffers some 
limitations and thus results based on this technique should be interpreted with care. 
This was shown on depth profiling of AuNP in skin, where AuNP could be detected 
up to variable depths from the skin surface ranging from 14-100 µm, depending on 
the skin type (reconstructed skin and human skin), skin pretreatment (tissue fixation) 
and area of examination (presence or absence of wrinkles). Surprisingly, measured 
lateral and axial PSF were found not to degrade with depth, possibly due to the low 
tissue compactness, in case of reconstructed skin, or due to possible dominance of 
the distortions caused by the optical system along the relatively short detection depth 
for AuNP in human skin (~ 14 µm). Another limitation which should also be taken into 
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consideration on depth profiling of nanoparticles in skin from the top is the variable 
thickness of the SC. Therefore, particles located at a depth more or less than 20 µm 
are not essentially in the DSL or yet in the SC, respectively. This means that 
examination of longitudinal skin sections, though suffering possible sectioning 
artifacts, still provides more accurate information on the status of skin penetration of 
nanoparticles rather than optical sectioning of skin specimens examined from the 
top. 
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Supplementary information 
 
Supplementry 3.2.1: Human skin punch, 8 mm in diameter, injected with 1 ml AuNP at a 
concentration 97.4 µg/ml (left) in comparison to control non-treated skin punch (right). 
 
 
Supplementary 3.2.2: Representative images of AuNP (indicated as white spots) in longitudinal 
sections of human skin treated with AuNP at a concentration of 97.4 µg/ml, imaged by multiphoton 
laser scanning microscopy, showing distribution of AuNP in (a) the SC (stratum corneum) and DSL 
(deeper skin layers) and (b) even in much deeper layers inside the skin. The left panel is overlaid 
multiphoton/transmission images of AuNP in skin, while signals due to AuNP alone are shown in the 
right panel. 
(a) 
(b) 
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Abstract 
Purpose: To measure penetration and metabolic effects of ion-stabilized, polar, 15 
nm gold nanoparticles in aqueous solution (AuNP-Aq) and sterically stabilized, non-
polar, 6 nm gold nanoparticles in toluene (AuNP-TOL) on excised human skin.  
Methods: Gold nanoparticles were characterized with dynamic light scattering and 
transmission electron microscopy (TEM). Skin penetration studies were done on 
frozen or fresh excised skin using static Franz diffusion cells. Viable treated skin was 
assessed by dermoscopy, reflectance confocal microscopy (RCM), multiphoton 
tomography (MPT) with fluorescence lifetime imaging microscopy (FLIM), and TEM.  
Results: Dermoscopy and RCM showed large aggregates in the furrows of AuNP-
Aq-treated skin. Treatment of thawed and viable skin only showed enhanced 
permeability to nanoparticles in the AuNP-TOL group with MPT and FLIM imaging to 
stratum spinosum of epidermis. TEM analysis revealed gold nanoparticles within 
AuNP-treated stratum corneum. FLIM analysis of NAD(P)H showed a significant 
decrease in total NAD(P)H in all toluene-treated groups.  
Conclusions: Gold nanoparticles, 15 nm, in aqueous solution aggregated on the 
skin surface. Toluene treatment eliminated skin metabolism; skin treated with 
toluene/gold nanoparticles (6 nm) for 24 h, but not at 4 h, showed increased 
nanoparticle permeability. These results are of value to nanotoxicology.  
Keywords: confocal reflectance microscopy; fluorescence lifetime; multiphoton 
microscopy; nanoparticle; skin. 
 
Labouta, HI et al., Pharm Research, 28 (2011)2931-2944                    Publications 
-73- 
 
Abbreviations 
ANOVA: analysis of variance 
AuNP: gold nanoparticle(s) 
AuNP-Aq: gold nanoparticle in aqueous solution 
AuNP-TOL: gold nanoparticle in toluene 
BP: band pass filter 
EDXS: energy-dispersed X-ray spectroscopy 
FLIM: fluorescence lifetime imaging microscopy 
HFT KP: dichroic low pass filter 
ICP: inductively coupled plasma 
MPT: multiphoton tomography 
MPT-FLIM: multiphoton tomography with fluorescence lifetime imaging microscopy 
NA: numerical aperture 
NAD(P)H: nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide 
phosphate 
RCM: reflectance confocal microscopy 
SB: stratum basale 
SC: stratum corneum 
SG: stratum granulosum 
SS: stratum spinosum 
TEM: transmission electron microscopy 
TEWL: trans-epidermal water loss 
VE: viable epidermis 
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3.3.1. Introduction 
Penetration and adverse effects of topical nanoparticle exposure is an important 
issue for public health, regulatory agencies, and industry [42, 137-138]. Our skin is 
exposed to a number of nanoparticles from natural and manmade sources. 
Nanoparticulates, such as zinc oxide and titanium dioxide, are useful sunscreens 
found in cosmetics. The penetration and nanotoxicology in skin is a debated topic in 
academia, from small interest groups and regulatory agencies [139-140]. The 
capacity of nanoparticles to overcome the SC and reach the viable skin is dependent 
on the model, barrier integrity, nanoparticle (size, shape, surface properties, and 
charge) and nanoparticle degradation kinetics [137, 141-142]. Tape stripping [143], 
mechanical flexion [144], UV exposure [87], sonophoresis [76], and microneedles 
[145] have all been shown to increase nanoparticle penetration in skin. However, 
there is a gap in the literature with regard to nanoparticle studies done in human skin 
with a focus on workplace exposure. Yet, there are several toxicity studies based on 
cell-culture experiments as well as skin penetration studies to evaluate the safety of 
topical application of nanoparticles. These studies were previously reviewed by 
Crosera et al. [146], Cevc and Vierl [41], Prow et al. [142], Schneider et al. [42], and 
others. 
Nanoparticle skin exposure can come from topical products, but, importantly, 
workplace exposure is a critical area of nanotoxicology without a significant 
knowledge base [141, 147-148]. Solvents are commonly used in the workplace [149] 
and in the synthesis of nanomaterials [150]. While solvent effects on drug 
penetration kinetics have been studied extensively [151-152], very few studies exist 
on penetration and toxic effects of solvent/nanoparticle in topical exposure 
scenarios[148]. 
Beyond the workplace, separating solvent and nanoparticle effects is critical for 
estimating toxicity. One example is the case of colloidal fullerene nanoparticles 
reported to be toxic in a variety of tests, where the toxicity is now being attributed to 
the solvent, tetrahydrofuran, and not the nanoparticle [153]. We hypothesised that 
AuNP could serve as model nanoparticles for examining the combined effects of 
topical nanoparticles and solvents. This is the first report to simultaneously quantify 
Labouta, HI et al., Pharm Research, 28 (2011)2931-2944                    Publications 
-75- 
 
nanoparticle penetration and metabolic effects of toluene and nanoparticles in 
human skin. 
Xia et al. (2010) reported on the penetration of small fullerene nanoparticles, 1 nm, in 
four solvents—toluene, cyclohexane, chloroform, and mineral oil—on Yorkshire 
weanling pigs [148]. Chloroform, cyclohexane, and toluene increased nanoparticle 
penetration into deeper layers of the SC. Toluene was the second solvent after 
chloroform promoting fullerene penetration into SC. Xia et al. proposed that the 
mechanism of action was not wholly due to the solubility of the nanoparticle in the 
solvent. Further, two other mechanisms were proposed including solvent flux and 
solvent evaporation-induced supersaturation [148]. Our goal was to evaluate the 
solvent and nanoparticle combination. We chose AuNP as a model nanoparticle 
because of the inert nature of gold and the capacity to track these particles by two-
photon luminescence [118, 134]. 
Noble metal photoluminescence was described in 1969 [137] and two-photon 
luminescence reported in 1986 [154]. The optical and photonic properties of AuNP 
are favorable for biomedical imaging, in part because of enhanced light absorption to 
1.4×107 and 3.7×108 M−1cm−1 for 5 nm and 15 nm particles, respectively. However, 
the body of literature in the field of dermatology is limited with regard to topical AuNP 
application. There are several reports on AuNP effects on cultures of skin-derived 
cell lines [155-157]. However, there are no reports on the metabolic consequences 
of topical AuNP application on skin or any reports measuring penetration depth of 
nanoparticles less than 12 nm in human skin. Sonavane et al. (2008), showed 
penetration of 15 nm AuNP through excised rat skin after 24 h [45]. These data show 
that there is potential for small AuNP to penetrate deep enough through skin to reach 
the circulatory system in the dermis; thus, there may be some risk of systemic 
nanoparticle exposure. A recent report by Larese Filon et al. (2011) supports the 
earlier findings of Sonavane. They found similar results when evaluating AuNP 
penetration (12.9 nm) in thawed human skin [58]. AuNP were detected in the 
receiving solution of the Franz cells after 24 h of skin exposure. The authors also 
investigated the effects of skin abrasion on AuNP penetration. 
The objectives of this study include an in-depth investigation of the consequences of 
topical exposure to two AuNP formulations, with different size, charge, surface 
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chemistry, and vehicle, in terms of penetration and metabolic changes in human skin 
using multiphoton tomography (MPT), TEM, reflectance confocal microscopy (RCM), 
dermoscopy, and fluorescence lifetime imaging microscopy (FLIM). Our data 
suggest that toluene, a common industrial solvent, is associated with increased 
nanoparticle penetration through viable human skin, but only after long-term 
exposure. 
 
3.3.2. Materials and methods 
AuNP-Aq synthesis. Ionically-stabilized polar AuNP were prepared using the 
Turkevich method [132]. A 100 μg/ml solution of hydrogen tetrachloroaurate (70 ml, 
HAuCl4·3H2O, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) was heated to 
100°C under stirring at 440 rpm and then reduced by adding a solution of trisodium 
citrate dihydrate (Na3C6H5O7·2H2O, Sigma-Aldrich) containing 5-fold molar 
concentration of gold salt. After the gold colloid had formed, the temperature was 
lowered to 25°C. The colloid was then stored at 4°C in the dark. 
AuNP-TOL synthesis. Sterically stabilized apolar AuNP were synthesized as 
described by Zheng et al. [158]. AuNP were formed upon gold reduction by an 
amine-borane complex in the presence of an alkyl thiol. In a typical synthesis, 0.31 g 
chlorotriphenylphosphine gold (purity 98%, ABCR, Karlsruhe, Germany) was 
dissolved in 50 ml of benzene (purity >99.5%, Riedel-de Haen, Germany), forming a 
colorless solution. A mixture of 0.53 g tert-butylamineborane (purity, 97%, Fluka, 
Germany) and 0.31 ml dodecanethiol (purity >98%, Fluka, Germany) was added to 
the formed solution and left to react at 55°C for 1 h. Upon completion of the 
reduction reaction, the red solution was cooled to room temperature, precipitated by 
the addition of ethanol and washed by centrifugation and subsequent resuspension 
in toluene. Finally, the resuspended particles were stored at room temperature away 
from light. 
Nanoparticle characterization. The optical properties of the AuNP were recorded 
using a UV/Vis spectrophotometer (lambda 35, Perkin Elmer LAS, Germany) in the 
range of 400–800 nm. Mean particle size of the gold core (n=30) and morphology 
were determined by transmission electron microscopy (TEM) using a JOEL Model 
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JEM 2010 instrument (JOEL GmbH, Eching, Germany) operated at an accelerating 
voltage of 120 kV. Samples for TEM analysis were prepared by placing 12 μl of 
dispersed nanoparticles on carbon-coated 400 mesh copper grids. The solvent was 
allowed to evaporate at room temperature. The nanoparticle hydrodynamic radius 
was measured using a Malvern Zetasizer Nano (Malvern Instruments, Malvern, UK) 
based on dynamic light scattering at 25°C. The surface charge of AuNP-Aq was 
estimated by measuring the zeta potential based on the electrophoretic mobility 
(Zetasizer Nano, Malvern Instruments, Malvern, UK) in water. The samples (1.5 ml) 
were run in triplicate using disposable folded capillary cells that contained the 
electrodes. 
Excised human skin preparation. Human skin was obtained from abdominoplasty 
patients with the approval of either the Research Ethic Committee of Saarland, 
Germany (Ärztekammer des Saarlandes, Dec. 2008) (thawed skin experiments) or 
Princess Alexandra Hospital Research Ethics Committee (No. 1997/097), Australia 
(viable skin experiments). All volunteers had previously signed informed consent 
forms. Eleven skin donors were used in this study. The subcutaneous fatty tissue 
was immediately removed from the skin. The surface of each specimen was cleaned 
with water. For thawed skin experiments, skin specimens were wrapped in aluminum 
foil and stored in polyethylene bags at 4°C or −26°C for less than 6 months before 
further usage. Previous investigations have shown that there is no change in the 
penetration characteristics of drugs through thawed skin stored frozen for 6 
months [159]. 
Skin discs, 25 mm in diameter, were cut, thawed, cleaned with deionized 
water/Ringer solution, and transferred into the Franz diffusion cells. Transepidermal 
water loss (TEWL) was measured with a Biox AquaFlux Condenser Chamber unit 
(model AF200) to assess barrier integrity before and after 24 h treatment. 
Skin penetration studies. Ex vivo penetration experiments were carried out in static 
Franz diffusion cells with previously frozen and viable skin. Skin was mounted in 
Franz cells with a diffusion area of 1.8 cm2 and 1.1 cm2 and receptor compartment 
volumes of 12 ml and 3.2 ml volume for frozen and viable skin experiments, 
respectively.  Receptor solution was phosphate-buffered saline, pH 7.4, magnetically 
stirred at 500 rpm. Nanoparticle-containing solutions in their original dispersion 
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medium, 500 μl at 90 μg/ml, were topically applied in the donor cell. Diffusion cells 
were maintained at 32°C throughout the 4 and 24 h exposure experiments. Following 
treatment, the excess nanoparticle solution was drained, and the skin was removed. 
Cryosectioning. Skin was fixed, embedded, and sectioned as previously  
described [138]. Skin was fixed in 2% paraformaldehyde in 0.1 M phosphate buffer 
pH 7.4 for 2 h at room temperature. Skin sections (10–50 μm thick) were cut at 
−20°C using a SLEE cryostat type mev (SLEE medical GmbH, Mainz, Germany) or 
Leica CM1850 cryostat (Leica microsystems, Heidelberger, Nussloch, Germany). 
The sections were mounted in Prolong Gold (Invitrogen, Mulgrave, Victoria, 
Australia) or FluorSaveTM (Calbiochem, San Diego, USA) prior to microscopic 
analysis. On cryosectioning, placement of the skin punch was not parallel to the 
cutting blade of the cryotome to avoid dislocation of the particles from outside into 
the deeper skin layers or vice versa, but in a perpendicular position limiting 
sectioning artifacts [134]. 
Dermoscopy and reflectance confocal microscopy (RCM). Treated skin was 
visualized using RCM (Vivascope 1500, Lucid Inc., Henrietta, NY) with an in-built 
dermascope used for visualization of treated skin surface and localization of 
nanoparticle aggregates on and within skin. Color dermoscopy images were taken to 
6×6 mm2 at 1000×1000 px2. RCM carried out at 830 nm with an optical power 
between the range of 3–6.9 mW was used to take 500×500 μm images at 30X 
magnification.  
A z-stack was taken with images taken every 2 μm from the skin surface to a depth 
of 100 μm. ImageJ (National Institutes of Health, Bethesda, Washington, D.C., USA) 
was used to analyse the mean intensity of AuNP in the SC of furrow depth using a 
threshold of 240–255 to identify highly reflective areas and to render RCM images in 
3D. 
Thawed skin MPT. MPT imaging was performed using an inverted confocal/two-
photon excitation fluorescence microscope (Zeiss LSM 510 META system, Carl 
Zeiss, Jena, Germany), equipped with a Chameleon infrared laser (λ=710–930 nm). 
The objective was a water immersion lens 63X NA=1.2; an excitation wavelength of 
800 nm, dichroic beam splitters HFT KP 700/488 nm, and an emission filter BP 560–
615 nm filter were used. Transmission light images of the skin sections were also 
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taken simultaneously and shown as overlays with the nanoparticle luminescence. Z-
stacks were taken with steps every 1 μm until there was no detectable signal. An 
excitation radiation with transmission energy of 0.6 and 0.5 mW was used for skin 
and nanoparticle tracks, respectively. 
Viable skin MPT and FLIM. A multiphoton tomograph (DermaInspect®, JenLab 
GmbH, Jena, Germany) equipped with a time-correlated single photon counting 
detectors, FLIM system (Becker and Hickl, Berlin, Germany) was used to 
simultaneously image nanoparticles and endogenous NAD(P)H as described 
previously [142]. A tuneable laser (Mai Tai, Spectra physics, Mountain View, USA) 
with a range of 710–920 nm was used as the excitation source and ultra-short pulse 
width (65 fs) in pulsed mode-locked at 80 MHz. Treated skin was optically sectioned 
using MPT-FLIM with a 740 nm excitation wavelength from SC to SB in 5 μm 
increments using 40X objective lens with an image size of 210×210 μm2. The 
emission was filtered with a 350–650 nm band pass filter (BG39), a <700 nm short 
pass optical filter, and a 350–450 nm band pass filter. A constant excitation power of 
30 mW at the rear of the objective was used. At least three biological replicates were 
analysed at 4 and 24 h of treatment for each group. 
Resulting FLIM data were analyzed with SPC 830 2.9 Image software (Becker and 
Hickl) to generate fluorescence lifetime decay and photon contribution curves from 
NAD(P)H autofluorescence and gold luminescence. The instrument response 
function of each FLIM image was calibrated to a sucrose crystal standard (Ajax 
Finechem Pty Ltd.). The fluorescence decay curve was fitted with a double 
exponential model,           
          
     , that defines the short and long 
lifetime/amplitude values. NAD(P)H-related metabolic rate and AuNP luminescence 
were quantified as previously described [142, 160]. NAD(P)H autofluorescence was 
isolated using α1% from 45–85, and AuNP luminescence was isolated from NAD(P)H 
using α1% from 90–100. The α1% is the proportion of the emission photons that 
return to the detector during the short lifetime phase of the decay curve, and the α2% 
represents the proportion of long lifetime photons. Although fluorescence lifetime 
changes with changes in the microenvironment, the α1% does not. This allows the 
AuNP luminescence positive pixels to be separated from skin autofluorescence. 
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Transmission electron microscopy. A high resolution TEM microscope, fitted with 
EDXS and selected area electron diffraction, was used to visualize AuNP in treated 
skin samples. High pressure freezing was used to preserve the skin ultrastructure 
using a Leica EM PACT2 system. Skin was placed in a 1.5×0.2 mm well with a 
membrane carrier coated with 1-hexadecene and filled with 1-hexadecene and then 
rapidly frozen. Samples were then stored in liquid nitrogen and transferred to vials 
containing 1% osmium tetroxide (OsO4), 0.5% uranyl acetate, and 5% H2O in 
acetone. Samples were then cryosubstituted at −85°C for two days before being 
gradually warmed to room temperature. After cryosubstitution, the sample was 
removed from the membrane carrier, washed in acetone, and infiltrated in Epon resin 
with the use of a microwave (3×40 s, 250 W, no vacuum). Infiltration was gradually 
carried out with Epon in steps of 1:3, 1:2, 1:1, 2:1, 3:1, 100% and 100% 
Epon:acetone steps (2×3 min, 250 W, vacuum) using a microwave (Biowave, Pelco) 
at 60°C. Ultrathin sections (60 nm thickness) were cut from the polymerised block, 
collected on Formvar-coated 200 mesh copper grids, and examined using a JOEL 
2010 transmission electron microscope with 80 kV power. 
 
Statistical analysis. Differences in measured macroscopic parameters of treated 
and control groups were tested applying the non-parametric Mann-Whitney t-test. 
Two-way ANOVA analysis was used to determine significance within multiple 
groups. Level of significance was accepted at p≤0.05.  
 
3.3.3. Results 
 
Characterization of AuNP. Dynamic light scattering was used to assess physical 
properties of two nanoparticles formulations (Table 3.3.1). Both nanoparticles were 
monodisperse as shown by TEM. Nanoparticle diameters were confirmed with TEM 
(Figure 3.3.1). Zeta potential measurements showed that the AuNP-Aq were 
negatively charged and the AuNP-TOL were uncharged. Both prepared AuNP 
dispersions showed physical stability and no aggregation. Aggregation of AuNP 
would be indicated by a large red-shift of the spectral peak and/or strong peak 
broadening [161]. 
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Table 3.3.1: Characteristics of the Prepared AuNP Dispersion 
AuNP-code Surface 
chemistry 
Size of gold 
core, nm 
DLS 
diameter, nm 
Zeta 
potential, mV 
Vehicle 
AuNP-Aq Citrate ions 14.9±1.8 15.3±0.7 -35.1±1.87 Water 
AuNP-TOL Dodecanethiol 6.0±0.8 7.2±0.9 Uncharged Toluene 
 
(a)             (b) 
 
Figure 3.3.1: (a) Citrate-stabilized AuNP-Aq and (b) thiol-coated AuNP-TOL imaged with TEM. 
 
Excised human skin barrier integrity. Transepidermal water loss was used as an 
indicator of barrier integrity. After receipt, skin was cut into circular pieces and 
mounted in Franz cells. We then evaluated TEWL in specimens before and after 24 
h of treatment. The mean±SE of TEWL was 26±1, 25±1, 25±2 and 27±1 g/(m2h) for 
the aqueous, toluene, AuNP-Aq, and AuNP-TOL groups before treatment. After 24 h, 
TEWL had increased to double for all groups. There was no statistical significance 
between any two groups within a single time point, and there was significant TEWL 
increase in all groups after 24 h treatment to p<0.0001. 
 
Dermoscopy of AuNP-treated skin. After 24 h treatment, skin surface of AuNP-
treated and vehicle-only skin samples was visualized using dermoscopy (Figure 
3.3.2a–d). Fine purple lines corresponding to the furrows can be seen in AuNP-
treated skin (Figure 3.3.2c–d). The color is reminiscent of AuNP aggregates. There 
was more intense and bluer color associated with the AuNP-Aq treated skin 
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compared to the AuNP-TOL group, pointing towards increased aggregation with the 
aqueous-formulated AuNP. 
 
RCM of AuNP-treated skin. The resolution of RCM enables visualization of cellular 
morphology and large, reflective nanoparticle aggregates [142]. Treated skin was 
imaged with RCM after 24 h treatment. With RCM we observed distinct 
morphological changes that suggested toxicity in toluene-treated skin (Figure 3.3.2f, 
h) but not in skin treated with aqueous dispersions (Figure 2e, g). Highly reflective 
aggregates were seen in both nanoparticle treated groups (Figure 2g, h) but not in 
vehicle-only controls (Figure 3.3.2e, f). Aggregates were most prominent in the 
AuNP-Aq group, supporting the hypothesis that the AuNP-Aq were highly 
aggregated on the skin surface (Figure 3.3.2c, g). As in the dermoscopy images, 
there were fewer AuNP-TOL aggregates than observed in the AuNP-Aq group 
(Figure 3.3.2g, h). Aggregates were only observed on and within the upper SC in 
nanoparticle-treated groups. The dermoscopy and en face RCM images showed that 
there were AuNP aggregates within the skin furrows. A 3D reconstruction of the 
RCM z-stacks confirmed the presence of large aggregates within the furrows of 
AuNP-Aq treated groups and the absence of these aggregates in all other groups 
(Figure 3.3.3). Figure 3.3.3 shows treated skin from a cross-sectional point of view. 
The dotted line highlights the surface of the skin; the arrowhead in Figure 3.3.3b 
indicates a representative cluster deep within a furrow. 
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Figure 3.3.2: Dermoscopy, RCM and MPT-FLIM images of treated human skin. Dermoscopy and 
RCM images showing the surface of skin specimens treated with aqueous solution, toluene, AuNP-
Aq, and AuNP-TOL for 24 h for dermoscopy (a–d) and for RCM images (e–h). Black dashed line 
indicates abnormal reflectance structure within the toluene treated skin (f, h); white dashed line shows 
highly reflective particles on the surface of the skin (g). FLIM images from the stratum granulosum 
layer of the epidermis from skin treated for 4 (i–l) and 24 h (m–p). Scale bars: 4 mm (d); 50 μm (h, l, 
p); pseudocolored MPT-FLIM images are α1% 50–100 from blue to red. Blue-green coloration 
indicates cellular autofluorescence, i.e. NAD(P)H, and gold nanoparticle luminescence is orange to 
red (k, l, o, p). 
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Figure 3.3.3: 3D reconstructed RCM images rendered in cross section. 3D reconstructed RCM 
images of skin specimens treated with aqueous solution, AuNP-Aq, toluene and AuNP-TOL. The 
stratum corneum within the furrows is highlighted with dotted lines. The arrowhead indicates gold 
nanoparticle aggregates deep within the furrow. Scale bar: 50 μm. 
 
En Face MPT-FLIM analysis of viable skin treated for 4 and 24 hours. The 
fluorescence lifetime decay curve contains a short and a long component in this 
context. The short component represents the photons that return to the detectors 
quickly, i.e. in the ultrafast multiphoton excited photoluminescence that results from 
metal nanoparticles and second harmonic generation from collagen. The lifetime is 
usually reported in picosecond or nanosecond units. Fluorescence lifetimes can 
change with the microenvironment and are thus not optimal for separating AuNP and 
NAD(P)H. The α% is the proportion of photons that have short or long lifetimes; this 
proportion does not change with changes in the microenvironment or concentration. 
Therefore, we use α% ranges to separate AuNP and NAD(P)H, where intensity 
changes represent changes in concentration. Skin treated for 4 and 24 h was 
subjected to MPT-FLIM analysis. The images shown in Figure 3.3.2i–p are from the 
SG layer and are pseudocolored at α1% 50–100% (blue to red). The autofluorescent 
components of living skin, i.e. NAD(P)H and keratin, can be seen in Figure 3.3.2i, m, 
k, o in green and blue. AuNP luminescence is shown in orange to red in Figure 
(a) 
(b) 
(c) 
(d) 
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3.3.2k, l, o, p. AuNP signal can be seen primarily in the furrows of nanoparticle 
treated skin. Skin treated with aqueous formulations shows clear keratinocyte 
morphology due to NAD(P)H, found primarily in active mitochondria. Toluene-treated 
skin shows an absence of NAD(P)H autofluorescence. Skin treated for 24 h with 
AuNP-TOL revealed AuNP signals from the SG suggesting some nanoparticle 
penetration. This phenomenon was not observed in any other group. 
 
Cross-section analysis of nanoparticle penetration with TEM, MPT, and MPT-
FLIM. Frozen sections of thawed skin treated with nanoparticle formulations for 24 h 
showed AuNP luminescence within the epidermis in AuNP-TOL but not in AuNP-Aq 
treated samples (Figure 3.3.4). We then used TEM to assess nanoparticle 
penetration and tissue ultrastructure in viable human skin. Skin treated for 24 h was 
subject to high pressure freezing for TEM or cryopreservation for MPT-FLIM (Figure 
3.3.5). TEM imaging showed ultrastructure indications of toxicity in toluene-treated 
skin. SC showed some delamination, but there were significant signs of toxicity in the 
viable epidermis. Cell membranes were severely disrupted, including mitochondria 
and cell junctions (Figure 3.3.5b, d). The electron-dense nature of AuNP results in 
increased electron scattering of the incident electrons and thus appears as dark 
spots in TEM images. AuNP were found on the skin surface and up to two cell layers 
deep in SC of AuNP-Aq-treated skin (Figure 3.3.5g). AuNP were found up to ten cell 
layers deep in the AuNP-TOL-treated skin, but could not be identified within the 
viable epidermal layers. This may be due to increased particulate background from 
the staining solution binding to particulates associated with toluene-damaged tissue 
(Figure 3.3.5c, d). 
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    (a)      (b) 
 
    (c)      (d) 
 
Figure 3.3.4: MPT of thawed skin treated for 24 h. (a–d) 10 μm-thick cryosectioned skin from 
aqueous, toluene, AuNP-Aq, and AuNP-TOL groups. The images are overlays of light transmission 
and gold luminescence images. The stratum corrneum and viable epidermis are labelled SC and VE; 
the SC is outlined in white. The white arrows indicate AuNP in the AuNP-Aq image and the circle 
indicates AuNP in the AuNP-TOL image that is 13 μm deep. 
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Figure 3.3.5: Gold nanoparticle penetration in cross-sections using TEM and MPT-FLIM. Low and 
high magnification images of the epidermis and superficial stratum corneum from each of the 
treatment groups (a–h). Scale bars: 1 μm (a–d); 200 nm (e, f); 500 nm (g, h). Pseudocolored MPT-
FLIM images (i–l) show the penetration pattern of gold nanoparticles (orange to red). MPT-FLIM 
imaging with a 740 nm excitation wavelength and emission was filtered with a 350-650 nm band pass 
filter (BG39). (i–l) Scale bar: 50 μm; pseudocolored MPT-FLIM images are α1% 50–100 from blue to 
red. 
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Quantification of multiphoton images was conducted. Representative optical z-
stacks, 1 μm nominal step width, for examined thawed skin cross-sections were then 
quantified, according to a method we developed and recently published elsewhere 
[134]. Briefly, the method of quantification is based on calculation of Σpixel frequency 
due to AuNP in the SC and DSL, from which weighed number of particles were 
calculated. No particles were quantified in DSL of thawed skin specimens treated 
with AuNP-Aq. On the other hand, results showed depth-profile for AuNP-TOL 
having higher numbers of AuNP in the upper skin layer, SC (1082 nanoparticles) 
rather than viable epidermis (470 nanoparticles) [134]. 
We used MPT-FLIM to separate cellular autofluorescence from AuNP luminescence. 
In Figure 3.3.5i, j, cryosections of treated skin are shown with MPT-FLIM and are 
pseudocolored from blue to red for α1% 50–100%. Cellular autofluorescence is 
shown in green to yellow; AuNP luminescence is shown in orange to red. These 
colors correspond to relatively slow autofluorescence lifetime and relatively 
instantaneous nature of AuNP luminescence. Images are oriented so the SC is at 
the top and dermis is towards the bottom. Aqueous-treated samples (Figure 3.3.5i, j) 
show an even green signal through the viable epidermis with dark ellipsoids 
suggestive of nuclei in position, size, and absence of NAD(P)H signals. These 
morphological queues are not prominent in toluene-treated skin (Figure 3.3.5k, l), 
suggesting a lack of the usual membranes that partition NAD(P)H out of the nucleus. 
The orange signal at the bottom of Figure 3.3.5j, k is likely to be collagen second 
harmonic generation, where the green-orange interface is the dermal epidermal 
junction. The second harmonic signal from collagen has overlapping lifetime 
characteristics with gold luminescence, resulting in an indistinguishable lifetime 
signature that limits identifying AuNP signals to the epidermis. Only AuNP-treated 
groups show strong signals at the skin surface (Figure 3.3.5k, l). The key difference 
between the AuNP-Aq and AuNP-TOL images was the presence of punctuate AuNP 
signals with a depth-dependent decrease in number from within the viable epidermis 
in the AuNP-TOL (Figure 3.3.5l), but not in the AuNP-Aq-treated skin (Figure 3.3.5j). 
These data indicate that AuNP penetrated deeper within human skin in presence of 
toluene for 24 h. Importantly, these images were taken from the centre of thick (50 
μm) cryosections to minimize potential edge contamination effects, and the 
punctuate signal pattern was not observed in any of the other treatment groups, 
including toluene-only control.  
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En Face MPT-FLIM intensity measurement of AuNP luminescence in human 
skin. Penetration profiles of AuNP luminescence signals are shown for 4 and 24 h 
treatment groups in Figure 3.3.6a, b. Depth stacks of MPT-FLIM images were taken 
of treated human skin; AuNP luminescence signal was quantified using a stringent 
range of α1% 90–100 to exclude skin autofluorescence. Significantly more AuNP 
signal was detected deep in the SC in the AuNP-TOL group at 4 h (p<0.001), but not 
in the other 4-hour treatment groups (Figure 3.3.6a). AuNP luminescence signals 
were found within the SC in both AuNP treatment groups after 24 h treatment, but 
not in vehicle-only groups (Figure 3.3.6b). AuNP luminescence signals were found 
significantly deeper in the AuNP-TOL-treated group than AuNP-Aq group at 24 h 
(p<0.05), supporting the histological findings above. Intensity of gold aggregate 
reflectance signal in furrows was quantified from RCM analysis (Figure 3.3.6c). 
These data show the presence of significantly more highly reflective aggregates 
deep within the furrows of AuNP-Aq-treated skin (p<0.0001), compared to all other 
groups. 
 
MPT-FLIM analysis of NAD(P)H at 4 and 24 hours post-treatment. MPT-FLIM 
analysis of NAD(P)H was carried out in epidermis of excised human skin. FLIM data 
were taken via a depth series of en face images that were processed to quantify total 
NAD(P)H intensity and α1/α2 ratio. The α1/α2 ratio is inversely related to the metabolic 
rate [162]. Toluene-treated skin, including toluene alone and AuNP-TOL, at both 4 
and 24 h showed low NAD(P)H signals similar to those seen in non-viable skin 
(Figure 3.3.2j, n, l, p; Figure 3.3.7a, b) [163]. Total NAD(P)H signal in toluene-treated 
groups was significantly depressed when compared to the aqueous groups, p<0.001. 
After 4-hour treatment with AuNP-Aq, total NAD(P)H levels were significantly lower 
than aqueous-only controls, p<0.01. α1/α2 data mirrored the total NAD(P)H results 
with a significant increase in the ratio of toluene-treated groups compared to the 
aqueous groups (p<0.001) (Figure 3.3.7c, d). At 24-hour treatment, differences in 
α1/α2 ratio were less pronounced than in total NAD(P)H analysis. This may be due to 
natural skin necrosis after removal from the donor, as we have previously reported 
[163]. Unlike the total NAD(P)H data, the α1/α2 ratio data showed no differences 
between the aqueous groups. 
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Figure 3.3.6: Gold nanoparticle luminescence and reflectance skin profiles. Data from MPT-FLIM 
depth series (SG indicates the stratum granulosum) were processed to identify gold nanoparticle 
luminescence intensity as a function of depth in non-furrow-containing regions. Data are shown for 
both 4 and 24 h treatment groups (a, b). Furrow reflectance intensity was derived from the stratum 
corneum and outer surface of furrow areas; the top of the skin is at 0 μm (c). These data were 
gathered from a depth series of en face images. 
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3.3.4. Discussion 
 
Nanoparticle skin penetration is a multi-factorial and multistep process that is 
affected by a number of factors, including the skin type, barrier damage, and 
inherent physicochemical attributes (size, shape, surface charge, etc.) and vehicle of 
the applied colloids. Measuring nanoparticle penetration and NAD(P)H effects in 
excised human skin was the focus of this microscopy study. Human skin was 
chosen, being regarded as the ―gold standard‖ and most reliable set-up for in vitro 
skin penetration studies, especially in human dermal risk assessment [48]. The 
public could come in contact with nanoparticles non-intentionally in daily life via 
handling of several products such as cleaning agents, sport clothes, paints, etc., in 
addition to environmental exposure to water and air contaminated with nanoparticles.  
 
 
Figure 3.3.7: NAD(P)H effects from MTP-FLIM imaging. NAD(P)H signals were separated from gold 
nanoparticle luminescence by selecting α1% 45–85. NAD(P)H intensity with depth in non-furrow areas 
(SG (stratum granulosum), SS (stratum spinosum) and SB (stratum basale)) from skin treated for 4 
and 24 h (a, b). The α1/α2 ratio is inversely related to the metabolic rate and was calculated for each of 
the treatment groups at 4 and 24 h (c, d). 
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Last but not least, the safety of personnel working in industry and research handling 
nanoparticles was not in focus. Though nanotechnology is finding a lot of 
applications in pharmaceutical industry, safety issues should be further studied, 
highlighting the importance of this study. Aside from occupational health issues, 
studying the behavior of nanoparticles with the skin barrier is a very important basic 
research approach for later application in designing topical drug delivery systems 
with optimal parameters. This is especially true when solvents like terpenes are used 
in topical formulations [164]. Our experimental design was congruent with previous 
gold nanoparticle skin penetration studies with similar exposure times and use of 
static Franz cells. Our study design was unique because we evaluated viable human 
skin and utilized clinical dermoscopy, RCM and MPT-FLIM. Therefore, our results 
can be directly compared to future clinical studies because our assessment 
technologies can be applied in vivo. 
Sonavane et al. (2008) showed that 15-nm AuNP in aqueous solution were capable 
of penetrating through full thickness rat skin over 24 h using spectrophotometry and 
TEM [45]. Similarly, Larese Filon et al. (2011) showed AuNP penetration after 24 h 
using ICP to detect gold ions in the receptor [58]. Our study showed penetration into 
SC but not beyond using 14.9-nm AuNP in aqueous solution with TEM, MPT-FLIM, 
and RCM. This incongruity with the rat skin study by Sonovane et al. and thawed 
human skin by Larese Filon et al. might be due to the type of skin used. Viable rat 
skin is thinner and more permeable to nanoparticles than viable human skin [73, 
142]. Thawed human skin is non-viable [163] and, therefore, is likely to be more 
permeable to nanoparticles than viable human skin. The use of MPT-FLIM to detect 
luminescent nanoparticles eliminates the possibility of solubilized nanoparticle 
residues from our analysis because luminescence only occurs in the presence of the 
intact particle, thus eliminating potentially confounding factors like soluble or 
endogenous ions, as can occur with ICP analysis. The inability of the 15-nm AuNP-
Aq to cross skin barrier could be also attributed to their surface aggregation, as 
observed by dermoscopy. This could be attributed to the exchange of the citrate ions 
on the AuNP surface with skin proteins or lipids, as shown in other biological 
environments [165-166]. 
There were substantial similarities between our results with nanoparticles in toluene 
and the study by Xia et al. (2010) [148]. They showed increased nanoparticle 
penetration in the presence of solvents that included toluene. As pig skin is more 
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similar to human skin and this study was done in vivo using Yorkshire weanling pigs, 
it is a more relevant comparison to our study than rat skin or thawed human skin. 
The expected similarities in nanoparticle penetration between human and porcine 
skin are based on similar solute fluxes previously observed [167-168]. 
Our TEM data showed widespread disruption of the epidermal ultrastructure in 
toluene-treated samples. These TEM images showed discontinuous cell membranes 
and particulates throughout the samples that were not present in aqueous-treated 
groups. Disruption of lipid barriers by toluene could have directly led to the increased 
nanoparticle penetration we observed in the AuNP-TOL-treated skin. We observed 
dramatic decreases in total NAD(P)H autofluorescence with toluene treatment. 
These data were similar to those from necrotic skin we previously published [163]. 
Therefore, we hypothesize that toluene-treated skin was metabolically disrupted 
within 4 h of treatment by chemically induced necrosis. TEWL measurements 
indicate the integrity of the skin specimens with general increase in values after 24 h 
of occlusive conditions due to over-hydration of the skin. Regarding nanoparticle 
penetration only, long-term incubation revealed some penetration, indicating that 
skin barrier was not completely disrupted. Skin treated with AuNP in aqueous 
solution revealed lower total NAD(P)H signal, but metabolic rate appeared 
unchanged. We have observed decreases in the metabolic rate of silver 
nanoparticle-treated human skin [142], so we hypothesize that the unchanged 
metabolic rate data from AuNP treatments suggest that the total NAD(P)H signal 
may have been reduced by AuNP light scattering and not metabolic effects. 
 
3.3.5. Conclusion 
 
Our data showed that 15-nm AuNP in aqueous solution tended to aggregate on the 
superficial SC after 24 h exposure, while 6-nm AuNP in toluene penetrated through 
SC and into epidermal layers of human skin. Our NAD(P)H imaging data showed 
that epidermis was not viable at 4 and 24 h post-toluene treatment regardless of the 
presence of AuNP. Nevertheless, an exclusive role of the size or solvent on skin 
penetration should not be the conclusion of this research work. A more in-depth 
study of the single size and solvent effects is therefore in need. The results of this 
paper, however, should raise public awareness regarding the environmental 
exposure to nanoparticles, especially for personnel in research and industry. In the 
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future, similar studies are needed characterizing the impact of different 
physicochemical properties of nanoparticles with regard to penetration and metabolic 
effect on the skin. 
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Abstract 
The ability of nanoparticles to penetrate the stratum corneum was the focus of 
several studies. Yet, there are controversial issues available for particle penetration 
due to different experimental setups. Meanwhile, there is little known about the 
mechanism and determinants of their penetration. In this paper the penetration of 
four model AuNP, of diameter 6 and 15 nm differing in surface polarity and the 
vehicle nature through human skin was studied using multiphoton microscopy. This 
is in an attempt to profoundly investigate the parameters governing particle 
penetration through human skin. Our results imply that nanoparticles at this size 
range permeate the stratum corneum in a similar manner to drug molecules, mainly 
through the intercellular pathways. However, due to their particulate nature, 
permeation is also dependent on the complex microstructure of the stratum corneum 
with its tortuous aqueous and lipidic channels, as shown from our experiments 
performed using skin of different grades of barrier integrity. The vehicle (toluene-
versus-water) had a minimal effect on skin penetration of gold nanoparticles. Other 
considerations in setting-up a penetration experiment for nanoparticles were also 
studied. Results obtained are very important for designing a new transdermal carrier 
and for the basic understanding of skin-nanoparticles interaction. 
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3.4.1. Introduction 
The potential ability of nanoparticles to overcome the barrier function of the stratum 
corneum (SC) has been recently the target of several studies. Nevertheless, there is 
a controversy among researchers whether nanoparticles do penetrate the SC into 
the viable tissue [50, 75] or not [60, 62, 115]. The different results are mainly due to 
different experimental setups, in terms of the skin type, skin surface area, exposure 
time and type and concentration of applied nanoparticles. A great deal of the recent 
work was mainly focused on treating the skin physically, e.g., tape stripping [73, 90], 
mechanical flexion [144], UV exposure [87], sonophoresis [76], microneedles [145] 
or chemically using penetration enhancers [85] to cause or enhance the penetration 
of nanoparticles into the deeper skin layers (DSL). In this study, however, a well-
designed skin penetration experiment, using excised human skin as the gold 
standard for ex vivo skin penetration is considered crucial in regard to the extensive 
studies on animal skin [45, 75, 90, 144, 148]. The physicochemical parameters, size, 
surface polarity, physical state of the nanoparticles, in addition to the effect of vehicle 
were in focus. 
Surface polarity of nanoparticles and the vehicle nature are expected to play a role in 
skin penetration of nanoparticles. Yet, to our knowledge, only three studies 
investigated the effect of surface charge of nanoparticles on skin penetration, though 
they were also controversial in terms of the surface charge which leads to higher 
affinity of the particles to porcine skin [75, 169-170]. Senzui et al. [78] studied the 
penetration of 35 nm titanium dioxide nanoparticles, uncoated and coated with 
alumina/silica/silicon, through porcine skin. However, no penetration was reported for 
both particles.  
Apart from the size factor, the effect of surface polarity of nanoparticles, having the 
same size diameter, on skin penetration was not the scope of any investigation so 
far. On the other hand, the only evidence for the effect of solvents on the skin 
penetration of nanomaterials was recently reported by Xia et al. [148] for pristine 
fullerenes of 1 nm in diameter. Several industrial organic solvents: chloroform, 
toluene, cyclohexane and mineral oil were examined. Porcine skin biopsies showed 
penetration of particles for all of the tested solvents except for mineral oil, with much 
higher penetration in case of chloroform. Baroli et al. [53], however, compared the 
effect of nanoparticle formulation to blank solutions on human skin resistivity and 
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concluded a minor effect of the vehicle on their results. Finally, the physical stability 
of nanoparticles when coming in contact with the skin and its effect on skin 
penetration, though not studied so far, is an important parameter that could partly 
explain the disagreement of results reported by different researchers concerning the 
penetration of nanoparticles of the same size range [60, 75]. Hence, a more 
systematic study on the penetration of nanoparticles through human skin taking into 
account that all the mentioned relevant physicochemical parameters together has 
not been done so far. 
Several nanoparticles, polymeric or inorganic nanoparticles, were investigated for 
possible skin penetration [42]. Among these particles, gold nanoparticles (AuNP) are 
considered a good model for studying skin penetration of nanoparticles [58, 86, 134]. 
They have unique optical properties. They show distinctive extinction bands in the 
visible region, due to surface plasmon oscillation of free electrons [114]. This 
property allows for tracking the physical state of the particles under different 
conditions throughout the experiment and for their detection in human skin. AuNP 
have also high clinical significance due to their ability to deliver various payloads [5, 
23-24] such as drug molecules [25], large biomolecules, such as proteins [28], DNA 
[29-30], or RNA [31]. Moreover, AuNP cause local heating when they are irradiated 
with light in the visible range allowing for the potential use of AuNP in photothermal 
destruction of tumors [22]. 
In an earlier study, we reported on the consequences of topical exposure to two 
selected polar and apolar gold nanoparticles in regard to their effect on skin 
metabolism and penetration into deeper layers of human skin using multiphoton 
tomography and fluorescence lifetime imaging [55]. The present work, however, is a 
mechanistic study of the penetration of nanoparticles into human skin using a full 
matrix of particles of different surface polarity, size and vehicle. In addition, 
concentration of applied nanoparticles, skin exposure time, physical state of the 
particles on skin exposure and skin integrity were investigated. 
 
3.4.2. Materials and Methods 
Preparation of AuNP. Sterically stabilized, apolar gold nanoparticles (AuNP1) were 
synthesized from an organometallic precursor. The synthetic procedure was adapted 
from Zheng et al. [158]. Gold nanoparticles were formed upon reduction of the gold 
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source by an amine-borane complex in the presence of an alkyl thiol. In a typical 
synthesis, 0.31 g chlorotriphenylphosphine gold (purity 98%, ABCR, Karlsruhe, 
Germany) was dissolved in 50 ml of benzene (purity >99.5%, Riedel-de Haen, 
Germany) forming a colorless solution. A mixture of 0.53 g tert-butylamineborane 
(purity, 97%, Fluka, Germany) and 0.31 ml dodecanethiol (purity >98%, Fluka, 
Germany) were added to the formed solution and left to react at 55°C for 1 hour. 
Upon completion of the reduction reaction, the red solution was cooled to room 
temperature, precipitated by the addition of ethanol and washed by centrifugation 
and subsequent resuspension in toluene. Finally, the particles were resuspended in 
toluene and stored at room temperature protected from light. 
Phase transfer of apolar AuNP1 into water. AuNP1 were transferred into water using 
an emulsification method. A solution of 10 g lecithin (Pure lecitine (98% 
phospholipids), Boma-Lecithin GmbH, Otter, Germany) in 400 ml water was 
prepared and stirred overnight to ensure complete dissolution. About 40 ml of the 
AuNP dispersion in toluene was added to the solution and the mixture was shaken 
and further emulsified at the maximum energy of an ultrasonic bath (Elmasonic 
S100H, Elma GmbH & Co KG, Singen, Germany) for 5 min and at half its maximum 
energy for 15 min, followed by heating it to 90°C under stirring for 1 h. This 
procedure was repeated several times to ensure emulsification and toluene 
evaporation. Unemulsified parts of the AuNP dispersion were separated from the 
mixture and emulsified separately using additional sonication steps. Finally, AuNP2 
dispersion with hydrophilized surface was stirred at 90°C until all toluene had 
evaporated leaving a clear red aqueous solution. 
 
Ionically-stabilized, polar gold nanoparticles (AuNP3) were prepared according to 
Turkevich method [132]. Briefly, 70 ml solution of hydrogen tetrachloroaurate  
(HAuCl4·3H2O, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) containing 
about 100 µg/ml gold was first heated to boiling at 100°C under magnetic stirring at 
about 440 rpm and then reduced by a solution of trisodium citrate dihydrate 
(Na3C6H5O7·2H2O, Sigma-Aldrich) containing 5-fold the molar concentration of the 
gold salt. All solutions were used without filtration. After the gold colloid had formed, 
the temperature was lowered to about 25°C. The colloid was then transferred into a 
suitable glass container and stored in the refrigerator protected from light. 
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Phase transfer of polar AuNP3 into toluene. The method of phase transfer followed 
the protocol published by Zhu et al. [171] after several modifications. Practically, a 
volume of thioglycolic acid (TGA) (C2H4O2S, 99%, Sigma-Aldrich Chemie GmbH, 
Steinheim, Germany) equivalent to 1.29x10-3 moles was added to 2 ml of AuNP 
dispersion, with a concentration of 99.05 µg/ml gold and stirred until the solution gets 
purple, indicating chemical bonding of –SH group of TGA onto the surface of AuNP. 
N-cetyl-N,N,N-trimethylammonium bromide (cetrimide) (C19H42BrN, Merck KGaA, 
Darmstadt, Germany) was then introduced to the AuNP dispersion portionwise while 
stirring. The molar ratio between TGA and cetrimide is 2:1. Stirring was continued for 
30 min to allow for the adsorption of surfactant molecules through electrostatic 
interaction between TGA and cetrimide. A volume of 2 ml toluene was then mixed 
with the dispersion for 10 min, resulting in O/W emulsion. Finally, 2 ml ethanol, 
containing 0.21 M cetrimide, was added to break the emulsion, in addition to 3 ml 
toluene for better extraction of AuNP with hydrophobized surface. The whole two-
phase system was vigorously shaken for 20 min. Ethanol is miscible with water, thus 
the dissolved cetrimide further coat AuNP that are still in the aqueous phase 
resulting in more particles transfered into toluene. Extracted AuNP in toluene were 
further treated with cetrimide. A weight of cetrimide equivalent to 6.86 x 10-6 moles is 
required for each 1 ml of prepared AuNP4 dispersion to keep it stable over a 
prolonged period of time. 
 
Characterization of the optical and colloidal properties for the prepared AuNP. 
The optical properties of prepared AuNP were checked using a UV/Vis 
Spectrophotometer (lambda 35, Perkin Elmer, Rodgau-Jürgesheim, Germany) in the 
range of 400-800 nm. The mean particle size and the morphology of the gold core 
were determined by transmission electron microscopy (TEM) using a JOEL Model 
JEM 2010 instrument (JOEL GmbH, Eching, Germany) operated at an accelerating 
voltage of 120 kV. Core diameters determined by TEM were used as particle size 
facilitating comparison of particle diameters as hydrodynamic radius is only available 
in aqueous solution. Samples for TEM analysis were prepared by placing 12 µL drop 
of dispersed nanoparticles in water on carbon-coated 400 mesh copper grid. The 
solvent was allowed to evaporate slowly at room temperature. Finally, the surface 
charge of AuNP2 and AuNP3 was estimated by measuring the zeta potential based 
Labouta, HI et al., Nanoscale, 3 (2011) 4989-4999                               Publications 
 
-100- 
 
on the electrophoretic mobility (Zetasizer Nano, Malvern Instruments, Malvern, UK). 
The prepared dispersions (1.5ml) were directly measured (solvent is water) in 
triplicate using disposable folded capillary cells that contained the electrodes. 
Measurements were done at room temperature. Since particle dispersion in the non-
polar solvent, toluene, in case of AuNP1 and AuNP4, would not allow for 
development of surface charge (though a value near zero could be measured by 
zetasizer), this was denoted as ―uncharged‖ in Table 3.4.1. 
 
Table 3.4.1: Characteristics of the prepared AuNP dispersions. 
AuNP 
code 
Surface 
chemistry 
Diameter of gold core* 
[nm] 
Zeta potential** 
[mV] 
Vehicle 
AuNP1 Dodecanethiol 6.00 ± 0.81 Uncharged Toluene 
AuNP2 Lecithin ‖ -53.5 ± 1.44 Water 
AuNP3 Citrate ions 14.90 ± 1.76 -35.1 ± 1.87 Water 
AuNP4 cetrimide ‖ Uncharged Toluene 
* measured by TEM (n is more than 30). 
** given as a criterion indicating surface charge. 
 
Study of the penetration of AuNP through Human Skin. 
 
Skin preparation. Human skin was obtained from female patients aged 30 to 57 
years, who had undergone abdominal plastic surgery after approval of the ethic 
committee of Saarland, Germany (Ärztekammer des Saarlandes, Dec. 2008); three 
skin donors were used in the study. Adequate health and no medical history of 
dermatological disease were required. Immediately after excision, the skin was cut 
into pieces and the subcutaneous fatty tissue was removed from the skin specimen 
using a scalpel. Afterwards the surface of each specimen was cleaned with water, 
wrapped in aluminium foil and stored in polyethylene bags at –26°C until used. 
Previous investigations have shown that no change in the penetration characteristics 
occurs during the storage time of 6 months [159]. 
Skin discs, 25 mm in diameter, were punched out from frozen skin, thawed, cleaned 
with deionized water and transferred into the Franz diffusion model. 
 
Skin penetration study. In vitro penetration experiments were run in static Franz 
diffusion cells having a diffusion area of 1.76 cm2 and a receptor compartment of 12 
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ml volume. The prepared human skin was fastened carefully between the donor and 
receptor compartments, with the SC side up and held in place with a clamp. The 
dermal side of the chamber contained a receptor solution of phosphate buffer saline, 
pH 7.4 magnetically stirred at 500 rpm. A volume of 500 µl of the prepared AuNP 
dispersion was placed on the skin then the donor compartment was occluded. The 
diffusion cells were maintained at 32°C throughout the experiment. Following 
exposure, the skin was removed and the skin surface was gently cleaned with 
cotton. Collected skin was examined after longitudinal cryo-sectioning and the donor 
solution was analyzed directly by UV/Vis spectroscopy to determine the physical 
state of the particles following skin contact.  
Additional penetration experiments involved skin pre-exposure to toluene (vehicle) or 
chloroform/methanol mixture (discussed later) or tape-stripping of the stratum 
corneum before application of particle dispersion. Infrared densitometry was used for 
determining the endpoint of tape-stripping, i.e. complete SC removal, a method 
described by Hahn et al. [172].  
 
Longitudinal skin cryo-sectioning. Cross-sections of ~10 μm thickness were 
performed at −20°C using a SLEE cryostat type mev (SLEE medical GmbH, Mainz, 
Germany). It is important to note here that on sectioning, the skin piece should not 
be placed tangential to the blade to avoid dislocation of the particles from outside 
into DSL or vice versa, but in a perpendicular direction to the cutting blade limiting 
sectioning artifacts. Skin sections were placed on microscopical slides and were 
stored at −20°C until imaged by multiphoton laser scanning microscopy. Before 
examination, specimens were mounted by an aqueous mounting medium 
(FluorSaveTM reagent, Calbiochem, San Diego, USA) and covered with glass cover 
slips. At least 20 cuts were used for microscopical examination. 
 
Multiphoton laser scanning microscopy. Fluorescence imaging was performed using 
an inverted confocal/two photon excitation fluorescence microscope (ZEISS LSM 
510 META, Carl Zeiss, Jena, Germany), equipped with a tunable pulsed IR laser 
(λ=720-930 nm) (Chameleon, Coherent, Dieburg, Germany) for multiphoton laser 
microscopy, in addition to other conventional laser lines for confocal microscopy. The 
objective used was water immersion lens 63X (NA=1.2). A wavelength of 800 nm 
was used for both excitation of AuNP and scanning the skin using a transmission 
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energy of 0.485 and 0.647 mW in the focal plane, respectively. The optical settings, 
discussed in detail earlier [55], allowed for the separation of both signals with no 
signal interference among tracks. Z-stacks of the skin samples were taken with steps 
every 1 μm. Each optical scan is composed of 512 x 512 pixels² and a size of 0.14 x 
0.14 µm². The gain settings were adjusted for each measurement individually. No 
significant photobleaching has been observed in our experiments under the 
conditions used to quantify penetration. 
 
Data analysis. Multiphoton images of the longitudinal skin sections were then 
analyzed using the software by the supplier. Semiquantitative data for the distribution 
of AuNP in different skin layers were extracted as published earlier. Shortly, z-stacks 
were adopted for analysis. For each optical layer, the intensity was first thresholded 
in order to remove the background. Pixels due to luminescence of AuNP were 
determined in the SC and in the DSL for this optical layer. Summing up these values 
in all the optical layers of the z-stack ends up with ∑pixel frequency due to AuNP in 
the SC and in DSL of this z-stack, from which the weighed number of particles were 
calculated according to Equation 3.4.1, where Apixel = 0.139 x 0.139 µm² and Aparticle 
(area of diffraction-limited AuNP) =~0.365 µm2 for the optical settings used in this 
study as detailed elsewhere [134]. It should be noted here that the summed value 
developed by data analysis is regarded as a semi-quantitative index to compare 
penetration into the SC and DSL under the same conditions as well as for different 
formulations and conditions. Summed values were found more informative than 
mean values (±SD) due to the non-homogeneous distribution of the particles 
throughout the diffusion area. In other words, a summed value on analysis of x 
number of image fields offers a relatively more rigid and resistant parameter to the 
great variability of particle localization.  
 
particle
pixel
A
APixel
wN
            
Equation 3.4.1 [134], 
Finally, maximum penetration depths could be also determined for these skin 
experiments. 
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Study of the vehicle effect on skin penetration of AuNP. 
 
i. Gravimetric analysis 
 
(a) Preparation of epidermal sheets. 
 
Heat-separated human epidermal sheets were prepared from specimens of full 
thickness human skin of 15 or 25 mm diameter according to Kligman and  
Christophers [173]. Shortly, full thickness human skin was immersed in water of 
60°C for 90 seconds. The epidermis was then carefully peeled off the dermis using 
forceps.  
 
(b) Determination of the wet and dry weights of the epidermis. 
 
Heat-separated epidermal sheets are then carefully dried using a filter paper and 
weighed on Teflon sheets. This represents the wet weight of the epidermis. 
Epidermal sheets were then dried for two days in a desiccator at room temperature 
then weighed once more to obtain the dry weight of the epidermis. 
 
(c) Determination of lipid amount extracted by toluene. 
 
Epidermal sheets, prepared from 25 mm skin punches, were fitted in static vertical 
Franz diffusion cells having a diffusion area of 1.76 cm2 and a receptor compartment 
of 12 ml volume. The receptor compartment was filled with phosphate buffer saline, 
pH 7.4 and magnetically stirred at 500 rpm. A volume of 500 µL toluene was used as 
a donor solution for 0.5, 2, 6 and 24 h and the donor compartment was occluded. At 
the end of the skin exposure time, the donor solution was filtered and dried under 
nitrogen. Dried lipid extracted by the donor solution was then placed in a desiccator 
overnight and weighed for the lipid amount. 
 
(d) Determination of the total epidermal lipid content. 
 
Another set of epidermal sheets, prepared from 15 mm skin punches, were used to 
determine the total amount of lipid present in the epidermis of this skin donor having 
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the same diffusion area as in Franz diffusion experiment. Each epidermal sheet was 
extracted with 5 ml chloroform/methanol, 2: 1 in well-closed test tubes for 24 h under 
mild shaking. As described above, solutions were filtered, dried and lipid amounts 
were weighed. 
 
ii. High performance thin layer chromatography (HPTLC) 
 
Dried lipid extracts of 2 h skin exposure were then redispersed in 100 µl toluene or 
chloroform /methanol, 2: 1 and a volume of 1-5 µl of the lipid extract was spotted on 
silica gel 60-HPTLC plates (Merck KGaA, Darmstadt, Germany) along with 1 µl spots 
of standard solutions containing serial concentrations of cholesterol, cholesteryl 
oleate, glyceryl trioleate, oleic acid and ceramide NP (a ceramide consisting of a 
nonhydroxy N-acyl fatty acid and phytosphingosine). A maximum of 8 spots are 
applied on each plate of 20 x 10 cm dimensions. Plates are then separated into two 
groups according to the developing system. The first group was developed using the 
following sequential development system: (1) n-Hexane: diethyl ether: acetic acid 
(80:20:10) for a distance of 12 cm from the spotting level, (2) n-hexane for 14 cm 
distance, for separation of cholesterol, oleic acid, triglycerides and cholestryl ester. 
The plates were allowed to dry before the second development step. The second 
group of plates were developed using chloroform: methanol: acetic acid (95:4.5:0.5) 
for separation of skin ceramides. All plates were then dried and sprayed with a 
solution 10% CuSO4 in 8.5% H3PO4 under nitrogen flow. The plates were then 
placed on a thermoplate of preadjusted temperature of 110°C and heated until 
160°C. Separated lipid fractions were then quantified using IR densitometry using 
Image J (version 1.43, available as freeware from http://rsbweb.nih.gov/ij/). Area 
under the curve was calculated for all the separated spots and quantification was 
based on the known quantities of the co-migrated standards used to develop a 
calibration curve. 
 
3.4.3. Results and Discussion 
 
Monodisperse gold nanoparticles, AuNP1 and AuNP3, with ~ 6 and 15 nm diameter, 
respectively, were successfully prepared. AuNP1 were uncharged, thiol coated and 
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dispersed in toluene. On the contrary, AuNP3 were negatively charged due to 
stabilization with citrate ions and dispersed in water. In order to study the effect of 
surface polarity, vehicle nature, in addition to size of nanoparticles on their skin 
penetration, each of the prepared AuNP1 and AuNP3 were transferred into water 
and toluene, respectively, using a suitable phase transfer agent, as indicated in the 
experimental section. The surface chemistry was therefore changed accordingly 
keeping the core size unchanged hence having same-sized particles of different 
surface polarity and different vehicle stability. All AuNP were fully characterized. The 
characteristics of the prepared AuNP are summarized in Table 3.4.1 and their TEM 
images are shown in Figure 3.4.1. 
Prepared and characterized AuNP were then applied to excised human skin at 
different concentrations and skin exposure times (Table 3.4.2). After skin penetration 
experiment, skin punches were longitudinally sectioned and analyzed using 
multiphoton microscopy (Figure 3.4.2), an efficient technique to track the penetration 
of nanoparticles in skin [55, 85, 115, 134, 174]. All AuNP formulations could 
penetrate the SC into the DSL after 24 h of skin exposure, except for AuNP3. It 
should be noted here that though penetration of AuNP was observed not being 
homogenous throughout the examined longitudinal sections, conclusion was made 
based on repetitive observation as indicated in the methodology section. 
Representative optical z-stacks, 1 µm nominal step width, for all examined 
longitudinal skin sections were then quantified by calculation of signal pixel 
frequency due to AuNP in the stratum corneum (SC) and deeper skin layers (DSL) 
for each optical layer. Finally a summed value of pixels (∑pixel) due to AuNP in each 
the SC and DSL were calculated. From this parameter the weighed number of 
particles was calculated [134]. Therefore this method takes into account the non-
homogeneous distribution of AuNP all over the diffusion area and is not depending 
on one image field only. Results showed depth-profiles for AuNP having higher 
values in the upper skin layer, SC, decreasing reaching DSL (Figure 3.4.3). The 
following factors were found critical in skin penetration of nanoparticles. 
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Table 3.4.2: Conditions of skin penetration experiments for the prepared AuNP dispersions. 
AuNP 
code 
Concentration 
[µg/ml] 
Time of skin exposure 
[h] 
AuNP1 
90 0.5, 2, 6 and 24 
437 0.5, 2, 6 and 24 
AuNP2 90 24 
AuNP3 90 24 
AuNP4 90 24 
 
 
Effect of size and surface polarity of AuNP. The physicochemical attributes of 
nanoparticles are key factors governing their skin penetration and permeation. 
Overlaid multiphoton/transmission microscopy images of longitudinal sections from 
skin specimens after 24 h exposure to 90 µg/ml concentration of AuNP1-4, different 
in size and surface chemistry are shown in Figure 3.4.2. Only hydrophilic, citrate-
stabilized, 15 nm diameter AuNP3 were shown not to penetrate the SC into  
DSL [55]. 
Interestingly, surface modification of AuNP3 using thioglycolic acid and cetrimide, 
resulted in AuNP4 with hydrophobic surface showing skin penetration into deeper 
layers. A similar pattern was observed for the smaller particles, AuNP1 and AuNP2. 
Surface modification of hydrophobic AuNP1 using lecithin yielded hydrophilic AuNP2 
with lower skin penetration ability under the experimental conditions, as indicated by 
the number of AuNP in the SC and DSL in representative optical z-stacks of the 
respective 10 µm thickness longitudinal skin sections examined by multiphoton 
microscopy (Figure 3.4.3a). Therefore, nanoparticles with more hydrophobic 
character, AuNP1 and AuNP4, were more favorable for skin penetration. This 
indicates that nanoparticles, in this size range, follow the same penetration pathways 
postulated for the penetration of drug molecules. However their particulate nature will 
reduce the speed of diffusion [42] through the intercellular route dominated mainly by 
fluid lipidic pores [175].  
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Figure 3.4.1: TEM images of prepared (a) AuNP1 (6 nm thiol-coated AuNP, dispersed in toluene), (b) 
AuNP2 (6 nm lecithin-coated AuNP, dispersed in water), (c) AuNP3 (15 nm citrate-stabilized AuNP, 
dispersed in water) and (d) AuNP4 (15 nm cetrimide-coated AuNP, dispersed in toluene). 
 
(a) (b) 
(c) (d) 
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Figure 3.4.2: Selected overlaid multiphoton/transmission images of AuNP (indicated as green 
pseudo-colored spots) in longitudinal skin sections in which the stratum corneum (SC) is outlined by 
a white line to separate it from the deeper skin layers (DSL). Skin sections were obtained from skin 
punches exposed for 24 h to (a) AuNP1 (6 nm thiol-coated AuNP, dispersed in toluene), (b) AuNP2 (6 
nm lecithin-coated AuNP, dispersed in water), (c), AuNP3 (15 nm citrate-stabilized AuNP, dispersed 
in water) and (d) AuNP4 (15 nm cetrimide-coated AuNP, dispersed in toluene). As indicated in the 
figure, exclusive localization of nanoparticles in the SC for AuNP3 and penetration of AuNP1, AuNP2 
and AuNP4 into the DSL at variable penetration depths were observed. 
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Figure 3.4.3: The effect of the physicochemical parameters of nanoparticles, the vehicle and skin 
integrity on skin penetration of AuNP as extracted from optical layers of z-stacks (1 µm step width) 
of longitudinal skin sections imaged by multiphoton microscopy. (a) Skin penetration of AuNP1 (6 nm 
thiol-coated AuNP, dispersed in toluene), AuNP2 (6 nm lecithin-coated AuNP, dispersed in water), 
AuNP4 (15 nm cetrimide-coated AuNP, dispersed in toluene) at a concentration of 90 µg/ml of gold 
after 24 h of skin exposure. (b) Skin penetration of AuNP3 (15 nm citrate-stabilized AuNP, dispersed 
in water) on 22 h skin exposure following 2 h pre-exposure to toluene in comparison to skin 
penetration of AuNP1 and AuNP4 dispersed in toluene into the SC and DSL after 24 h of skin 
exposure. (c) Effect of 2 h pre-exposure to toluene “1” in comparison to removal of skin lipids using 
chloroform/methanol mixture, 2:1 “2” and to complete removal of the SC by tape stripping “3” on 
skin penetration of AuNP3 into DSL after 22 h of skin exposure. 
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Smaller sized AuNP1 and AuNP2, 6nm in diameter, showed higher skin penetration 
than 15 nm AuNP3 (no penetration into DSL) and AuNP4, as shown in Figure 3.4.3a. 
A similar pattern was also reported for drug penetration where high molecular weight 
compounds could penetrate the SC to a less extent than small molecules [176]. 
Though our results are partly contrary to the findings of Sonavane et al. [45] who 
showed skin permeation of AuNP, 15 nm in diameter after only 1 h (they used rat 
skin of different histology than human skin in our study), their results also indicated 
size-dependent skin permeation. According to them, higher permeation for 15nm 
AuNP compared to 102 nm and 198 nm AuNP was indicated and the permeability 
coefficient was reported to decrease on increasing the particle size. Another report 
also indicated skin penetration of latex nanoparticles of 50, 100, 200 and 500 nm 
diameter in a size-dependent manner [170].  
 
Effect of the physical state of AuNP dispersion. The physical state of the applied 
nanodispersion, whether composed of individual particles or aggregated ones, is 
considered critical and should be analyzed carefully in parallel with skin penetration 
study. This is to avoid any misinterpretation of the results in regard to the 
significance of particle size as a determinant of skin penetration. Here AuNP serve 
as a good model whose Plasmon band provides precise and easily accessible 
information on the aggregation state of the colloidal gold. Aggregation is indicated by 
a big red-shift of the spectral peak and/or strong peak broadening [161]. Therefore, it 
was important to analyze the applied AuNP dispersion spectrophotometrically before 
and after skin penetration experiment (Figure 3.4.4). At the beginning of the skin 
experiment, all applied AuNP dispersions showed physical stability. No significant 
red-shift was observed for the test nanodispersions AuNP1, AuNP2 and AuNP4, 
applied at a concentration of 90 µg/ml, after 24 h of skin contact. However, after 24 h 
of skin exposure, aggregation was observed for AuNP3 (hydrophilic, citrate-
stabilized and 15 nm in diameter) as evident from peak broadening (Figure 3.4.4c). 
The zeta potential also increased by about 2-fold. Aggregation of AuNP3 could be 
attributed to the exchange of citrate ions on the surface of gold nanoparticles with 
skin proteins or lipids, as shown in other biological environments [166, 177]. This 
could be also due limited citrate ionization in the slightly acidic pH of the skin 
surface. This overnight aggregation further decreased the availability of single 
Labouta, HI et al., Nanoscale, 3 (2011) 4989-4999                               Publications 
 
-111- 
 
dispersed particles of higher probability to penetrate the SC into DSL (Figure 3.4.2). 
On the other hand, all other particles (AuNP1, AuNP2 and AuNP4), penetrating the 
SC (Figure 3.4.2), showed no significant aggregation following skin contact (Figure 
3.4.4a, b, d).  
 
Effect of the vehicle of AuNP dispersion. Away from the physicochemical 
properties of nanoparticles, the vehicle is known to influence skin penetration 
profiles. Hence this effect also should hold true for nanoparticle penetration. 
Unfortunately, this effect of the vehicle was usually disregarded in skin penetration 
studies of nanoparticles. Here, however, the effect of the vehicle was in the focus of 
this study. AuNP1 and AuNP4 were dispersed and applied in toluene, in comparison 
to AuNP2 and AuNP3 (water). Therefore, the effect of toluene under the applied 
experimental conditions on the intercellular lipids of the SC, providing the main 
barrier function [175], was investigated. The percentages of lipid extracted from heat 
separated epidermal sheets on applying toluene for exposure times between 0.5 - 24 
h, relative to the dry weight of the epidermis were determined by gravimetry (Table 
3.4.3). These values were compared (as a percentage) to the total lipid content in 
the equivalent epidermal area for this skin donor (extracted by chloroform/methanol 
mixture, 2:1 after 24 h incubation), also calculated with respect to the dry weight of 
the epidermis. As shown in Table 3.4.3, a percentage of about 8 – 17% of the total 
epidermal lipid content was extracted by toluene. However, a closer look to the 
standard deviation values, one could conclude that the amount of lipid extracted by 
toluene is time-independent, i.e. the amount of lipid extracted after 0.5 h is not 
significantly different than that after 24 h. 
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Figure 3.4.4: UV/Vis spectra of (a) AuNP1 (6 nm thiol-coated AuNP, dispersed in toluene), (b) AuNP2 
(6 nm lecithin-coated AuNP, dispersed in water), (c) AuNP3 (15 nm citrate-stabilized AuNP, dispersed 
in water) and (d) AuNP4 (15 nm cetrimide-coated AuNP, dispersed in toluene) at a concentration of 
90 µg/ml of gold, showing particle stability before and after 24 h of skin contact. 
 
Table 3.4.3: Gravimetric analysis of toluene lipid extract of heat separated epidermis after 0.5, 2, 6 
and 24 h exposure time versus total epidermal lipids. 
Incubation time [h] 
% lipid extracted with 
respect to dry skin wt 
% lipid extracted with 
respect to total epidermal 
lipids 
0.5 2.43±0.08 7.82±0.26 
2 3.20±1.25 10.29±4.02 
6 2.79±1.89 8.97±6.08 
24 5.32±3.29 17.08±10.60 
Control (total 
epidermal lipids) [a] 
31.13±3.55  
 [a] determined by shaking the epidermal sheets with chloroform/methanol mixture, 2:1 for 24 h) 
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Furthermore, the barrier function of the SC depends not only on the lipid quantity in 
the SC but also on the lipid composition. The main lipid classes in the SC are 
ceramides, cholesterol and fatty acids. Detection of triglycerides in the SC has been 
explained in literature either by contamination with sebum glycerides or by extraction 
of subcutaneous fat. Other lipid ingredients present in minute amount include 
cholesterol esters [175, 178]. The quantitative composition of the SC lipids differs 
depending on the extraction method [179] and inter- and intraindividual variations. 
Among all the lipid members, ceramides are known to be the most important 
component of the SC multilamellar lipid structure with defined physicochemical 
properties necessary for the barrier function of the skin [178]. After 2 h of skin 
exposure, epidermal lipid members extracted by toluene or chloroform/methanol 
mixture (total lipid extract) were quantified using HPTLC versus increasing serial 
concentrations of standard lipid mixture. The lipid composition of each extract was 
then determined by densitometric analysis and the results are shown in Figure 3.4.5. 
Toluene could extract the surface lipids, however the structural lipids of the SC, 
ceramides, were not extracted by toluene. In contrast ceramides were found in the 
total lipid extract of this skin donor.  
Nevertheless, it could be concluded so far that toluene has an effect on the barrier 
function of the SC through lipid extraction. However, a drastic structural change in 
the skin barrier on toluene application is not likely, evident by the absence of 
ceramides in the toluene extract. Afterwards, it was important at this stage to 
determine whether the penetration of AuNP1 and AuNP4, dispersed in toluene, was 
mainly due to the effect of toluene on the barrier function of the skin, or this is only a 
contributing factor. Therefore, further skin penetration experiments were conducted, 
preincubating the skin with 500 µl toluene for 2 h, followed by application of non-
penetrating AuNP3, dispersed in water. The number of AuNP penetrating into the SC 
and DSL in a representative z-stack of a 10 µm thickness skin section was 
semiquantified according to a method we published recently [134] and the result was 
compared to that due to application of AuNP1 and AuNP4, dispersed in toluene, at a 
concentration of 90 µg/ml for 24 h (Figure 3.4.3b). It was found, however, that the 
number of AuNP penetrating into DSL was 16- and 7-fold higher for AuNP1 and 
AuNP4, respectively. This indicates that penetration of nanoparticles did not depend 
mainly on the vehicle, toluene. Yet, it is a complex mechanism depending on several 
parameters; and removal of SC lipids enhances the penetration ability. 
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Figure 3.4.5: Lipid composition of toluene extract of heat separated epidermis after 2 h of skin 
exposure time (a) versus total lipid extract using chloroform/ methanol mixture, 2: 1 (b). 
 
Effect of formulation ingredients. Skin penetration of nanoparticles should not be 
studied without considering formulation factors. Ingredients used in synthesis of 
nanoparticles could have an influence on their interaction with the skin when present 
in the dispersion. However, previous studies did not always take these factors into 
account when discussing nanoparticles penetration. This raises a question, whether 
nanoparticles do passively penetrate the SC due to their small size or this is a result 
of the physicochemical attributes of the nanoparticles as well as formulation, 
environmental and mechanical factors. In this study, chemicals used in particle 
synthesis could affect the skin hence possibly favoring more skin penetration 
including dodecanethiol and tert-butylamineborane (AuNP1), and thioglycolic acid 
(AuNP4). Furthermore, lecithin and cetrimide used in the preparation of AuNP2 and 
AuNP4, respectively are considered as penetration enhancers [104]. However, 
based on the amounts used relative to those described in literature [104, 180-181], 
they are assumed not to contribute much in skin penetration of nanoparticles. Yet, 
this is only an assumption and possibility for contribution is not discarded. 
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Effect of deteriorating the barrier function of the SC. In general, damaged skin is 
assumed to facilitate penetration. Hence, additional experiments were carried out to 
determine the effect of deteriorating the skin barrier function (i.e., the SC) on 
penetration of nanoparticles. AuNP3, shown not to penetrate the SC, were chosen 
for these experiments. The results were compared to skin penetration of AuNP3 after 
2 h skin pre-exposure to toluene.  
(1) Skin lipids were removed by treating the skin surface with 1 ml of 
chloroform/methanol mixture, 2: 1 for 22 h. HPTLC of the applied mixture showed 
extraction of the epidermal lipids: ceramides, cholesterol, fatty acids (oleic acid), 
triglycerides and cholestryl ester (cholestryl oleate) (data not shown). Removal of 
epidermal lipids was then followed by application of AuNP3 for further 22 h. 
However, it should be noted here that in order to set-up such an experiment a total of 
44 h skin treatment was required (22 h for removal of epidermal lipids, followed by 
22 h exposure to AuNP3). This would contribute to the penetrated amount due to 
decreased skin integrity [94]. Therefore, a supplementary experiment was performed 
which involves application of AuNP3 for only 2 h after skin treatment with 
chloroform/methanol mixture for 22 h, i.e. a total of only 24 h skin experiment. 
(2) SC was completely removed by 30 times tape stripping followed by application of 
AuNP3 for 22 h. The experimental setup was carefully adjusted to insure that the 
stripped skin area is the same area exposed to nanoparticles. At the end of the 
penetration experiment, the skin surface was cleaned before further sectioning and 
examination by multiphoton microscopy. 
As shown in Figure 3.4.3c, removal of the skin lipids using chloroform/methanol 
mixture resulted in AuNP3 penetrating the SC after 22 h of skin exposure. Even on 
skin exposure to AuNP3 for 2 h (Data not shown), 2-fold increase in penetration into 
the DSL was observed, compared to skin penetration of AuNP3 after 2 h skin pre-
exposure to toluene. This again confirms that as for drug molecules, the intercellular 
lipids are the main barrier for skin penetration of nanoparticles. Intercellular 
localization of nanoparticles was previously reported for QD [79, 89].  
On the other hand, for tape-stripping, previous reports did not show satisfactory 
results concerning particle penetration on the tape stripping part of the SC for QD of 
diameter ~ 4 nm [52], 6 nm [90] and ~ 37 nm [47] through human (20 tape-strips), rat 
(10 tape-strips) and mouse (5-20 tape-strips) skin, respectively. In this study, 
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complete removal of the SC by tape-stripping resulted, however, in about 16-fold 
further increase in penetration into DSL. This would rather indicate that the barrier 
function of the SC to particle penetration does not only rely on the intercellular lipids, 
however it is a complex mechanism that overall provides the rate-limiting step to 
penetration of nanoparticles. 
For both conducted experiments, the number of AuNP3 penetrating into DSL was 2- 
and 53-fold, respectively, higher than that after 2 h exposure to toluene (Figure 
3.4.3c). This again supports our previously drawn conclusion that toluene does have 
an effect on skin penetration of AuNP, however it is only a contributing factor and not 
the main factor. 
 
Effect of concentration of applied AuNP dispersion and skin exposure time. All 
studies investigating skin penetration of nanoparticles so far based their conclusion, 
whether the particles are penetrating or not on a single point concentration. This 
does not imply that their conclusion applies for dispersions with higher or lower 
concentrations leaving the reader sometimes with a degree of uncertainty about the 
results. This also partly explains the current controversy among researchers on the 
status of skin penetration of nanoparticles. Moreover, the time of skin exposure to 
nanoparticles is very critical on studying possible skin penetration of nanoparticles 
since they diffuse slower. Yet, variable exposure times, e.g. 0.5 [182], 5 [115], 6 
[169], 18 [183] and 24 [60] h, were reported in literature for in vitro particle 
penetration studies. Only few studies checked skin penetration on different time 
intervals. For instance, Baroli et al. [53] studied the penetration of magnetic 
nanoparticles through human skin after 3, 6, 12 and 24 h in which penetration was 
indicated by TEM images starting from 6 h skin exposure to the applied 
nanodispersion. 
In this study, AuNP1 were applied on skin with two different concentrations, 90 and 
437 µg/ml of gold, for exposure times of 0.5, 2, 6 and 24 h (Table 3.4.2). AuNP1 in 
both concentrations could penetrate the SC at 24 h. Applying AuNP1 dispersion with 
a concentration of 437 µg/ml resulted in higher number of AuNP in z-sections of 
longitudinal skin sections of 10 µm thickness in the SC as well as in DSL (Figure 
3.4.6). For the two tested concentrations, incubation time showed a strong effect on 
the amount of AuNP penetrating into the SC and DSL. An exposure time of 6 h was 
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required for AuNP1 with a concentration of 90 µg/ml to permeate the SC whereas 2 
h were enough for the high concentration AuNP dispersion (437 µg/ml) to penetrate 
into the DSL though this was a negligible amount. The longer the skin exposure time, 
the larger the amount of AuNP1 penetrating into the SC and DSL (Figure 3.4.6). This 
is also attributed to the amount of particles necessary to be detected favoring high 
concentrations to be visualized. 
Maximum penetration depths of AuNP1 inside the skin were further determined for 
these skin penetration experiments (Table 3.4.4). The same trend was also observed 
on changing the concentration and the skin exposure time. The higher the 
concentration and/or the longer the skin exposure time, the longer the distance that 
could be travelled by AuNP1 inside the skin. The longest penetration depth by 
AuNP1 in DSL after crossing the whole thickness of the SC was 51.38 µm (Table 
3.4.4). Knowing that the average thickness of the viable epidermis is 50-100 µm 
[184], particles could only reach the viable epidermis of human skin after 24 h of skin 
exposure. Longer exposure times could be needed for the particles to penetrate 
more into the dermis however skin penetration experiments were terminated at 24 h 
to avoid loss of skin integrity [94]. 
 
On further analysis of Figure 3.4.6, one could observe a gradually increasing 
difference between the densities of particle localization in the DSL for the two applied 
concentrations with time, reaching maximum at 24 h. This could be attributed to: 
(a) The higher the concentration of the nanodispersion the more the particles are 
available for penetration leading to much more particle accumulation in the deeper 
skin layers. 
(b) The higher concentration dispersion requires also a shorter exposure time (2 
h) than that at low concentration (6 h) to cross the stratum corneum (Table 3.4.4) 
leading to a higher cumulative concentration of particles in the deeper skin layer.  
It should be noted here that the whole area of the deeper skin layer in the image field 
is included in analysis. This means that the concentration measured is a more or 
less ―cumulative‖ concentration. 
Based on this, care should be taken on meta-analysis of the available literature on 
skin nanoparticle penetration. This means that extrapolation of the studies based on 
a single concentration or a short exposure time to indicate safety of nanoparticles or 
the opposite case should be avoided 
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Figure 3.4.6: Effect of concentration of applied AuNP1 (6 nm thiol-coated AuNP, dispersed in 
toluene) and skin exposure time on their penetration into the SC (a) and to DSL (b) after 24 h of skin 
exposure. 
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Table 3.4.4: Maximum skin penetration depths of AuNP1 (6 nm thiol-coated AuNP, dispersed in 
toluene) in 90 and 437 µg/ml concentration after 0.5, 2, 6 and 24 h of skin exposure, normalized to the 
thickness of the SC (i) and penetration depth inside DSL after crossing the whole thickness of SC (ii). 
(i) 
Incubation time [h] 
a Percentage depth of SC penetrated by AuNP1,% 
90 µg/ml 437 µg/ml 
0.5 48.55 77.99 
2 92.65 100 
6 100 100 
24 100 100 
a 
Percentage SC penetrated= penetration depth in SC / thickness of SC x 100 
 
(ii) 
Incubation time, h 
b Penetration depth of AuNP1 in DSL, µm 
90 µg/ml 437 µg/ml 
0.5 0 0 
2 0 23.86 
6 7.21 29.82 
24 35.72 51.38 
b 
Penetration depth in DSL = Total penetration depth - thickness of SC 
 
 
3.4.4. Conclusions 
As for drug molecules, the main barrier for particle penetration is the SC lipids, 
however it is not only the intercellular lipids that limit penetration of particles but the 
whole microstructure of the SC with its tortuous intercellular aqueous and lipidic 
channels. Furthermore, the varying polarities of the skin layers further reduce 
permeation into deeper skin layers. AuNP are expected to penetrate mainly through 
intercellular pathways. This penetration behavior is primarily dependent on their 
physicochemical attributes, of which the size is the most significant determinant of 
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penetration where 6 nm AuNP showed a greater extent of penetration than 15 nm 
AuNP. Similar to drug penetration, the surface hydrophobicity was also found as an 
important factor favoring skin penetration. This again implies that nanoparticles at 
this size range (6-15 nm) behave similar to drug molecules in permeation through 
the skin barrier but to a lower extent. On the other hand, the vehicle was found to 
have a minimal effect on skin penetration of AuNP.  
Skin exposure time was also found to be of crucial impact. Incubation times of at 
least 6 h were required to have a significant penetration extent for studying the effect 
of the different physicochemical, formulation and environmental factors. Shorter 
exposure time is thus not recommended by the authors for conducting experiments 
focusing on determination of skin penetration of nanoparticles. For a certain skin 
exposure time, the concentration of the applied nanodispersion could greatly 
influence or even determine the status of skin penetration of nanoparticles, whether 
they could be detected or not in the DSL. This should be regarded in future studies. 
The results obtained in this study are of great importance especially for the basic 
understanding of the interaction of nanoparticles with the skin barrier. 
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3.5. Could chemical enhancement of gold nanoparticle penetration 
be extrapolated from established approaches for drug permeation? 
 
Hagar I. Labouta, Labiba K. El-Khordagui and Marc Schneider 
 
In due publication.(submitted) 
 
Abstract 
Investigations on chemical enhancement of skin penetration of gold nanoparticles 
are considered crucial not only for the high clinical significance, but also for 
designing an ideal nanocarrier for transdermal drug delivery and to have a deeper 
insight into the main barrier of particle penetration. In this study, penetration of gold 
nanoparticles in presence of several chemical enhancers -urea, sodium lauryl 
sulphate, polysorbate 80 and dimethyl sulphoxide (DMSO)- through human skin was 
studied. Among the tested chemical enhancers, DMSO could induce the penetration 
of hydrophilic (citrate-stabilized) gold colloid of no intrinsic penetration ability, in a 
concentration-dependent manner. Pretreatment of the skin with DMSO however 
reduced penetration of hydrophobic (thiol-coated) gold nanoparticles as a result of 
aggregation in the top layers of the stratum corneum limiting penetration into the 
deeper skin layers. In addition, nanoparticles-vehicle interaction and the stability of 
the nanoparticles in the applied vehicle were found important determinants of skin 
penetration. Our results demonstrate that the already established approaches for 
chemical permeation enhancement of drug molecules and their postulated 
mechanisms could be used as preliminary guidelines for enhancing the penetration 
of nanoparticles. At this size range, 15 nm, intercellular lipids provide the main 
barrier to particle permeation through the stratum corneum. 
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3.5.1. Introduction 
The main barrier of the skin resides in the stratum corneum (SC) due to its complex 
micro- and macrostructure. Several pathways are postulated for drug transport 
across the skin including intercellular, intracellular and transappendageal pathways, 
of which the intercellular route is regarded as the most likely route for transdermal 
drug permeation. In this context, the barrier function of the SC against penetration of 
drugs or molecules in general depends mainly on the intercellular lipids [175]. 
Currently, the most widely used approach to drug permeation enhancement is the 
use of chemical penetration enhancers with already several theories and postulated 
mechanisms of action of the different classes of chemical enhancers in favoring 
transdermal drug permeation. They work mainly by temporarily reducing the barrier 
function of the SC allowing for more drug transport [104]. 
Skin penetration of nanoparticles in presence of these chemical enhancers would be 
of interest to evaluate if data from skin penetration enhancement of drug molecules 
can be extrapolated to particles. Among formulation factors influencing skin 
penetration, stand both the vehicle nature and vehicle-nanoparticles interaction as 
important parameters that should be carefully studied. In this context, changing the 
vehicle composition together with investigating the effect of chemical permeation 
enhancers on skin penetration of nanoparticles would ultimately lead to more insight 
into the possible barrier of skin penetration of nanoparticles. Kuo et al. [85] studied 
the effect of oleic acid and ethanol on the penetration of zinc oxide nanoparticles 
(Ø = 10 nm) through mouse skin. They showed enhanced transport values for 
nanoparticles in presence of oleic acid, ethanol and oleic acid-ethanol mixture. 
However, no penetration of quantum dots (Ø = 37 nm) was observed on 
pretreatment of mouse skin with acetone [47]. Yet, in these two studies, mouse skin, 
known to have different penetration and structural characteristics than human skin, 
was used as the skin model. 
The aim of this work was therefore to study the penetration of gold nanoparticles 
(AuNP) through human skin in presence of selected chemical enhancers from 
different classes: Urea (amide), sodium lauryl sulphate (SLS) (anionic surfactant), 
polysorbate 80 (non-ionic surfactant) and dimethyl sulphoxide (DMSO) 
(sulphoxide/solvent) proved effective in promoting transdermal drug permeation. 
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AuNP were used as a model due to their multiphoton-induced luminescence [134]. 
Hydrophilic citrate-stabilized AuNP, 15 nm in diameter at a gold concentration of 90 
µg/ml (2.7 x 1012 particles/ml) were selected for this study, since they were shown to 
lack an intrinsic ability to penetrate human skin after 24 h skin contact [55]. 
Furthermore, the enhancement of penetration of hydrophobic AuNP was studied.  
 
3.5.2. Materials and methods 
Preparation of AuNP. Ionically-stabilized, polar gold nanoparticles (AuNP1) were 
prepared according to Turkevich method [25, 132]. Briefly, 70 ml solution of 
hydrogen tetrachloroaurate (HAuCl4·3H2O, Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany) containing about 100 µg/ml gold was reduced by trisodium citrate 
dihydrate (Na3C6H5O7·2H2O, Sigma-Aldrich) containing 5-fold the molar 
concentration of the gold salt at 100°C. 
 
Phase transfer of AuNP into toluene. Thioglycolic acid (TGA) (Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany) equivalent to 1.29x10-3 moles was added to 2 
ml of AuNP dispersion, with a concentration of 198.1 µg/ml gold and stirred until the 
solution gets purple. Cetrimide (Merck KGaA, Darmstadt, Germany) was then 
introduced to the AuNP dispersion. The molar ratio between TGA and cetrimide was 
2:1. Stirring was continued for 30 min to allow for the adsorption of surfactant 
molecules through electrostatic interaction between TGA and cetrimide. The 
dispersion was then mixed with 2 ml toluene for 10 min, resulting in O/W emulsion. 
Finally, 2 ml ethanol, containing 0.21 M cetrimide, was added to break the emulsion, 
in addition to 3 ml toluene for better extraction of AuNP2 with hydrophobized surface. 
The whole two-phase system was vigorously shaken for 20 min. Extracted AuNP in 
toluene were further treated with cetrimide (6.86 x 10-6 moles for each 1 ml of AuNP 
dispersion) to enhance stability. 
Characterization of the optical and colloidal properties for the prepared AuNP. 
The optical properties of prepared AuNP were checked using a UV/Vis 
Spectrophotometer (lambda 35, Perkin Elmer, Rodgau-Jürgesheim, Germany) in the 
range of 400-800 nm. The mean particle size and the morphology of the gold core 
were determined by transmission electron microscopy (TEM) using a JOEL Model 
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JEM 2010 instrument (JOEL GmbH, Eching, Germany) operated at an accelerating 
voltage of 120 kV. Finally, the surface charge was estimated by measuring the zeta 
potential based on the electrophoretic mobility (Zetasizer Nano, Malvern 
Instruments, Malvern, UK). 
 
Study of the penetration of AuNP through human skin. 
Skin preparation. Healthy human skin was obtained from female patients, who had 
undergone abdominal plastic surgery after approval of the ethic committee of 
Saarland, Germany (Ärztekammer des Saarlandes, Dec. 2008). Immediately after 
excision, the subcutaneous fatty tissue was removed from the skin specimen using a 
scalpel. Afterwards the surface of each specimen was cleaned with water, dried, 
wrapped in aluminum foil and stored in polyethylene bags at –26°C until use. 
Previous investigations have shown that no change in the penetration characteristics 
occurs during the storage time of 6 months [159]. 
Skin discs, 25 mm in diameter, were punched out from frozen skin, thawed, cleaned 
with water and transferred into a Franz diffusion cell. 
Skin penetration study. In vitro penetration experiments were run in static Franz 
diffusion cells having a diffusion area of 1.76 cm2 and a receptor compartment of 12 
ml, containing phosphate buffer saline, pH 7.4 magnetically stirred at 500 rpm. A 
volume of 500 µl of AuNP dispersion was placed on the skin then the donor 
compartment was occluded. The diffusion cells were maintained at 32°C throughout 
the experiment. Following exposure, the skin was removed and the skin surface was 
gently cleaned with cotton. Collected skin was examined after longitudinal cryo-
sectioning. 
 
Longitudinal skin cryo-sectioning. Cross-sections of 10 μm thickness were 
performed at –26 °C using a cryomicrotome (Slee, Mainz, Germany). The skin punch 
was placed in a perpendicular direction to the cutting blade piece to avoid dislocation 
of the particles from outside into DSL or vice versa, thus limiting sectioning artifacts 
[134]. Skin sections were placed on microscopical slides and mounted by an 
aqueous mounting medium (FluorSaveTM reagent, Calbiochem, San Diego, USA) 
and covered with glass cover slips. 
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Multiphoton Laser Microscopy. Imaging was performed using an inverted 
confocal/two photon excitation fluorescence microscope (ZEISS LSM 510 META 
system, Carl Zeiss, Jena, Germany). The objective used was water immersion lens 
63X (NA=1.2). A wavelength of 800 nm was used for both excitation of AuNP and 
scanning the skin using an energy of 0.485 and 0.647 mW, respectively. The optical 
settings, discussed in detail earlier [55], allowed for separation of both signals with 
no signal interference among tracks. Z-stacks of the skin samples were taken with 
steps every 1 μm. Each optical scan is composed of 512 x 512 pixel2 and a size of 
0.14 x 0.14 µm2. The gain settings were adjusted for each measurement individually. 
Data analysis. Detailed description of the method of analysis is published earlier 
[134]. In short, semiquantitative data for the distribution of AuNP in the SC and DSL 
were extracted based on calculation of ∑pixel frequency due to AuNP in the optical 
layers, 1 µm thickness, of the respective z-stacks of the examined longitudinal skin 
sections. These values were then used to calculate the total number of AuNP in the 
SC and DSL according to Equation 3.5.1: 
 
particle
pixel
A
APixel
wN
            
Equation 3.5.1 [134], 
,where Apixel = 0.139 x 0.139 µm² and Aparticle (area of diffraction-limited AuNP) 
=~0.365 µm
2 for the optical settings used in this study as detailed elsewhere [134]. 
 
3.5.3. Results and discussion 
AuNP1 (hydrophilic, negatively charged (zeta-potential -35.1±1.87 mV), citrate-
stabilized, Ø = 14.90±1.76 nm) were shown earlier not to penetrate the SC into DSL 
(deeper skin layers) [55]. Skin penetration of AuNP1 was studied in presence of 
different chemical enhancers at concentrations reported in literature to enhance 
transdermal drug permeation, as shown in Table 3.5.1. AuNP1 were stable for at 
least 2 days in all the tested systems (data not shown). 
Figure 3.5.1a shows the behavior of AuNP1, at a concentration of 90 µg/ml, when 
topically applied on human skin dispersed in 5% urea solution. The particles can be 
found exclusively within the SC. Hence, Urea was found ineffective to drive AuNP to 
penetrate into DSL. Urea is known to promote transdermal drug permeation by 
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facilitating hydration of the SC and formation of hydrophilic diffusion channels, and 
by acting on the SC corneocytes (protein deformation). Yet, urea itself is a 
hydrophilic compound of no lipid disruption mechanism [104]. This suggests that the 
intercellular lipids represent the barrier to skin penetration of hydrophilic AuNP1. 
Moreover, as suggested for drugs [185], the physicochemical parameters of the 
nanoparticles and the chemical enhancer should be considered on selecting an 
appropriate enhancer, for example, the penetration of hydrophilic nanoparticles 
maybe increased by using a lipophilic enhancer. On the other hand, the aggregation 
state of the applied nanodispersion, is considered critical and should be analyzed 
carefully in parallel with skin penetration study. Aggregation of AuNP is indicated by 
a big redshift of the spectral peak and/or peak broadening [161]. Aggregation of 
AuNP result in big redshift of λmax. Depending on the number of particles in the 
aggregate, the shift can easily exceed 150 nm [161].  This is in addition to significant 
peak broadening. Weisbecker et al. [186] calculated the AUC from 600 to 800 nm as 
a marker for broadening of gold colloids. As shown in Figure 3.5.2, AuNP1 in water 
aggregate on skin contact (an index higher than 6 is assumed to indicate strong 
aggregation). Similarly, topical application of AuNP1 in 5% urea solution for 24 h 
resulted in strong aggregation and precipitation of AuNP (Figure 3.5.2). This reduces 
the ability of the nanodispersion to penetrate through the SC into DSL. 
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Table 1: Conditions of skin penetration experiments for the prepared AuNP dispersions, at a 
concentration of 90 µg/ml. 
Nanoparticles 
code 
Chemical enhancer* 
Concentration of 
chemical enhancer 
[%] 
Skin exposure 
time to AuNP 
dispersion, [h] 
AuNP1** 
- - 24 
Urea 5 24 
Sodium lauryl sulphate 
(SLS) 
5 24 
Polysorbate 80 5 24 
Dimethyl sulphoxide 
(DMSO) 
20 24 
50 24 
80 24 
 - 
22 (after 2 h 
exposure to 
100% DMSO) 
AuNP2*** 
 - 24 
 - 
22 (after 2 h 
exposure to 
100% DMSO) 
*added to the nanodispersion. 
**hydrophilic, citrate-stabilized AuNP, ~15 nm in diameter 
***hydrophobic, coated with thioglycolic acid and cetrimide, ~15 nm in diameter. 
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Figure 3.5.1 (a-c): Overlaid multiphoton/transmission images of AuNP1 (indicated as green spots) at 
a concentration of 90 µg/ml in longitudinal skin sections, showing exclusive localization of AuNP in the 
SC (stratum corneum) when applied in 5% concentration of urea (a) or SLS (sodium lauryl sulphate) 
(b) after 24 h of skin exposure or penetration of minute amounts into DSL (deeper skin layers) in case 
of polysorbate 80, 5% in concentration (c). 
 
 
 
 
(a) (b) 
(c) 
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Figure 3.5.1 (d-g): Overlaid multiphoton/transmission images of AuNP1 (indicated as green spots) at 
a concentration of 90 µg/ml in longitudinal skin sections. AuNP1 applied in 20% (d), 50% (e) and 80% 
DMSO (dimethyl sulphoxide) (f) for 24 h, as well as pre-exposure of the skin to 100% DMSO for 2 h, 
followed by 22 h exposure to AuNP1 (g) resulted in permeation of AuNP1 of the SC (stratum 
corneum) into DSL (deeper skin layers). 
 
  
(d) (e) 
(f) (g) 
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Figure 3.5.2: Plasmon peak broadening over wavelengths from 600 to 800 nm of AuNP1 in the 
prepared polysorbate 80, SLS (sodium lauryl sulphate), urea and DMSO (dimethyl sulphoxide) at a 
concentration of 90 µg/ml and redshift of the respective maximum wavelength compared to that of 
AuNP1 dispersion in water, designated as ―control‖, as markers for particle stability before and after 
24 h skin contact. 
 
As an alternative strategy, anionic (SLS) and non-ionic (polysorbate 80) surfactants 
were investigated as potential chemical penetration enhancers for nanoparticles 
through human skin. The use of cationic surfactants was excluded due to possible 
electrostatic interaction with the negatively charged AuNP1. SLS and polysorbate 80 
are water-soluble with fatty acid moieties, lauric and oleic acid, respectively, 
providing a lipophilic character for better penetration of the nanoparticles. However, 
both applied surfactants, applied at a concentration of 5% (above critical micelle 
concentration ―CMC‖) were found ineffective for driving AuNP1 to penetrate the SC 
in considerable amounts (Figure 3.5.1b, c). 
In general, the mechanisms of action of the different classes of surfactants for 
promoting drug permeation are still not clear. Yet, the action of anionic surfactants, 
including SLS, on skin was previously postulated to be mainly due to their ability to 
interact with and bind to epidermal proteins, thus causing a reversible denaturation 
and an uncoiling of the filaments, exposing more water binding sites, possibly 
increasing the hydration level of the tissue. This is in addition to possible effect on 
the lipid organization above CMC concentration, though penetration into the skin lipid 
channels is likely hindered by micelle formation [187]. On the other hand, nonionic 
surfactants, e.g. polysorbate 80 were generally reported to have little effect in 
AUC (600-800 nm) relative to control  
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promoting percutaneous drug absorption. Unexpectedly, however, minute amounts 
of AuNP were found in DSL in case of polysorbate 80 but not on applying AuNP1 in 
SLS solution. This observation could be related to the aggregation behavior of the 
AuNP1 in surfactant solutions on topical application. The different chemical 
enhancers after being in contact with the skin affected the plasmon resonance peak 
of the particles. Peak broadening of AuNP1 in presence of SLS after 24 h of skin 
contact, as well as the big redshift of λmax (111 nm) is a clear indication of 
aggregation (Figure 3.5.2). This would rather limit the probability of skin penetration 
due to the bigger sized objects. On the other hand, aggregation was also observed 
in case of polysorbate 80, but to a lesser extent (Figure 3.5.2). Nevertheless, 
application of AuNP1 in surfactant solutions was not an effective strategy in 
promoting skin penetration of nanoparticles in this study. 
Therefore, it was important at this stage to choose a penetration enhancer with an 
evident effect on the intercellular lipids. DMSO is a solvent that is absorbed into the 
corneocytes changing the keratin conformation. However, at a concentration ≥ 60%, 
DMSO has an additional evident effect on the intercellular lipid domains. It causes 
reversible disorder or fluidization of the lipid structure of the SC. It forms 
microcavities within the lipid bilayers and increases the drug partitioning across the 
skin [188]. DMSO has a long clinical history of topical use to treat allergy, 
inflammation, especially in combination with NSAIDs; the applied concentrations 
varies largely reaching to 90 or 100% concentration [189-194]. 
AuNP1 were applied in DMSO solutions of 20 and 50% concentrations on human 
skin for 24 h, in which the main mechanism of penetration enhancement should be 
through the effect of DMSO on skin proteins resulting in higher intracellular transport. 
AuNP1 was also applied in a higher DMSO concentration, 80% to study the effect of 
lipid fluidization on penetration of AuNP1. For these three experiments, there was a 
possible change in the surface properties of AuNP that could also have an influence 
on penetration. Therefore, another skin experiment was conducted involving skin 
exposure to DMSO (100%) for 2 h followed by application of AuNP1 in water for 
another 22 h to study the intrinsic effect of DMSO. 
All skin penetration experiments involving the use of DMSO as a chemical 
penetration enhancer resulted in penetration of AuNP1 into DSL (Figure 3.5.1d-g). 
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The sum of the pixels due to gold luminescence was then determined in the SC and 
DSL in representative optical z-stacks, 1 µm thickness for each layer, of the 
examined longitudinal skin sections and finally the weighed number of AuNP in the 
SC and DSL was calculated using a method we developed earlier [134]. Results of 
semiquantitative analysis are shown in Figure 3.5.3. In all skin experiments, more 
AuNP were found in the SC rather than DSL. Depending on the concentration of 
DMSO, variable amounts of AuNP penetrated into the SC and DSL. Application of 
AuNP1 in 20% resulted in 261 and 38 fold increase in the SC and DSL, respectively, 
compared to control AuNP1 (no penetration). Increasing the concentration of DMSO 
from 20 to 50% resulted in 1.4 and 1.6 fold further increase in the amount of AuNP 
penetrating into the SC and DSL, respectively. This is possibly due to looser and 
more permeable SC. An equivalent increase in DMSO concentration from 50 to 80% 
resulted however in more pronounced skin penetration of AuNP into the SC and DSL 
(3.1 and 5.7 fold, respectively). This underlines the expectation that as for drug 
molecules, intercellular lipids provide the main barrier to penetration of nanoparticles. 
 
Figure 3.5.3: Effect of DMSO (dimethyl sulphoxide) in a concentration of 20%, 50% and 80% on skin 
penetration of AuNP1, at a concentration of 90 µg/ml into the SC (stratum corneum) and DSL (deeper 
skin layers) on 24 h skin exposure, in comparison to pre-exposure of the skin to 100% DMSO for 2 h, 
followed by 22 h exposure to AuNP1, expressed as the total number of AuNP in optical layers, 1 µm 
thickness, of 10 µm longitudinal skin sections imaged by multiphoton microscopy. 
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Spectrophotometric analysis of the applied AuNP1 in DMSO dispersions was also 
performed in parallel with skin penetration study in order to determine the physical 
state of nanoparticles under the variable experimental conditions. Results of 
spectrophotometric analysis, shown in Figure 3.5.2, indicate the stability of AuNP1 in 
DMSO solutions on skin contact compared to control AuNP1 dispersion without 
DMSO. This is evident from the only small plasmon redshifts of 8, 11 and 17 nm for 
the applied AuNP1 in 20, 50 and 80% DMSO, respectively after 24 h contact with 
human skin in addition to unobvious peak broadening (Figure 3.5.2). However, 
application of hydrophilic citrate-stabilized AuNP without DMSO on human skin 
resulted in clear aggregation, as shown in Figure 3.5.2. This indicates that DMSO 
increased the stability of AuNP1 and prevented their aggregation when coming in 
contact with the skin surface. This represents an additional mechanism by which 
DMSO favors skin penetration of AuNP1 into DSL from these applied dispersions 
keeping the number of single dispersed nanoparticles high. On the other hand, 
application of AuNP1 dispersion on human skin following 2 h skin exposure to 
DMSO does not prevent aggregation of nanoparticles as shown by peak broadening 
in Figure 3.5.2. This explains the decrease in the population of AuNP that could 
penetrate into the SC by 1.4 fold compared to those on application of AuNP1 in 80% 
DMSO solution. This also explains an even higher decrease in AuNP penetration 
into the DSL, relative to all other experiments involving application of AuNP1 in 
DMSO solutions (Figure 3.5.3). This is despite the fact that DMSO at this high 
concentration, 100%, acts on both the corneocytes’ keratin and the intercellular lipids 
compromising the barrier function of the SC to a great extent. This implies that 
nanoparticles-vehicle interaction is a critical determinant of skin penetration of 
nanoparticles and should be carefully considered when choosing a suitable chemical 
penetration enhancer. This is of even more importance as the particle aggregation is 
not instantaneous and hence might be overlooked. 
The results so far show that DMSO is effective as a skin penetration enhancer for 
the hydrophilic nanoparticles, AuNP1. Therefore, it was employed in further 
experiments were conducted to investigate the effect of the physicochemical 
properties of nanoparticles on skin penetration enhancement mechanism using 
hydrophobic AuNP2, prepared by phase transfer of AuNP1 into toluene using 
thioglycolic acid and cetrimide. AuNP2 are uncharged and of the same core-
diameter as for AuNP1. However, due to instability of AuNP2 in DMSO even at very 
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low concentration, 2.4% (data not shown), AuNP2 was applied on human skin for 22 
h after 2 h pre-exposure to DMSO. The weighed number of AuNP in the SC and in 
DSL in a representative optical z-stack of the examined longitudinal skin sections 
were then determined. The results were compared to those of a control experiment 
involving skin exposure to AuNP2 for 24 h in absence of DMSO as shown in Figure 
3.5.4a. Skin exposure to DMSO for 2 h before AuNP2 application resulted in 1.6 and 
1.5 fold decrease in the number of AuNP penetrating into the SC and DSL, 
respectively, relative to the control experiment. This is despite the fact that AuNP2 in 
the donor compartment was stable on skin contact for 24 h (Figure 3.5.4b). It is 
assumed that DMSO could not enhance the penetration of the hydrophobic AuNP2 
as much as for hydrophilic particles since the intercellular lipids, fluidized by DMSO, 
are less barrier to their transport than for the hydrophilic nanoparticles, AuNP1. Yet, 
the decrease in skin penetration of AuNP2 following skin exposure to DMSO can be 
explained by the assumption that particle aggregation could have taken place in the 
upper layers of the SC due to absorption of a trace amount of DMSO during the pre-
incubation stage with the solvent. This would decrease the probability of their 
penetration into the deeper layers of the SC and furthermore into the DSL. To prove 
this assumption, circular discs of a dialysis membrane MW-cut-off 12-14 kDa 
(Medicell International Ltd, London, UK), 15 mm in diameter (the same skin 
exposure area in Franz diffusion experiment) were placed in small vials and exposed 
to aqueous solutions with increasing concentration of DMSO (0, 20, 50, 80 and 
100%) for 2 h. DMSO was then removed and the dialysis membranes in the vials 
were left to dry in the hood, then AuNP2 were added for another 22 h. At the end of 
the experiment, AuNP2 dispersions were analyzed using UV/Vis spectrophotometry 
and the results are shown in (Figure 3.5.5). The higher the initial concentration of the 
applied DMSO solution, the more aggregation of the nanodispersion was observed. 
This represents a proof of concept that the trace amount of DMSO absorbed into the 
upper layers of the SC which could not be removed by cleaning the skin surface 
resulted in aggregation of AuNP2. Hence penetration deeper inside the skin was 
hindered. 
 
In conclusion, chemical enhancement of skin penetration of gold nanoparticles could 
be extrapolated from already established approaches for transdermal permeation of 
drug molecules. In the size range of 15 nm, the intercellular lipids provide the main 
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barrier for penetration. As for drugs, the physicochemical attributes of nanoparticles 
and the chemical enhancer determine the success of the approach. However, the 
nanoparticles-vehicle interaction and the stability of the nanoparticles in the applied 
vehicle represent critical parameters in transdermal delivery of nanoparticles. 
 
 
Figure 3.5.4: (a) Effect of skin pre-exposure to 100% DMSO (dimethyl sulphoxide) for 2 h on skin 
penetration of AuNP2, at a concentration of 90 µg/ml into the SC (stratum corneum) and DSL (deeper 
skin layers) on 22 h skin exposure, expressed as the total number of AuNP in optical layers, 1 µm 
thickness, of a representative Z-stack in a 10 µm thickness longitudinal skin section imaged by 
multiphoton microscopy, in comparison to control skin penetration experiment of AuNP2 for 24 h.  
(b) UV/Vis spectra of AuNP2 at a concentration of 90 µg/ml showing particle stability before, 
designated as ―control‖, and after 24 h skin contact in comparison to their stability following 22 h 
contact with a skin pre-exposed to 100% DMSO for 2 h. 
 
 
Figure 3.5.5: Stability of AuNP2 dispersions of a concentration of 90 µg/ml after 22 h contact with 
dialysis membranes presoaked in increasing concentrations of DMSO (0-100%) in comparison to 
control AuNP2 dispersion. 
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3.6. Statements of effort 
ad publication 3.1 
The author of the thesis performed all the skin experiments, multiphoton microscopy, 
data analysis and interpretation, as well as writing the manuscript and planning for 
the experiments under the guidance of the supervisor and the other authors. Tobias 
Kraus was responsible for gold nanoparticles preparation and characterization. 
 
ad publication 3.2 
The author of the thesis prepared the gold nanoparticles, treatment of human skin 
with the prepared particle dispersion, preparation of all skin specimens for 
microscopy, multiphoton microscopy, data analysis, as well as writing the manuscript 
and planning for the experiments under the guidance of the supervisor and the other 
authors. Dr. Martina Hampel, Sibylle Thude and Katharina Reutlinger prepared the 
reconstructed human skin models. 
 
ad publication 3.3 
The author of this thesis prepared and characterized AuNP-Aq and performed 
thawed skin experiments (skin preparation, penetration experiments and multiphoton 
microscopy). Dr. Tobias Kraus was responsible for preparation and characterization 
of AuNP-TOL. Our partners from Australia performed the other experiments done on 
viable human skin (skin preparation, penetration experiments, cryosectioning, 
dermoscopy and reflectance confocal microscopy, TEM of skin samples). Both 
laboratories contributed equally in terms of practical work and writing the manuscript. 
 
ad publication 3.4 
The author of this thesis prepared and characterized AuNP3 and AuNP4. The author 
performed all the skin experiments, multiphoton microscopy, semiquantitative 
analysis, gravimetry and high performance thin layer chromatography, as well as 
writing the manuscript and planning for the experiments under the guidance of the 
supervisor and the other authors. Dr. Tobias Kraus was responsible for preparation 
and characterization of the two gold nanoparticles of diameter 6 nm. 
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ad publication 3.5 
The author of this thesis prepared the nanoparticles and characterized them, 
performed skin experiments, microscopy, data analysis, as well as writing the 
manuscript and planning for the experiments under the guidance of the supervisor 
and the other author. 
 
All the work done was directly supervised by Junior Prof. Dr. Marc Schneider, my 
principal supervisor. In addition, since the work done throughout the thesis was 
initially funded by the Egyptian government and the DAAD as a joint channel project, 
part of this work was also co-supervised by Prof. Dr Labiba K. El-khordagui, Dept. of 
Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt. 
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4.1. Results and discussion 
The potential ability of nanoparticles to overcome the skin barrier, attributed mainly 
to the stratum corneum (SC), has been the subject of recent research. Studying skin 
penetration of nanoparticles is considered crucial in the field of nanotoxicology, as 
well as on the basic research level for future pharmaceutical and clinical 
applications. 
We have established a method by multiphoton microscopy for investigating skin 
penetration of gold nanoparticles (AuNP) based on gold luminescence. The 
optimized optical settings allowed for the separation of both skin and gold signals 
with no signal interference among tracks. This was also confirmed by examination of 
control skin (Figure 4.1).  
  
  
Figure 4.1: Overlaid multiphoton/transmission images of AuNP (indicated as green spots) in 
longitudinal skin sections (b), in comparison to control longitudinal skin section (a). Multiphoton 
images of skin-treated with AuNP from the top view (d), in comparison to control skin (c). 
(a) (b) 
(d) 
SC 
DSL 
SC 
DSL 
(c) 
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A combined multiphoton imaging-pixel analysis approach was then developed for 
semiquantitation of AuNP population in the SC and deeper skin layers (DSL) in 
terms of pixels, from which the weighed number of particles could be calculated 
(Figure 4.2). This method offers a relatively higher degree of accuracy and more 
freedom on selecting the optical settings and thus overrides previous approaches 
involving intensity measurement of fluorescence [89] and confocal [52] images. The 
latter approach necessitates fixed optical settings for all the experiments. This would 
rather limit the imaging capability of nanoparticles deep inside the skin using optical 
sectioning. 
 
Figure 4.2: A schematic presentation of the combined multiphoton imaging-pixel analysis developed 
throughout the thesis [134].   
 
Further work has been directed to the determination of the imaging parameters of 
multiphoton microscopy in skin in terms of achievable detection depths and the 
resolution limit. Multiphoton microscopy was shown to be a promising non-invasive 
technique with some limitations. Factors such as skin compactness and presence of 
wrinkles were found to deteriorate the accuracy of depth profiling. Lateral 
(0.5±0.1μm) and axial (1.0±0.3μm) point spread functions (PSF) in reconstructed 
and human skin specimens were determined practically. Both determined values 
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were higher than experimental values determined in water [128], glycerol [129] and 
turbid media (gel and lipid emulsion) [130]. This was explained by the higher optical 
density of the skin as an imaging medium. Surprisingly, lateral and axial PSF did not 
deteriorate with depth. This was attributed to the low tissue compactness, in case of 
reconstructed human skin or due to dominance of optical distortions caused by the 
optical system along the relatively short detection depth (~14 µm) in human skin. 
More importantly, our results in human skin showed that AuNP could be tracked up 
to a shallow depth, ~14 µm, less than or equal to the average thickness of the SC 
due to scattering phenomenon in the heterogeneous skin tissue with depth, 
representing a major problem when tracking the penetration of nanoparticles into the 
DSL. According to our findings, examination of longitudinal skin sections was found 
more accurate and informative, rather than examination of non-sectioned skin from 
the top view. Therefore, longitudinal skin sections were used for further 
examinations. 
AuNP of diameter 6 and 15 nm differing in surface polarity and vehicle nature (water 
and toluene) were successfully prepared and characterized. Their penetration 
through the skin was studied using multiphoton microscopy after validating the 
method as discussed earlier. Before studying the penetration of nanoparticles 
through the skin barrier, the effect of two selected nanoparticle dispersions (citrate-
stabilized 15 nm AuNP in water and thiol-coated 6 nm AuNP in toluene) on the 
metabolic machinery of the skin was investigated using MP-FLIM (Multiphoton-
fluorescence life-time imaging microscopy). Our results showed that the viability of 
the epidermis was deteriorated with distinct morphological changes after skin 
exposure to toluene regardless of AuNP presence. This was also shown by TEM and 
dermoscopy. The toluene-extracts after skin application were then analyzed 
gravimetrically and by means of HPTLC (high performance thin layer 
chromatography). Toluene was shown to have an effect on the barrier function of the 
SC by means of lipid extraction. Yet, only about 17% of the epidermal lipids were 
extracted after 24 h of skin application. Moreover, there were no drastic changes in 
the intercellular lipid structure on toluene application. Ceramides, known as the most 
important component of the SC multilamellar lipid structure with definite 
physicochemical properties necessary for the barrier function of the skin [178], were 
not extracted by toluene. This was supported by further results of the skin 
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penetration experiments conducted in this thesis indicating that the vehicle did not 
have a major effect on the penetration of the prepared nanoparticles. 
Penetration studies involved skin application of four types of AuNP differing in size (6 
and 15 nm), surface chemistry and vehicle (water and toluene). Results indicated 
penetration of all applied AuNP after 24 h of skin exposure except for citrate-
stabilized AuNP, 15 nm in diameter. The physicochemical parameters were found 
key factors governing their skin penetration and permeation. Surface hydrophobicity 
of the nanoparticles was shown to favor skin penetration of AuNP through human 
skin. Citrate-stabilized ~ 15 nm AuNP could not penetrate human skin after 24 h of 
skin exposure. However, surface modification having cetrimide on the outer surface, 
i.e., hydrophobic surface, resulted in skin penetration into the deeper layers. A 
similar pattern was observed for smaller ~ 6 nm AuNP, in which surface modification 
of hydrophobic thiol-coated AuNP using lecithin yielded relatively hydrophilic AuNP 
with lower skin penetration ability under the same experimental conditions.  
Away from the particle physicochemical and formulation factors, concentration of the 
applied nanodispersion and skin exposure time could greatly influence the skin 
penetration of nanoparticles. We applied thiol-coated AuNP on human skin with two 
different concentrations, 90 and 437 µg/ml of gold, for exposure times of 0.5, 2, 6 
and 24 h. Both the amount of AuNP penetrating into the DSL and the penetration 
depth increased with higher concentration and longer skin exposure time. Some 
other studies investigated skin particle penetration on different time intervals. For 
instance, Baroli et al. [53] studied the penetration of magnetic nanoparticles through 
human skin after 3, 6, 12 and 24 hr, where particle penetration was reported starting 
from 6 h skin exposure time. Based on these studies, generalized conclusions 
indicating safety of nanoparticles on topical application or the opposite case, based 
on studying a single concentration, is inappropriate.  
The effect of deteriorating the barrier function of human skin by removal of the all 
epidermal lipids (using chloroform/methanol mixture) or by even total removal of the 
SC via tape-stripping on the skin penetration of citrate-stabilized 15 nm AuNP (no 
intrinsic penetration ability) was investigated. Removal of the epidermal lipids 
resulted in penetration of the tested AuNP indicating that the intercellular lipids are 
the main barrier for skin penetration of nanoparticles. Complete removal of the SC 
resulted, however, in about 28 fold further increase in penetration into DSL. This 
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would rather indicate that the barrier function of the SC to particle penetration does 
not rely only on the intercellular lipids but on the whole microstructure of the SC with 
its tortuous intercellular aqueous and lipidic channels. 
Finally, attempts to induce the penetration of citrate-stabilized 15 nm AuNP were 
conducted. Penetration in presence of selected chemical enhancers from different 
classes, urea (amides), sodium lauryl sulphate (SLS) (anionic surfactant), 
polysorbate 80 (non-ionic surfactant) and dimethyl sulphoxide (DMSO) (sulphoxides) 
was investigated. The nanoparticles-vehicle interaction and the stability of the 
nanoparticles in the applied vehicle were shown to be a critical parameter in 
transdermal delivery of nanoparticles. DMSO could significantly induce the 
penetration of the applied gold colloid, in a concentration-dependent manner. On the 
other hand, pretreatment of the skin with DMSO reduced the penetration of 
cetrimide-coated 15 nm gold nanoparticles. This was experimentally shown to be 
attributed to aggregation in the top layers of the stratum corneum limiting penetration 
into the deeper skin layers, since the latter particles were found unstable in DMSO 
solutions. In addition, nanoparticles-vehicle interaction and the stability of the 
nanoparticles in the applied vehicle were found important determinants of skin 
penetration.  
4.2. Conclusion 
Multiphoton microscopy was found a promising technique in tracking skin penetration 
of nanoparticles with several limitations. Hence, the results based on this technique 
should be interpreted with care. Our results showed that examination of longitudinal 
skin sections, though suffering possible sectioning artifacts, still provides more 
accurate information on the status of AuNP penetration rather than optical sectioning 
of skin specimens examined from the top. 
A combined multiphoton imaging-pixel analysis was successfully developed to 
semiquantify gold nanoparticles in the stratum corneum (SC) and DSL. Detection of 
gold nanoparticles in skin by multiphoton microscopy was based on gold 
luminescence. This experimental approach should be used as a tool in future studies 
to advance our basic understanding of nanoparticle interaction with the skin barrier. 
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As for molecules, the main barrier to particle penetration through the skin barrier was 
found to be the intercellular lipids. However, the whole microstructure of the SC with 
its intercellular aqueous and lipidic channels significantly limited particle penetration. 
This was shown from experiments performed using different grades of skin integrity. 
The penetration behavior was primarily dependent on their physicochemical 
attributes, of which the size is the most significant determinant of penetration where 
6 nm AuNP showed much higher extent of penetration rather than 15 nm AuNP. Our 
results however indicate a minimal effect of the vehicle on particle penetration. 
Furthermore, experimental considerations in setting-up a penetration experiment for 
nanoparticles were also studied. For instance, exposure times of at least 6 h are 
recommended for future studies on skin penetration of nanoparticles.  
Findings obtained in the thesis are very important for the basic understanding of the 
interaction of nanoparticles with the skin barrier. This would find future 
pharmaceutical and clinical applications, e.g. designing optimal topical and 
transdermal delivery systems. This has also a direct impact on the field of 
nanotoxicology, especially in the area of work-place exposure. 
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